The Gary Null Show
The Gary Null Show - 09.30.20

The Gary Null Show - 09.30.20

September 30, 2020

Ginkgo extends neuroprotective effects to the neurons located near the retinas

Gyeongsang National University (South Korea), September 29, 2020

In a recent study, South Korean researchers demonstrated the neuroprotective effects of Ginkgo biloba. They reported that an extract obtained from G. biloba leaves successfully protected retinal ganglion cells (RGC) — the output neurons of the retina — from hypoxic injury both in vivo and in vitro.

The researchers discussed their findings in an article published in the Journal of Medicinal Food.

Ginkgo biloba can prevent glaucoma caused by oxidative stress

The oldest records of G. biloba’s use in TCM suggest that only its seeds were used at first by traditional healers. It took a long time before they discovered the medicinal properties of G. biloba leaves and began using them to treat heart and lung diseases.

When G. biloba reached Western shores, its leaf extracts gained traction for their brain benefits. Standardized extracts of G. biloba leaves have since been used for the treatment of mild to moderate age-related memory impairment, dementia and peripheral vascular diseases.

According to the South Korean researchers, oxidative stress, or excess free radical production, induced by hypoxia — a condition in which tissues do not receive an adequate supply of oxygen — is linked to the pathogenesis of glaucoma. Glaucoma refers to a group of eye conditions that affect the optic nerve and is one of the leading causes of blindness among older adults.

Fortunately, recent findings show that G. biloba leaf extract (GBE) can help reduce oxidative stress as well as treat disturbed vascular circulation. To evaluate the neuroprotective effects of G. biloba, the researchers first induced oxidative stress in rat RGC. They then treated the cells with either a standardized GBE (EGb 761) or a control.

For their in vivo experiment, the researchers induced hypoxic optic nerve injury in rats by using a microserrefine clip with an applicator to clamp the animals’ optic nerves. They then gave the rats various concentrations of EGb 761 via intraperitoneal injection and measured RGC density to estimate cell survival.

The researchers reported that treatment with 1 or 5?mcg/mL EGb 761 significantly increased the survival of RGC after exposure to oxidative stress. In vivo, treatment with 100?mg/kg or 250?mg/kg EGb 761 also significantly improved RGC survival, proving the neuroprotective effects of G. biloba.

Based on these findings, the researchers concluded that G. biloba leaves can be used to protect against hypoxic injury that leads to glaucoma.

 

Dietary folate, magnesium, and dairy products may all help stave off bowel cancer

Service de Gastroenterologie (France), McGill University (Quebec), Erasmus University (Netherlands), September 29, 2020

Folate, magnesium, and dairy products may all help stave off bowel cancer, but there's no evidence that garlic or onions, fish, tea or coffee protect against the disease, finds an overarching analysis of published pooled data analyses in the journal Gut.

In the US alone around 1 in every 20 people is likely to develop bowel cancer at some point during their lifetime. And worldwide, more than 2.2 million new cases and 1.1 million deaths from the disease are predicted every year by 2030.

While deaths from the disease have been falling in most developed countries, the numbers of new cases have been rising in some, including in Canada, the UK, and the Netherlands.

Screening for the disease can pick up the disease at an early treatable stage, but take-up varies considerably from country to country. And as it takes more than 15 years for bowel cancer to develop, a healthy lifestyle likely has a key role in helping to halt or stop its progress altogether, say the researchers.

They therefore trawled relevant research databases for published systematic reviews and meta-analyses (pooled data analyses) of clinical trials and observational studies assessing the impact of dietary and medicinal factors on bowel cancer risk.

The medicinal factors included: aspirin; non-steroidal anti-inflammatory drugs (NSAIDs), such as paracetamol; and statins.

The dietary factors included: vitamins or supplements (magnesium, calcium, folic acid, vitamin A, B, C, E, D, β-carotene and selenium); coffee; tea; fish and omega 3 fatty acids; dairy products; fibre; fruit and vegetables; meat; and alcohol.

They included relevant studies published in French or English between September 1980 and June 2019, but excluded those involving people at high risk of developing bowel cancer. Some 80 articles out of a total of 343 were included in the overarching (umbrella) analysis of pooled data analyses.

The results showed that aspirin is likely protective against bowel cancer, lowering the risk by between 14% and 29% at doses as low as 75 mg/day, with a dose-response effect reported up to 325 mg/day.

NSAID use for up to 5 years was associated with a significant (26% to 43%) fall in the incidence of bowel cancer.

Magnesium intake of at least 255 mg/day was associated with a 23% lower risk compared with the lowest intake, and high intake of folic acid was associated with a 12-15% lower risk, although it wasn't possible to pinpoint a threshold dose from the available data.

Similarly, eating dairy products was associated with 13% to 19% lower risk of the disease. But the small number of available meta-analyses, and the many different research outcomes and variety of dairy products included make it difficult to draw firm conclusions about the quantities required to ward off the disease, caution the researchers.

Fibre intake was associated with a 22%-43% lower risk, while fruit/vegetable intake was associated with up to a 52% lower risk, with added benefit for every additional 100 g/day increase in intake.

Dietary soy intake was associated with a modest, but significant, fall (8-15%) in risk.

But there was no evidence that vitamins E, C, or multivitamins were protective. Similarly, there was no evidence that β-carotene or selenium helped stave off the disease.

The data were weak or equivocal on the impact of tea; garlic or onions; vitamin D either alone or combined with calcium; coffee and caffeine; fish and omega 3; and inconsistent on the protective effect of vitamin A and the B vitamins.

A modest protective effect was found in observational studies for high calcium intake, but a meta-analysis of clinical trial data found no protective effect, and even an increased risk.

Similarly, although meta-analyses of observational studies suggest that statins may lower cancer risk, no positive effect was noted in meta-analyses of clinical trial data.

Most of the available meta-analyses of observational studies reported an increased risk of between 12% and 21% for meat, particularly red and processed meat. Dose-effect studies reported a 10-30% increased risk for each additional 100 g/day of red meat eaten.

Alcohol was associated with a significantly increased risk. The higher the intake, the greater the risk. This was evident even at the lowest level of consumption studied: 1-2 drinks/day.

The researchers caution that the level of evidence is low or very low in most cases, mainly due to wide differences in study design, end points, numbers of participants, etc. And they were unable to define "an optimal dose and duration of exposure/intake for any of the products, even in the case of low dose aspirin and other compounds that have been extensively assessed," they point out.

Nevertheless, they suggest that their findings could help clinicians advise patients on the best diet to lower bowel cancer risk and guide the direction of future research.

Pomegranate improves mitochondria function and counters age-related disorders

Ecole Polytechnique Federale de Lausanne (Switzerland) September 27, 2020

With their vibrant scarlet color and sweet-but-tart flavor, pomegranate has become an increasingly popular (and delicious) addition to salads, dressings, beverages and desserts. They are also a proven superfood, credited by researchers with the potential to prevent and help resolve many disease conditions.

Now, a new Swiss study shows that urolithin A, a molecule produced when pomegranate is digested, could hold the key to rejuvenating cell mitochondria – and even prolonging the quality of your life. Let’s take a closer look at urolithin A – and its amazing restorative potential.

Pomegranate triggers urolithin A to rejuvenates the powerhouse of our cells

Mitochondria are tiny structures inside of cells that have the all-important task of turning fuel into energy. Over time, however, they can degrade and deteriorate.

In young, healthy cells, these aging and damaged mitochondria are swiftly broken down and eliminated. This beneficial process, known as mitophagy, helps to ensure optimal cellular function.

Mitophagy becomes less efficient with age, causing malfunctioning mitochondria to accumulate in cells – where they weaken muscle tissues and impair cellular health. Researchers believe that these deposits of mitochondrial debris can trigger degenerative disorders such as Parkinson’s disease, as well as decreased mobility and frailty in elderly people.

This is where pomegranates come in

A molecule called urolithin A is produced by the body upon the digestion of two polyphenols – punicalagins and ellagitannins – that exist naturally in pomegranates. In cell and animal studies, this newly-discovered molecule was shown to induce mitophagy, and prevent the accumulation of dysfunctional mitochondria.

In fact, new research supports the ability of urolithin A to actually rejuvenate cell mitochondria – not only increasing muscle function, but extending life.

What did the study show?

In a study published in 2016 in Natural Medicine, researchers found that urolithin A maintained mitochondrial respiratory capacity and extended the lifespan of C. elegans – a short-lived worm commonly used in longevity studies – by a stunning 45 percent.

And that isn’t all.

In another phase of the study, researchers administered urolithin A to aging mice, and found that it improved muscle function by 57 percent and running endurance by 42 percent.

And it was not only aging mice that benefited from urolithin A. The substance increased the running capacity of young, healthy mice – by a dramatic 65 percent.

The research suggests that boosting levels of urolithin A – through consuming pomegranate extracts – can enhance mitochondrial function, thereby improving muscle quality.

Researchers noted that this finding holds particular significance for elderly people. By helping to enhance muscle function, urolithin A may help ward off the loss of mobility and general decline that can accompany weakened muscle tissue.

Calling urolithin A a “promising approach to improving mitochondrial and muscle function in the aging population,” the team called for further research.

Pomegranate has a proven ability to combat heart disease and cancer

The new study is not the first to reveal important health benefits from pomegranates – these tasty members of the berry family have been impressing researchers with their ability to combat serious degenerative diseases.

In a recent review published in Advanced Biomedical Research, the authors noted that pomegranate can help prevent or treat a veritable laundry list of dangerous conditions known to trigger potentially life-threatening diseases – including high blood pressure, high cholesterol, oxidative stress, high blood sugar, atherosclerosis and inflammation.

Interestingly, in some cases pomegranate has been found to work in much the same way as pharmaceutical medications. For instance, pomegranate extracts help to suppress pro-inflammatory COX-2 and tumor necrosis factor-alpha – much as anti-inflammatory drugs do. And, when it comes to regulating blood pressure, pomegranate extracts seem to function like ACE inhibitors, a group of pharmaceutical hypotensive medications.

Pomegranates also have been shown in studies to reduce incidence of tumors, reduce the number and size of cancerous stem cells, and induce apoptosis – or cancer cell death. Pomegranate extracts are currently used to treat a variety of cancers, including those of the prostate, breast, colon, lung and skin.

Finally, pomegranate extracts have protective effects against neurodegenerative conditions. Research has shown that they help to prevent accumulations of beta-amyloid, a protein associated with Alzheimer’s disease.

Pomegranates owe much of their potent disease-fighting powers to their extraordinary antioxidant capabilities.

The juice of a single pomegranate contains more than 40 percent of the RDA of vitamin C – itself a potent antioxidant and immune system booster. Pomegranates are also rich in beneficial amino acids, polyphenols and anthocyanins – natural pigments that give the pulp its intense scarlet color. These colorful flavonoids also contribute to pomegranate’s ability to scavenge free radicals and prevent oxidative damage in cells and tissues.

And, wait, there’s more good news about pomegranates: no side effects or adverse changes have been reported – even in a clinical study in which participants received 1, 420 mgs a day of pomegranate fruit extract.

However, the researchers noted that pomegranate could interact with certain prescription drugs. Before supplementing with pomegranate extracts, consult a trusted, healthcare provider.

You can consume pomegranates in the form of various beverages – such as juice or tea – or nibble the luscious seeds out of hand as a snack. Pomegranate extracts are also available in the form of capsules and tablets.

By rejuvenating fragile, indispensable cell mitochondria, pomegranate can help combat the muscle weakness and frailty often associated with aging – leading to a stronger, longer life.

High-fiber diet, low level inflammation: Sidestepping the effects of radiation

Universities of Gothenberg and Lund (Sweden) and University of South Australia, September 29, 2020

Loved or hated, the humble oat could be the new superfood for cancer patients as international research shows a diet rich in fiber could significantly reduce radiation-induced gut inflammation.

Conducted by the University of Gothenburg, Lund University and the University of South Australia, the preclinical study found that dietary oat bran can offset chronic gastrointestinal damage caused by radiotherapy, contradicting long-held clinical recommendations.

Gastroenterology and oncology researcher UniSA's Dr. Andrea Stringer says the research provides critical new insights for radiology patients.

"Cancer patients are often advised to follow a restricted fiber diet. This is because a diet high in fiber is believed to exacerbate bloating and diarrhea—both common side effects of radiotherapy," Dr. Stringer says.

"Yet, this advice is not unequivocally evidence-based, with insufficient fiber potentially being counterproductive and exacerbating gastrointestinal toxicity. Our study compared the effects of high-fiber and no-fiber diets, finding that a fiber-free diet is actually worse for subjects undergoing radiotherapy treatment. A diet without fiber generates inflammatory cytokines which are present for a long time following radiation, resulting in increased inflammation of the digestive system. Conversely, a fiber-rich diet decreases the presence of cytokines to reduce radiation-induced inflammation, both in the short and the long term."

Intestinal issues following radiotherapy are problematic for many cancer survivors.

"In Europe, approximately one million pelvic-organ cancer survivors suffer from compromised intestinal health due to radiation-induced gastrointestinal symptoms," Dr. Stringer says.

"This is also commonplace in Australia and around the world with no immediate cure or effective treatment. If we can prevent some of inflammation resulting from radiation simply by adjusting dietary fiber levels, we could improve long-term, and possibly life-long, intestinal health among cancer survivors."

Poor bone quality is linked to poor heart health

Queen Mary University of London and University of Southampton, September 28, 2020

New research by Queen Mary University of London and the University of Southampton's Medical Research Council Lifecourse Epidemiology Unit (MRC LEU) has found associations between lower bone mineral density and worse cardiovascular health in both men and women.

Published in the Journal of Bone and Mineral Research, the study used the internationally unique UK Biobank cohort to investigate links between bone and cardiovascular health. They used a combination of imaging and blood biomarker data to investigate the relationship in the largest sample of people reported to date.

Osteoporosis and heart disease are important public health problems. These conditions share a number of risk factors such as increasing age, smoking, and a sedentary lifestyle. Research shows that there may be links between the two conditions even after accounting for shared risk factors. This suggests that there may be biological pathways linking the two conditions, and investigating these links could reveal targets for novel drug therapies. However, current research studies lack objective measures of bone and heart health and are often limited to studies of small numbers of people for relatively short periods of time.

The researchers found that lower bone density was linked to greater arterial stiffness (indicating poor cardiovascular health) in both men and women. They also found that individuals with poor bone health had an increased risk of dying from ischaemic heart disease. These links were not explained by shared risk factors or traditional cardiovascular risk factors. Interestingly, they found that the mechanisms underlying the bone-heart relationship appeared different in men and women.

Dr. Zahra Raisi-Estabragh, BHF Clinical Research Training Fellow from Queen Mary University of London, led the analysis. She said: "Our study demonstrates clear links between bone disease and cardiovascular health. The underlying pathophysiology of the bone heart axis is complex and multifaceted and likely varies in men and women."

Professor Nick Harvey, Professor of Rheumatology and Clinical Epidemiology at the MRC LEU, University of Southampton, who supervised the work added: "The wealth of information available in the UK Biobank permitted a highly detailed analysis of the complex interactions between musculoskeletal and cardiovascular health, helping to elucidate potential underlying mechanism, and informing novel approaches to clinical risk assessment."

Professor Steffen Petersen, Professor of Cardiology at Queen Mary University of London co-supervised the project. He comments: "Increasing our understanding of novel determinants of heart disease, such as the bone-heart axis, is key to improving disease prevention and treatment strategies and for improving population health."

Professor Cyrus Cooper, Director of the MRC LEU, University of Southampton, added: "This study directly complements our program of research investigating the lifecourse determinants of musculoskeletal health and disease. It illustrates the importance for the University of Southampton and the MRC LEU of our ongoing contribution to the leadership of the large, state-of-the-art, multidisciplinary Imaging Study as part of the unique world-leading UK Biobank resource."

Researchers Say THC From Cannabis May Treat Acute Respiratory Distress Syndrome, Study

University of South Carolina, September 24, 2020

Since Covid-19 first became a dangerous pandemic, many have wondered how cannabis use might factor into risk or healing for the deadly disease. While some immediately assumed cannabis was harmful, like tobacco, and others assumed it could cure or preventthe disease, scientists quickly began to explore the question.

Early research focused on the cannabinoid CBD as a potential treatment for cytokine storms and acute respiratory distress syndrome (ARDS) - a symptom in severe cases of Covid-19, which can lead to death. The results suggested that CBD may be an effective treatment, although human studies need to be conducted to confirm.

Now, researchers are exploring whether another popular cannabinoid, THC, might help with treating the novel coronavirus. And they suggest THC may actually be able to prevent Covid-19 from escalating into a fatal condition.

The new research from the University of South Carolina, Columbia investigated whether using THC might be able to prevent Covid-19 deaths. THC is the notorious chemical in cannabis that produces psychoactive effects like feeling ‘high’ or having an elevated mood. But it is also a highly medicinal chemical with potent anti-inflammatory and pain relieving traits.

In this case, researchers were looking to see if THC’s anti-inflammatory powers might be able to fight against cytokine storms and ARDS.

Cytokine storms are a dangerous symptom of Covid-19 (and other severe infections) which happens when the immune system goes overboard in its attempt to fight off an infection. Cytokines are normally part of a healthy immune response - triggering inflammation to fight against an infection. But when the infection is severe enough, our bodies can release way too many cytokines, and thus create a dangerous level of inflammation. This leads to ARDS, where breathing becomes difficult or even impossible. And cytokine storms can also lead to death from organ failure. Several studies point to CBD as a potential treatment for ARDS, and the FDA recently greenlighted clinical trials for a synthetic cannabinoid treatment for ARDS.

In the new research, scientists explored whether THC might be able to treat cytokine storms and ARDS, by studying its effects on mice.

In this animal model, researchers exposed two groups of healthy mice to a bacterial infection called Staphylococcus aureus or SEB. SEB is known to cause cytokine storms and ARDS in mice, and it almost always leads to death for those exposed. In this case, however, the researchers gave one group of mice a treatment of THC right after they infected them with SEB, along with doses 24 and and 48 hours afterward.

Amazingly, 100% of the mice who were given THC before being infected survived having SEB. Meanwhile, 100% of the mice who weren’t given THC died from the ARDS that resulted from their infection.

While some researchers suggested early on that cannabis’ anti-inflammatory effects could potentially be dangerous in early phases of an infection - suppressing the immune system when it should be defending against attack. This study suggests that using THC early in the infection drastically improved the prognosis and avoided damage to the lungs. While the results need to be confirmed by human research, it could be good news for cannabis users who fear ongoing cannabis use could increase their risk of infection with Covid-19. For mice with SEB, THC helped even when administered immediately after the infection.

Researchers also found that THC was also able to significantly suppress the inflammatory cytokines that are involved with ARDS. It also was able to elevate regulatory T cells which help suppress inflammation. Interestingly, researchers also noticed a shift in the expression of miRNA in cells in the lungs - which may play an important role in suppressing cytokine storms, reducing lung injury and preventing death from ARDS.

In a follow up study, the same researchers went a step further, exploring whether the results from the first study are relevant to those suffering from ARDS as a result of Covid-19. While both Covid-19 and SEB lead to cytokine storms and ARDS, it’s not clear that this happens in the same way. So, given the way THC acted on RNA in mice, these researchers decided to perform an analysis comparing gene expression in Covid-19 patients with ARDS and mice with ARDS from SEB. They found similarities suggesting THC may work well in both cases.

The researchers explain that “Collectively, this study suggests that the activation of cannabinoid receptors may serve as a therapeutic modality to treat ARDS associated with Covid-19.”

While this is a very early study, and more studies should be conducted in human populations with Covid-19, the research suggests that cannabis’ active ingredient THC could be able to prevent Covid-19 from escalating to ARDS - or treat it if it does.

Meditation keeps emotional brain in check

Michigan State University, September 29, 2020

 

Meditation can help tame your emotions even if you're not a mindful person, suggests a new study from Michigan State University.

Reporting in the journal Frontiers in Human Neuroscience, psychology researchers recorded the brain activity of people looking at disturbing pictures immediately after meditating for the first time. These participants were able to tame their negative emotions just as well as participants who were naturally mindful.

"Our findings not only demonstrate that meditation improves emotional health, but that people can acquire these benefits regardless of their 'natural' ability to be mindful," said Yanli Lin, an MSU graduate student and lead investigator of the study. "It just takes some practice."

Mindfulness, a moment-by-moment awareness of one's thoughts, feelings and sensations, has gained worldwide popularity as a way to promote health and well-being. But what if someone isn't naturally mindful? Can they become so simply by trying to make mindfulness a "state of mind"? Or perhaps through a more focused, deliberate effort like meditation?

The study, conducted in Jason Moser's Clinical Psychophysiology Lab, attempted to find out.

Researchers assessed 68 participants for mindfulness using a scientifically validated survey. The participants were then randomly assigned to engage in an 18-minute audio guided meditation or listen to a control presentation of how to learn a new language, before viewing negative pictures (such as a bloody corpse) while their brain activity was recorded. The participants who meditated – they had varying levels of natural mindfulness – showed similar levels of "emotion regulatory" brain activity as people with high levels of natural mindfulness. In other words their emotional brains recovered quickly after viewing the troubling photos, essentially keeping their negative emotions in check.

In addition, some of the participants were instructed to look at the gruesome photos "mindfully" (be in a mindful state of mind) while others received no such instruction. Interestingly, the people who viewed the photos "mindfully" showed no better ability to keep their negative emotions in check.

This suggests that for non-meditators, the emotional benefits of mindfulness might be better achieved through meditation, rather than "forcing it" as a state of mind, said Moser, MSU associate professor of clinical psychology and co-author of the study.

"If you're a naturally mindful person, and you're walking around very aware of things, you're good to go. You shed your emotions quickly," Moser said. "If you're not naturally mindful, then meditating can make you look like a person who walks around with a lot of mindfulness. But for people who are not naturally mindful and have never meditated, forcing oneself to be mindful 'in the moment' doesn't work. You'd be better off meditating for 20 minutes."

 

 

Freezing prostate cancer: Study shows notable outcomes with cryoablation

University of California Los Angeles, September 28, 2020 

A less-invasive treatment technique called hemi-gland cryoablation (HGCryo) - destroying the areas of the prostate where cancers are located by freezing them - provides a high rate of effective prostate cancer control, according to a new study published in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

"Freedom from cancer, as documented by biopsy, was found in 82 percent of men who underwent HGCryo, at their 18 month follow-up," according to the research by Ryan Chuang, MD, and colleagues at the University of California, Los Angeles. The importance of utilizing modern magnetic resonance imaging (MRI)-guided prostate biopsy in monitoring the effectiveness of HGCryo is also emphasized as part of this study.

'Hemi-Gland Cryoablation' Eliminates Clinically Significant Cancer in Most Patients

In the HGCryo procedure, using an advanced ultrasound/MRI fusion system, needles are precisely placed in and around the area of the prostate where the cancer is located. Argon gas is then injected to create extremely cold temperatures, destroying the cancer and surrounding area.

According to the study, 61 men with clinically significant prostate cancer (grade 2 or higher) involving one side of the prostate gland, underwent HGCryo. Cryotherapy was performed using general anesthesia; patients were discharged on the same day as the procedure. The results were assessed through follow-up imaging procedures and MRI-guided biopsies.

Biopsies were performed at 6 months in all patients; 27 patients underwent an additional biopsy after reaching 18 months' follow-up. At both times, biopsies showed no evidence of clinically significant prostate cancer in 82 percent of patients. In men who had areas of prostate cancer detected at follow-up, repeated HGCryo or other treatments were effective.

The study assessed three different biopsy approaches for monitoring the outcomes of HGCryo therapy: tracking of prior cancer-positive sites, biopsy targeting of MRI-visible lesions, and systematic biopsy of the entire prostate using a template. "While tracking biopsy was the most sensitive, all three methods were required for maximum cancer detection," Dr. Chuang and coauthors write.

HGCryo provided notable cancer control even in six patients with more advanced prostate cancers (grade 3 or 4). None of the patients died from their cancer, and none developed metastatic prostate cancer.

Postoperative complications of HGCryo were "generally mild and short-lived." There were no serious complications, including urinary incontinence - a common complication after prostate cancer surgery. One patient developed erectile dysfunction , which was successfully treated with medication.

Cryotherapy is an FDA-approved treatment for prostate cancer and is increasingly popular as a less-invasive alternative to surgery. However, there has been limited evidence on its long-term effectiveness in controlling prostate cancer. Most studies of prostate cryoablation were performed before the availability of modern multiparametric MRI scanning of the prostate, which can provide "a targeted path to precise biopsy and focal treatment" in most men with prostate cancer.

As with other types of partial gland ablation (PGA) for treatment of prostate cancer, the findings highlight the importance of follow-up biopsy as "the most important criterion for success" in evaluating the results of HGCryo. Dr. Chuang and colleagues conclude, "As utilization of MRI-guided biopsy increases, with resulting improved accuracy of prostate tissue characterization, numbers of candidates for PGA are expected to rise."

Early introduction of gluten may prevent celiac disease in children

Kings College London, September 28, 2020

Introducing high doses of gluten from four months of age into infants' diets could prevent them from developing coeliac disease, a study has found.

These results from the Enquiring About Tolerance (EAT) Study, published today in JAMA Pediatrics, by researchers from King's College London, Guy's and St Thomas' NHS Foundation Trust, St George's, University of London, and Benaroya Research Institute, Seattle, suggest the early introduction of high-dose gluten may be an effective prevention strategy for the disease, though researchers say further studies are needed before being applied in practice.

Coeliac disease is an autoimmune disease whereby eating gluten causes the body's immune system to attack its own tissues. There are currently no strategies to prevent coeliac disease and treatment involves long-term exclusion of gluten from the diet. Even very small amounts of gluten in the diet of those with coeliac disease can cause damage to the lining of the gut, prevent proper absorption of food and result in symptoms including bloating, vomiting, diarrhea, constipation, and tiredness.

Previous studies exploring early introduction of gluten in infants have varied in the amount of gluten consumed and the timing of the introduction. The EAT study investigated the effects of gluten alongside breastfeeding, from the age of four months. The results were compared to children who avoided allergenic foods and consumed only breast milk until age six months as per UK government guidelines.

Infants in the intervention arm of the EAT study were given 4g of wheat protein a week from four months of age. This was in the form of two wheat-based cereal biscuits such as Weetabix, representing an age-appropriate portion of wheat.

1004 children were tested for antitransglutanimase antibodies, an indicator of coeliac disease, at three years of age. Those with raised antibody levels were referred for further testing by a specialist.

The results showed that among children who delayed gluten introduction until after six months of age, the prevalence of coeliac disease at three years of age was higher than expected—1.4% of this group of 516 children. In contrast, among the 488 children who introduced gluten from four months of age, there were no cases of coeliac disease.

Lead author Professor Gideon Lack, Professor of Paediatric Allergy at King's College London and head of the children's allergy service at Evelina London Children's Hospital said: "This is the first study that provides evidence that early introduction of significant amounts of wheat into a baby's diet before six months of age may prevent the development of coeliac disease. This strategy may also have implications for other autoimmune diseases such as Type 1 diabetes."

Author Dr. Kirsty Logan, Researcher in Paediatric Allergy at King's College London said: "Early introduction of gluten and its role in the prevention of coeliac diseaseshould be explored further, using the results of the EAT Study as the basis for larger clinical trials to definitively answer this question."

The Gary Null Show - 09.29.20

The Gary Null Show - 09.29.20

September 29, 2020

Organic potatoes contain more microelements that are often deficient in soil

University of Warmia and Mazury (Poland), September 23, 2020

Researchers at the University of Warmia and Mazury in Olsztyn investigated the effect of three production systems, namely, conventional, integrated and organic farming, on the micronutrient and trace element content of tubers belonging to very early, early and medium-early maturing potato cultivars.

The researchers found that organic farming allows crops to obtain more essential micronutrients from the soil than either conventional farming or integrated farming systems. These microelements are crucial not only for plant growth and development but also for plant survival. Research also suggests that these nutrients can influence the appearance of plants and, most importantly, their fruit yields.

The researchers discussed their findings in an article published in the journal Acta Agriculturae Scandinavica, Section B – Soil & Plant Science.

Organic farming ensures good plant nutrition

Today, modern farmers have a variety of options when it comes to raising animals and growing crops. Organic farming, conventional farming and integrated farming are three of the most common production systems currently used in agriculture.

In organic farming, farmers use natural fertilizers (e.g., farm manure, organic compost), herbicides and pesticides to support the growth of their crops. They also use natural methods (e.g., clean housing, rotational grazing) to keep their livestock healthy and feed them nothing but organic and chemical-free feed. (Related: Do you know the history of organic farming?)

In conventional farming, farmers rely on chemical fertilizers, pesticides and herbicides to ensure the quality and quantity of their produce. They also use growth hormones and antibiotics to accelerate the growth of their livestock and keep them safe from diseases. Conventionally raised farm animals also have less access (or none at all) to the outdoors than organically raised animals.

Integrated farming is a relatively new approach that combines livestock and crop production to reduce costs and waste and improve income. In this agricultural system, waste from one component (e.g., livestock) is used to sustain the other component (e.g., crops or fish). Besides ensuring that farm waste is eliminated sensibly, integrated farming also promotes ecological diversity by including both plants and animals in the production.

For their study, Polish researchers grew five local potato cultivars using the three above-mentioned production systems under field conditions. They then analyzed samples from each to determine the amounts of select microelements and trace elements they contained.

Microelements that the researchers looked for included boron (B), copper (Cu), iron (Fe), manganese (Mn) and zinc (Zn) that are essential for living organisms. They also tested for trace elements, such as chromium (Cr), nickel (Ni) and lead (Pb), which are all important but are considered non-essential nutrients.

The researchers found that the micronutrient and trace element content of potato tubers were influenced by three factors, namely, the type of production system used to grow them, plant genotype and weather conditions during the growing season. Organic potatoes had higher B and Cu content but lower Fe, Mn and Zn content than potatoes grown in either conventional or integrated systems. Meanwhile, conventionally grown potatoes had the highest Pb content.

Organic cultivation resulted in better alimentation of potato tubers with B and Cu, which are crucial elements for plant growth and survival but are often found to be deficient in soil. In contrast, the researchers noted that conventional farming required the use of fertilizers to ensure adequate plant nutrition.

Based on these findings, the researchers concluded that organic farming is the best cultivation system to use as it ensures that crops receive proper nourishment, especially ample amounts of essential micronutrients.

 

 

 

Common Antioxidant Enzyme Catalase May Provide Potential Treatment for Covid-19

University of Caliornia Los Angeles, September 29, 2020

 

Researchers from UCLA and China have found that catalase, a naturally occurring enzyme, holds potential as a low-cost therapeutic drug to treat COVID-19 symptoms and suppress the replication of coronavirus inside the body. A study detailing the research was published in Advanced Materials.

Catalase is produced naturally and used by humans, animals and plants. Inside cells, the antioxidant enzyme kick starts the breakdown of hydrogen peroxide, which can be toxic, into water and oxygen. The enzyme is also commonly used worldwide in food production and as a dietary supplement.

"There is a lot of focus on vaccines and antiviral drugs, and rightly so," said Yunfeng Lu, a UCLA Samueli School of Engineering professor of chemical and biomolecular engineering and a senior author on the study. "In the meantime, our research suggests this enzyme could offer a very effective therapeutic solution for treatment of hyperinflammation that occurs due to SARS-CoV-2 virus, as well as hyperinflammation generally."

Lu's group developed the drug-delivery technology used in the experiments. Three types of tests were conducted, each addressing a different symptom of COVID-19.

First, they demonstrated the enzyme's anti-inflammatory effects and its ability to regulate the production of cytokines, a protein that is produced in white blood cells. Cytokines are an important part of the human immune system, but they can also signal the immune system to attack the body's own cells if too many are made -- a so-called "cytokine storm" that is reported in some patients diagnosed with COVID-19.

Second, the team showed that catalase can protect alveolar cells, which line the human lungs, from damage due to oxidation.

Finally, the experiments showed that catalase can repress the replication of SARS?CoV?2 virus in rhesus macaques, a type of monkey, without noticeable toxicity.

"This work has far-reaching implications beyond the treatment of COVID-19. Cytokine storm is a lethal condition that can complicate other infections, such as influenza, as well as non-infectious conditions, like autoimmune disease," said Dr. Gregory Fishbein, an author on the study and a pathologist at the UCLA David Geffen School of Medicine.

 
 

Effects of one month of Common Yoga Protocol practice appear to be mediated by the angiogenic and neurogenic pathway: A pilot study

Post Graduate Institute of Medical Education and Research (India),  25 September 2020.

Abstract

Objective

To examine the molecular effects of mindful activities such as yoga and meditation

Design

This was an open label single arm exploratory yoga intervention study.

Study participants

64 healthy individuals within the age of 18-60 years were recruited for this one month yoga intervention study.

Intervention

Common Yoga Protocol (CYP) is a standardized yoga protocol released by Ministry of AYUSH, India for International Yoga Day. It includes all aspects of yoga i.e. asanas, pranayama and meditation. It is designed for adoption by all age groups for the health of community.

Outcome measures

The participants were assessed for biochemical parameters including Fasting Sugar and Lipid profile. The molecular markers of neurogenesis (i.e. Brain derived Neurotropic Factor, BDNF) and Angiogenesis (i.e. Vascular Endothelial Growth Factor, VEGF and Angiogenin) along with Amyloid β (marker related to neuro-degenerative diseases) were assessed. All the assessments were made at baseline and after one month of the intervention.

Results

After one month of CYP practice High Density Lipoprotein (HDL) levels increased significantly (p<0.001), although other biochemical parameters i.e. fasting sugar and other lipid assessments were found to be unaltered. Angiogenesis marker, angiogenin was increased significantly (p<0.002), other angiogenesis marker VEGF did not show any change along with BDNF, marker of neurogenesis. Amyloid β levels were also unaltered. Even though individual levels of VEGF and Amyloid β did not show any change, proportion of VEGF to Amyloid β showed a significant increase (p<0.001) after one month of CYP intervention indicating that the change in VEGF levels were significantly higher than the change in Amyloid β levels.

Conclusion

CYP practice may influence cell survival pathways mediated by angiogenic and neurogenic cross talk. Hence, CYP can be considered as a preventive measure for diseases associated with impaired angiogenic and neurogenic mechanism. This is the first study to examine the effects of CYP at the molecular level.

 

Pterostilbene shows promise against inflammatory bowel disease

Tokyo University of Science, September 25 2020. 

 

Research described on September 22, 2020 in the FASEB Journal suggests that pterostilbene, a blueberry compound similar to resveratrol (found in grapes), has potential as a treatment for inflammatory bowel disease (IBD). Inflammatory bowel disease is caused by an increased immune response that results in chronic inflammation, which leads to ulcers in the lining of the gastrointestinal tract. 

"Resveratrol, a polyphenol, was known to have pronounced immunomodulatory and anti-inflammatory effects on animal models of colitis ulcer,” explained first author Takuya Yashiro of Tokyo University of Science. “Therefore, we investigated the possibility of other compounds structurally similar to resveratrol as a new type of treatment for IBD."

By testing the effects of resveratrol derivatives in cultured cells, the research team observed that pterostilbene had the strongest inhibitory effect against the proliferation of immune cells known as T cells that are activated by dendritic cells (another type of immune cell). Pterostilbene also decreased Th1 and Th17, which are subtypes of T cells. Pterostilbene was also associated with an increase in regulatory T cells that have an anti-inflammatory effect. The findings indicate that pterostilbene has a suppressive effect against the overactive immune response involved in IBD.

In mice with induced colitis, pterostilbene decreased the expression of the proinflammatory cytokine tumor necrosis factor-alpha and reduced symptoms.

“Pterostilbene supplementation may either inhibit the pathology of IBD or delay its onset,” the authors concluded. “Whether pterostilbene executes similar immunosuppressive effects in human immune cells requires further analysis.”

"For disease prevention, it is important to identify the beneficial components in foods and to understand the underlying mechanism by which immune responses and homeostasis are modulated in body,” Dr Yashiro remarked. “Our findings showed that pterostilbene possesses a strong immunosuppressive property, paving the way for a new, natural treatment for IBD."

 
 

Anxious, moody older adults are vulnerable to worse cognitive function

Northwestern University, September 26, 2020

Our aging brains collect tangles and sticky plaques that can interfere in our cognition and memory. But some older adults with this neuropathology have more cognitive resilience than others, reports a new Northwestern Medicine study. 

The reason: their personalities.

Personality traits were associated with cognitive resilience, which is the ability to better live with the neuropathology in the brain that causes dementia. Individuals with a greater tendency toward self-discipline, organization, diligence, high achievement and motivation -- a trait known as higher conscientiousness -- was associated with greater resilience.

Individuals with higher neuroticism -- a greater tendency towards anxiety, worry, moodiness and impulsivity -- were more likely to have worse cognitive function than expected given the amount of neuropathology detected at autopsy.

The study was published Sept. 24 in Journal of Gerontology: Psychological Sciences

"These findings provide evidence that it is possible for older adults to live with the neuropathology associated with Alzheimer's disease and related dementias while maintaining relatively healthy levels of cognitive function," said lead study author Eileen Graham, a research assistant professor of medical social sciences at Northwestern University Feinberg School of Medicine. 

"Our study shows personality traits are related to how well people are able to maintain their cognitive function in spite of developing neuropathology," Graham said. "Since it is possible for personality to change, both volitionally and through interventions, it's possible that personality could be used to identify those who are at risk and implement early interventions to help optimize function throughout old age."

Personality and other factors that promote cognitive resilience may be particularly important in the context of stress (like the COVID-19 pandemic) and this is an important area of future research, Graham noted.

This is believed to be one of the first studies showing an individual's personality traits are linked to how well they are able to sustain their cognitive function as they age. These findings lend credence to the idea that personality can be leveraged to help individuals maintain their cognitive function when they may otherwise be vulnerable to neurodegeneration.

The data was collected at Rush University Alzheimer's Disease Research Center. Individuals contributed annual psychosocial self-report survey and clinical data. At study enrollment they also consented to donating their brains for post-mortem autopsy. Study participants contributed years of rich data on their psychological and cognitive functioning while they were living, as well as autopsy data after they died.

 

Green soy extract could prevent cognitive dysfunction: Mouse data

University of Shizuoka (Japan), September 14, 2020

Intake of green soybean extract could help reverse cognitive dysfunction and its associated accumulation of beta-amyloid proteins in the brain, say researchers.

The accumulation of beta-amyloid proteins has long been linked to the development of brain stunting conditions including Alzheimer’s disease and other forms of dementia. 

The new findings come from a Japanese trial in mice with cognitive dysfunction.

Writing in the Journal of Functional Foods, the team revealed that brain functions were ‘significantly better-preserved’ in aged mice fed green soybean than age-matched control mice with or without yellow soybean feeding.

The molecular mechanisms of these beneficial effects on brain function were examined using transcriptome analysis.

An increased expression of lipocalin-type prostaglandin Dsynthase (Ptgds) and a significant reduction in the amyloid precursor protein Aplp1 was reported by the team, led by Keiko Unno from the University of Shizuoka in Japan.

“As Ptgds binds and transports small lipophilic molecules (…) it has been proposed as the endogenous Aβ chaperone,” noted the team, adding that lower levels of the usually abundant protein “may play an important role in the development of dementia and of Alzheimer's disease (AD).”

“Furthermore, the amount of beta-amyloid 40 and 42 was reduced in the insoluble fraction of cerebral cortex,” the team noted.

Soy benefits

Unno and colleagues noted that previous research has suggested several beneficial effects of soybean components such as so isoflavones, including previous suggestions of benefits for cognitive function and the prevention of oxidative damage.

In the current study, the isoflavones found to be present in soybean extracts were mostly the glycosides genstin and daidzin.

“The levels of genistein and daizein, aglycones of genstin and daidzin, respectively, were very low or not detected,” reported the team – adding that the content of oligo sugars, especially sucrose, was significantly higher in green soybean than in yellow.

Furthermore, the contents of saponin and carotene in green soybean were found to be slightly higher in the green than in yellow, however the contents of other components were not different between green and yellow soybeans.

“Soybean feeding did not change the weight of body, liver or cerebrum,” Unno and colleagues said – adding that the average food consumptions of each group were also not different. 

Source: Journal of Functional Foods

 

Cannabis use for menopause symptom management

San Francisco Veterans Administration, September 28, 2020)

As legislation relaxes regarding cannabis, it is being used to manage numerous chronic health conditions and mood symptoms. A new study indicates that a growing number of women are either using cannabis or want to use it for the management of bothersome menopause symptoms. Study results will be presented during the 2020 Virtual Annual Meeting of The North American Menopause Society (NAMS), which opens on September 28.

In a sample of 232 women (mean age, 55.95 y) in Northern California who participated in the Midlife Women Veterans Health Survey, more than half reported such bothersome symptoms as hot flashes and night sweats (54%), insomnia (27%), and genitourinary symptoms (69%). Roughly 27% of those sampled reported having used or were currently using cannabis to manage their symptoms. An additional 10% of participants expressed an interest in trying cannabis to manage menopause symptoms in the future. In contrast, only 19% reported using a more traditional type of menopause symptom management, such as hormone therapy. 

Cannabis for menopause symptom management was most often used in women reporting hot flashes and night sweats. Such use did not differ by age, race/ethnicity, socioeconomic status, or mental health conditions.

"These findings suggest that cannabis use to manage menopause symptoms may be relatively common. However, we do not know whether cannabis use is safe or effective for menopause symptom management or whether women are discussing these decisions with their healthcare providers--particularly in the VA, where cannabis is considered an illegal substance under federal guidelines. This information is important for healthcare providers, and more research in this area is needed," says Carolyn Gibson, PhD, MPH, a psychologist and health services researcher at San Francisco VA Health Care System and the lead author of the study. 

The study, "Cannabis use for menopause symptom management among midlife women veterans," will be one of many presentations during the 2020 NAMS Virtual Annual Meeting focused on novel approaches for treating menopause symptoms. 

"This study highlights a somewhat alarming trend and the need for more research relative to the potential risks and benefits of cannabis use for the management of bothersome menopause symptoms," says Dr. Stephanie Faubion, NAMS medical director.

Drs. Gibson and Faubion are available for interviews before and after the virtual annual meeting.

 

Pets Linked To Maintaining Better Mental Health And Reducing Loneliness During Lockdown

 

University of York and University of Lincoln (UK), September 25, 2020

Sharing a home with a pet appeared to act as a buffer against psychological stress during lockdown, a new survey shows.

Most people who took part in the research perceived their pets to be a source of considerable support during the lockdown period. (23 March – 1 June, 2020)

The study – from the University of York and the University of Lincoln – found that having a pet was linked to maintaining better mental health and reducing loneliness. Around 90 per cent of the 6,000 participants who were from the UK had at least one pet. The strength of the human-animal bond did not differ significantly between species with the most common pets being cats and dogs followed by small mammals and fish.

More than 90 per cent of respondents said their pet helped them cope emotionally with the lockdown and 96 per cent said their pet helped keep them fit and active.

However, 68 per cent of pet owners reported having been worried about their animals during lockdown, for example due to restrictions on access to veterinary care and exercise or because they wouldn’t know who would look after their pet if they fell ill.

Lead author, Dr Elena Ratschen from the Department of Health Sciences University of York said: “Findings from this study also demonstrated potential links between people’s mental health and the emotional bonds they form with their pets: measures of the strength of the human-animal bond were higher among people who reported lower scores for mental health-related outcomes at baseline.

“We also discovered that in this study, the strength of the emotional bond with pets did not statistically differ by animal species, meaning that people in our sample felt on average as emotionally close to, for example, their guinea pig as they felt to their dog.

“It will be important to ensure that pet owners are appropriately supported in caring for their pet during the pandemic.”

Co-author, Professor Daniel Mills from the School of Life Sciences at the University of Lincoln said: “This work is particularly important at the current time as it indicates how having a companion animal in your home can buffer against some of the psychological stress associated with lockdown. However, it is important that everyone appreciates their pet’s needs too, as our other work shows failing to meet these can have a detrimental effect for both people and their pets.”

Dr Ratschen added: “While our study showed that having a pet may mitigate some of the detrimental psychological effects of the Covid-19 lockdown, it is important to understand that this finding is unlikely to be of clinical significance and does not warrant any suggestion that people should acquire pets to protect their mental health during the pandemic.”

More than 40% of UK households are estimated to own at least one pet.

The study also showed that the most popular interaction with animals that were not pets was birdwatching. Almost 55 per cent of people surveyed reported watching and feeding birds in their garden

The Gary Null Show - 09.28.20

The Gary Null Show - 09.28.20

September 28, 2020

Michael Kane has worked as a New York City public school teacher for the past 13 years and is a steering committee member for New York Teachers for Choice, a grassroots organization that is 100 percent opposed to forced vaccination of teachers. During his teaching years, he is an active union member for the United Federation of Teachers as a former union delegate working on committees to improve public school conditions, lobby Albany and efforts to erase the Janus Supreme Court decision that threatened to break unions apart.  Michael also works closely with Bobby Kennedy's Childrens Health Defense and John Gilmore's Autism Action Network. His website is NYTeachersForChoice.org

The Gary Null Show - 09.25.20

The Gary Null Show - 09.25.20

September 25, 2020

Prof. Cahill received her degree in Molecular Genetics from Trinity College Dublin (1989) and her PhD in Immunology from Dublin City University in 1994. She was group leader of the Protein Technology Group in the Max-Planck-Institute of Molecular Genetics, Berlin, Germany (1996-2003) She co-founded a biotechnology company, Protagen AG (www.protagen.de) in Dortmund to commercialise this technology. Since 2005, she is Professor of Translational Science at the University College Dublin School of Medicine and Medical Sciences.

Her research, publication and patent record is in high content protein/antibody arrays and their biomedical applications. Application include the characterisation of antibodies specificity (including therapeutic antibodies), biomarker discovery validation, diagnostics, assay development, protein-interaction studies, proteomics, large scale/systems biology research. 

She is a member of a number of Editorial and Science Advisory and Review Boards. For the past 10 years she has been involved in policy development in the areas of science, technology and innovation, including in the EU Health, Innovation and Infrastructure. Since 2003, she is a Member of the Irish Government’s Advisory Science Council (ASC) (www.sciencecouncil.ie), appointed by the Minister for Industry, Trade and Employment. For the past ten years, she is on a number of Science Advisory & Review Boards, including for BMBF/DLR in Germany; BBSRC in the UK; Vinnova in Sweden. She has received prizes for her research, including the prestigious BMBF ‘BioFuture’ Award from the German Minister of Science. She was awarded the Federation of European Biochemical Societies (FEBS) 2009 Award for her research & its significance. Other recipients of this award include Prof. J. Craig Venter & Prof. Robert Huber.

The Gary Null Show - 09.24.20

The Gary Null Show - 09.24.20

September 24, 2020

The Gary Null Show is here to inform you on the best news in health, healing, the environment.

 

Racism has been redefined' Bret Weinstein on woke science & how humans succeed - BQ #31

Biologist, evolutionary theorist and member of the 'intellectual dark web' Bret Weinstein talks about the woke movement, how they have impacted the sciences and the US election. Weinstein talks to The Sun's Steven Edginton for 'Burning Questions'.
The Gary Null Show -  09.23.20

The Gary Null Show - 09.23.20

September 23, 2020

Economic Outlook During the Corona Pandemic Leading up to the Elections

Gerald Celente is one of today’s pioneers in trend strategy and identifying the developments of change occurring in our world. He founded the Trends Research Institute in Kingston NY and is the publisher of the Trends Journal that has been in publication since 1980. Gerald has since become one of the nation’s most sought after diagnosticians and forecasters.   He is also the host of the weekly show "Trends This Week," heard every Wednesday at 11 am Eastern Time on the Progressive Radio Network. More information can be found on the Institute's website TrendsResearch.com

The Gary Null Show -  09.22.20

The Gary Null Show - 09.22.20

September 22, 2020
Influence of a Novel Food-Grade Formulation of Red Chili Extract on Overweight Subjects
St. Thomas College (India), September 12 2020
Abstract

Capsaicinoids from pungent red chilies (Capsicum annum and Capsicum frutescens) have received significant attention as a natural supplement for the management of obesity. However, the consumption of chili extract at physiologically relevant dosage of capsaicinoids is a challenge owing to its pungency and gastrointestinal discomforts. The present study reports the systemic absorption, safety and influence of a novel, food-grade, and sustained-release formulation of capsaicinoids-rich red chili extract using fenugreek dietary fiber (Capsifen®). Twenty-four healthy overweight subjects were randomized into placebo (n = 12) and Capsifen (n = 12) groups and supplemented with 200 mg × 1/day of Capsifen (4 mg capsaicinoids/day) for 28 days. Influence of Capsifen on eating behavior and appetite was followed by Three-Factor Eating Questionnaire (TFEQ) and Council of Nutrition Appetite Questionnaire (CNAQ), respectively. Consumption of Capsifen did not reveal any adverse events or deviations in hematology and biochemical parameters related to safety. However, a significant decrease in body weight (2.1%), w/h ratio (4%) and body mass index (BMI) (2.2%) were observed among Capsifen group when compared to placebo. The TFEQ and appetite analysis revealed a significant improvement in uncontrolled eating and reduction in appetite among Capsifen subjects. The UPLC-ESI-MS/MS analysis confirmed the absorption of capsaicinoids from CAP supplementation. The study further demonstrated the safety and tolerability of Capsifen at the investigational dosage. Thus, the significant reduction in anthropometric parameters such as body weight, w/h ratio, and BMI along with the improvement in eating behaviour as well as appetite, indicated the potential body weight management effect of Capsifen.

 

Study on the effect of rosemary and ginger essential oils against Klebsiella pneumoniae

 
Damanhour University and  Pharos University (Egypt), September 21, 2020
 

Klebsiella pneumoniae is a nosocomial pathogen in outbreaks of hospital infections. It is one of the major factors for morbidity and mortality in hospitalized patients especially those infected with colistin resistant pathogens. Many plant essential oils have antimicrobial activities and have been investigated as natural sources to combat multiple antibiotic resistances. Moreover; recent advances in phytonanotechnology have created exciting opportunities for the management of many infections. 

This study aims at investigating the antimicrobial and antibiofilm effect of rosemary and ginger essential oil-based nano-sized formulations on colistin resistant K. pneumonia clinical isolates.

Isolation and identification of 30 K. pneumonia isolates from different human samples was done followed by antibiotic susceptibility testing and detection of biofilm gene (mrkD). Examination of the activity of the tested essential oils and their chitosan nanoparticle formulations against the selected isolates was made by determination of their MICs using broth microdilution method followed by biofilm inhibition test and quantitative real-time PCR for the expression of mrkD gene in the presence of the oils and nanoparticles formulations compared to untreated bacterial isolates.

Our results showed that the minimum inhibitory concentrations of rosemary and ginger oils were found to be 1250 μg/ml, nanostructured lipid carrier-rosemary oil and nanostructured lipid carrier-ginger oil were 625 μg/ml and rosemary oil loaded chitosan nanoparticles and ginger oil loaded chitosan nanoparticles were 156 μg/ml. Results also revealed complete (100%) inhibition for mrkD gene expression when compared to untreated K. pneumonia. 

We can conclude that oil loaded chitosan nanoparticles show a high antimicrobial and antibiofilm activity.

 

 

The unintended consequence of becoming empathetic

University of Michigan, September 16, 2020

When people say that they want to change things about their personalities, they might not know about the inadvertent consequences these changes could bring. In fact, changes in personality may also lead to changes in political ideologies, say researchers from Michigan State University and the University of Granada, who led the study.

"We found this interesting effect where people wanted to improve on things like being more emotionally connected to others -- or, becoming more empathetic," said William Chopik, assistant professor of psychology at MSU. "But we found that this leads to changes in their political souls as well, which maybe they weren't intending. We saw that in these personality changes toward greater empathy, people placed a lot more importance upon more liberal ideologies -- like how you should treat other people and take others' perspectives."

The study, published in the most recent edition of Journal of Research in Personality, is the first to look at shifts in personalities and morals due to volitional change -- or, changes one brings upon oneself.

Chopik and co-authors from Southern Methodist University and the University of Illinois asked 414 volunteer participants to take a weekly questionnaire. Such questions included how they would react in certain situations, if they wanted to improve or change themselves, how they felt about helping others and other personality-related queries. Additionally, the researchers measured participants' "empathic concern" -- or, feelings that would arise when they saw someone in need or doing poorly. The researchers continued the weekly questionnaire for four months.

"Among the questions, we asked participants how they felt about five broad moral foundations: care, fairness, loyalty, authority and purity. We tracked sentiments week-to-week," Chopik said. "While these are common for personality-related assessments, individual moral foundations can also help explain attitudes toward various ideologies, ethical issues and policy debates."

Generally, liberal and progressive people tend to prioritize two of the five moral foundations: care and fairness; whereas, conservatives draw from all five -- including the more binding foundations: loyalty to the ingroup, respect for authority, and observance of purity and sanctity standards, Chopik said.

"Our study shows that when people are motivated to change, they can successfully do so," he said. "What we were surprised to find was that an upward trajectory for something like perspective-taking aligned with the person's shift towards the more liberal foundations."

The researchers did not intend for their study to generalize personality traits of one political party or another, but rather to see if -- and how -- a person could change themselves and what might be a result of their "moral transformation."

"Being a better perspective-taker exposes you to all sorts of new ideas, so it makes sense that it would change someone because they would be exposed to more diverse arguments," Chopik said. "When you become more empathic, it opens up a lot of doors to change humans in other ways, including how they think about morality and ideology -- which may or may not have been intended."

 

 

Evidence for Korean Ginseng's effects on improving bone health

Hospital of Chonbuk National University, Sept. 9, 2019

The Korea Ginseng Association introduced new evidence of Korean Ginseng's efficacy on bone health.

Korean Ginseng refers to ginsengs produced in Korea. Ginseng's scientific name, Panax ginseng, is named after the Greek word 'Panax', meaning cure for all diseases; indeed, ginseng has been sought after medicine since the ancient times. It has been proven to improve immune system and fatigue previously, and now even for bone health, as seen in recent research released in Korea.

In June of 2019, Rural Development Administration, Korea Research Institute of Bioscience & Biotechnology (KRIBB) and Hospital of Chonbuk National University confirmed the efficacy of Korean ginseng's efficacy on bone health in a research conducted for 3 years and followed up for another two years. The clinical application study was performed with three groups of female participants over the age of 40 and who suffer from bone loss. There were a total of 90 participants, with 30 participants in each group. The participants in the control group were given placebo, while the other groups were given ginseng extracts (3g per day and 1g per day). 

The results indicated that the level of osteocalcin was 11.6 times higher in the test group than the control group; the level of calcium was 3 times higher in the test group with 3g extracts as well. The change in Osteoarthritis rating before and after taking the extract was also significant, indicating ginseng's efficacy on improving pain and rigidity due to bone loss. 

In animal testing, ginseng extract (300mg per kg of mouse body mass) was administered for 8 weeks in Panax that were 112 weeks old. The result also indicated that bone density was 32% higher in the test group. The calcium concentration and bone formation effect were also higher in the test group. 

The Korea Ginseng Association's president Mr. Ban mentioned, "With this new evidence on ginseng's efficacy on bone health, we have even more pride for our Korean Ginseng. We hope to continue to find scientifically based evidence for the ginseng's benefits."

 
 

Immune system may have another job—combatting depression

Yale University, September 18, 2020

An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects. The research, published Sept. 18 in the journal Science Immunology, suggests these immune cells may play a role other than protecting against microbial invaders—protecting our mental health.

The results buttress an emerging theory that gamma interferons, a type of immune cell that helps induce and modulate a variety of immune system responses, may also play a role in preventing depression in healthy people.

"We were surprised that normal spinal fluid would be so interesting," said David Hafler, the William S. and Lois Stiles Edgerly Professor of Neurology, professor of immunobiology and senior author of the study.

Previous research has shown that blocking gamma interferons and the T cells they help produce can cause depression-like symptoms in mice. Hafler notes that depression is also a common side effect in patients with MS treated with a different type of interferon.

Using a powerful new technology that allows a detailed examination of individual cells, the researchers show that while the characteristics of T cells in the spinal fluid of healthy people share similarities with those of MS patients, they lack the ability to replicate and cause the damaging inflammatory response seen in autoimmune diseases such as MS.

In essence, the immune system in the brains of all people is poised to make an inflammatory immune system response and may have another function than defending against pathogens, Hafler said.

"These T cells serve another purpose and we speculate that they may help preserve our mental health," he said.

Hafler said that his lab and colleagues at Yale plan to explore how immune system responses in the central nervous system might affect psychiatric disorders such as depression.

 

Avocado pulp improves cardiovascular and autonomic recovery following submaximal running

Sao Paulo State University (Brazil), August 23, 2020

Abstract

Previous studies have demonstrated that regular avocado consumption presents advantageous effects on cardiovascular system. However, little attention has been paid to the use of avocado as a dietary supplement, in particular, for individuals involved in physical exercise training. Therefore, this study aims to evaluate the effect of acute avocado pulp intake on cardiovascular and autonomic recovery subsequent to moderate exercise. Using a crossover, randomized, double-blind and placebo-controlled trial design, 16 healthy female adults underwent two protocols: Avocado pulp (600 mg in capsule) and placebo (600 mg starch in capsule). After the ingestion of Avocado pulp or placebo, the subjects were seated for 60 min at rest, followed by running on a treadmill at a submaximal level and then remained seated for 60 min during recovery from the exercise. Heart rate (HR), heart rate variability (HRV) [rMSSD, SD1, HF (ms2)] and skin conductance were evaluated before and during exercise, as well as during recovery. HR, systolic blood pressure, HRV and skin conductance recovered faster when subjects were given avocado pulp prior to exercise. In conclusion, avocado pulp improved cardiovascular and autonomic recovery after exercise, suggesting a reduced risk of cardiovascular events after exertion. The current results support the beneficial effects of ingestion of avocado prior to submaximal treadmill running.

 

Study shows vitamin E needed for proper nervous system development

Oregon State University, September 21, 2020

 

In research with key ramifications for women of childbearing age, findings by Oregon State University scientists show that embryos produced by vitamin E-deficient zebrafish have malformed brains and nervous systems.

"This is totally amazing - the brain is absolutely physically distorted by not having enough vitamin E," said Maret Traber, a professor in the OSU College of Public Health and Human Sciences.

The study led by Traber, the Ava Helen Pauling Professor at Oregon State's Linus Pauling Institute, was published today in Scientific Reports.

Zebrafish are a small freshwater species that go from a fertilized egg to a swimming fish in about five days. They are highly prized for studying the development and genetics of vertebrates. 

Zebrafish share a remarkable similarity to humans at the molecular, genetic and cellular levels, meaning many findings are immediately relevant to humans. Embryonic zebrafish are of special interest because they develop quickly, are transparent and are easy to care for.

Vitamin E was discovered in 1922, identified because it was essential for fertilized rat eggs to culminate in live births.

"Why does an embryo need vitamin E? We've been chasing that for a long time," said Traber, a leading authority on vitamin E who has been researching the micronutrient for three decades. "With this newest study we actually started taking pictures so we could visualize: Where is the brain? Where is the brain forming? How does vitamin E fit into this picture?"

In an embryo, a brain primordium and the neural tube appear early and will form the nervous system and "innervate" - supply with nerves - all organs and body structures. Without vitamin E, the zebrafish embryos showed neural tube defects and brain defects.

"They were kind of like folic acid-deficient neural tube defects, and now we have pictures to show the neural tube defects and brain defects and that vitamin E is right on the closing edges of the cells that are forming the brain," Traber said. 

In healthy organisms, neural crest cells drive the creation of facial bones and cartilage and innervate the body, building the peripheral nervous system.

"Acting as stem cells, the crest cells are important for the brain and spinal cord and also go on to be the cells of about 10 different organ systems including the heart and liver," Traber said. "By having those cells get into trouble with vitamin E deficiency, basically the entire embryo formation is dysregulated. It is no wonder we see embryo death with vitamin E deficiency."

Traber likens it to the children's game KerPlunk, in which kids take turns pulling out the straws that support several dozen marbles in a vertical tube. When the wrong straw is pulled out, everything collapses; vitamin E is the straw whose extraction brings down the house on embryo development, especially with the brain and nervous system.

"Now we're at the point where we're so close being able to say exactly what's wrong when there isn't enough vitamin E but at the same time we're very far away because we haven't found what are the genes that are changing," she said. "What we know is the vitamin E-deficient embryos lived to 24 hours and then started dying off. At six hours there was no difference, by 12 hours you see the differences but they weren't killing the animals, and at 24 hours there were dramatic changes that were about to cause the tipping point of total catastrophe."

Vitamin E, known scientifically as alpha-tocopherol, has many biologic roles and in human diets is most often provided by oils, such as olive oil. It is found in high levels in foods such as hazelnuts, sunflower seeds and avocados.

Vitamin E is a group of eight compounds - four tocopherols and four tocotrienols - distinguished by their chemical structure. Alpha-tocopherol is what vitamin E commonly refers to and is found in supplements and in foods associated with a European diet; gamma-tocopherol is the type of vitamin E most commonly found in a typical American diet.

"Plants make eight different forms of vitamin E, and you absorb them all, but the liver only puts alpha-tocopherol back into the bloodstream," said Traber. "All of the other forms are metabolized and excreted. I've been concerned about women and pregnancy because of reports that women with low vitamin E in their plasma have increased risk of miscarriage."

Joining Traber on the study were Brian Head of the Linus Pauling Institute, Jane La Du and Robyn Tanguay of the OSU College of Agricultural Sciences and Chrissa Kioussi of the OSU College of Pharmacy.

The Oregon Veterinary Diagnostic Lab supported the research with technical assistance, and the Ava Helen Pauling Endowment and the National Institute of Environmental Health Sciences of the National Institutes of Health contributed toward the study's funding.

 

Lactobacillus rhamnosus attenuates bone loss and maintains bone health 

All India Medical Institute (India), September 18, 2020

 

According to news reporting based on a preprint abstract, “Osteoporosis is a systemic-skeletal disorder characterized by enhanced fragility of bones leading to increased rates of fractures and morbidity in large number of populations. Probiotics are known to be involved in management of various-inflammatory diseases including osteoporosis.

“But no study till date had delineated the immunomodulatory potential of Lactobacillus rhamnosus (LR) in bone-health.

“In the present study, we examine the effect of probiotic-LR on bone-health in osteoporotic (Ovx) mice model.

“We observed that administration of LR attenuated bone-loss in Ovx mice. Both the cortical and trabecular bone-content of LR treated group was significantly higher than Ovx-group. Remarkably, the percentage of osteoclastogenic-CD4+Ror{gamma}t+Th17 cells at distinct immunological sites such as BM, spleen, LN and PP were significantly reduced, whereas the percentage of anti-osteoclastogenic-CD4+Foxp3+Tregs and CD8+Foxp3+Tregs were significantly enhanced in LR-treated group thereby resulting in inhibition of bone-loss. The immunomodulatory-role of LR was further supported by serum-cytokine data with a significant reduction in proinflammatory-cytokines (IL-6, IL-17 and TNF-) along with enhancement in anti-inflammatory-cytokines (IL-10, IFN-{gamma}) in LR treated-group. Altogether, the present study for the first time establishes the osteoprotective role of LR on bone-health, thus highlighting the potential of LR in the treatment and management of various bone related diseases including osteoporosis.”

 

 

The Gary Null Show - 09.21.20

The Gary Null Show - 09.21.20

September 21, 2020

Vitamin D supplementation can reduce cancer death risk by 16%, study shows

Cornell University, September 18, 2020

 

A recent review published in the British Medical Journal analyzed studies on vitamin D supplementation. Researchers from the United States and China found that it reduces the risk of cancer-related death by 16 percent.

Vitamin D linked to reduced risk of cancer death

There are three sources of vitamin D: from one’s diet, from supplements and through sunlight exposure. In the case of the latter, the body naturally produces the micronutrient, leading to its moniker “the sunshine vitamin.”

The cancer-related benefits of vitamin D have been reported numerous times in the past. One of the first studies demonstrated a link between non-skin cancers and the levels of sunlight that fall in different geographic latitudes. According to its lead researcher, Frank Apperly, the sunlight gave “a relative cancer immunity.”

While Apperly’s study was largely ignored during its time, it was rediscovered later on and more studies on the link between cancer and vitamin D appeared. For instance, previous research proposed that vitamin D deficiency increases the risk of colon and prostate cancer.

For the current study, the researchers looked at 52 randomized controlled trials that compared the effects of vitamin D supplementation to those of a placebo or no treatment. About 7,450 participants were included in the studies.

Results showed that vitamin D supplementation reduced cancer death risk by 16 percent. The finding was particular to cancer-related death as all-cause mortality risk remained virtually unchanged after supplementation.

The researchers added that the reduced risk of cancer death was best observed among participants who took supplements of vitamin D3 — what the human body produces naturally upon exposure to sunlight. Vitamin D3 is also found in animal-based foods such as egg yolk and fish oil.

They recommended taking vitamin D3 supplements for at least three years to reap its benefit. They explained that among the trials that they examined, those that involved longer supplementation showed greater evidence for the cancer-related benefit of vitamin D3. 

“Another finding from subgroup analysis suggested that […] the benefit of reduced mortality was seen in trials with longer follow-up but not in those with a shorter follow-up. According to these findings, supplementation with vitamin D3 for at least three years should be considered,” wrote the researchers.

More studies on the anti-cancer benefit of vitamin D

Recent studies also found the link between reduced risk of cancer-related death and vitamin D supplementation.

In a recent study published in the Journal of Clinical Oncology, researchers looked at previous research that examined the use of vitamin D versus a placebo over at least three years. The studies included almost 80,000 cancer patients with an average age of 68.

They found that those who took vitamin D supplements for three years and more had a 13 percent reduced risk of cancer-related death.

“The difference in the mortality rate between the vitamin D and placebo groups was statistically significant enough that it showed just how important it might be among the cancer population,” said lead author Tarek Haykal of the Michigan State University and the Hurley Medical Center in Flint, Michigan.

In another study published in the New England Journal of Medicine, researchers randomly assigned half of 25,800 participants to vitamin D supplementation and the other half to a placebo. They were followed up for an average of five years.

The researchers found that cancer-related deaths in the vitamin D group were reduced by 17 percent compared to the placebo group. When participants had been taking vitamin D for more than two years, deaths were reduced by 25 percent.

These findings illustrate that vitamin D can help reduce the risk of dying from cancer.

 

 

Mango Leaf Extract's brain-boosting capabilities revealed after 5 year R&D study

Northumbria University (UK), September 16, 2020

A new study has been published that builds upon previous research showing ‘experiential’ benefits from the Zynamite ingredient platform. The new clinical trial, led by Professor David Kennedy, Director of the Brain, Performance and Nutrition Research Centre at Northumbria University and published in Nutrients, suggests a rapid and sustained boost for a wide range of cognitive functions after a single use of the ingredient. Zynamite is a patent-pending, proprietary Mangifera indica extract, standardized to ≥ 60% mangiferin, developed from sustainably harvested mango leaves. A self-affirmed GRAS ingredient, it has a portfolio of safety data and has been the subject of three pre-clinical and now seven clinical studies that demonstrate performance enhancement in both cognitive and physical performance. 

The new study is indicative of a robust and continuing program of scientific study supporting Zynamite and underscores its potential as a leading ingredient for cognitive and physical performance. A randomized, double-blind, placebo-controlled crossover study, published in 2019, was conducted to determine whether a single dose of Zynamite administered one hour before exercise would increase cycle-sprint performance. Subjects performed three Wingate sprint tests interspaced by 4 minutes and a final 15-second sprint after induced ischemia (blood flow restriction, which simulates exhaustion). Peak power was improved by 3.8% in one hour compared to placebo in subjects who took just one dose of Zynamite. Of note, the amount of quercetin in Zynamite (140 mg) is significantly lower than amounts of quercetin shown to produce ergogenic effects in previous studies, suggesting that this combination may have synergistic effects.

 

 

Study links rising stress, depression in US to pandemic-related losses, media 

University of California at Irvine, September 19, 2020

Experiencing multiple stressors triggered by the COVID-19 pandemic—such as unemployment—and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study.

The report appears in Science Advances.

"The pandemic is not hitting all communities equally," said lead author E. Alison Holman, UCI professor of nursing. "People have lost wages, jobs and loved ones with record speed. Individuals living with chronic mental and physical illness are struggling; young people are struggling; poor communities are struggling. Mental health services need to be tailored to those most in need right now."

In addition, the research highlights the connection between mental health and exposure to media coverage of the COVID-19 pandemic, suggesting the need to step away from the television, computer or smartphone to protect psychological well-being.

"The media is a critical source of information for people when they're faced with ambiguous, ongoing disasters," said Roxane Cohen Silver, professor of psychological science and one of the study's principal investigators. "But too much exposure can be overwhelming and lead to more stress, worry and perceived risks."

With funding from a National Science Foundation RAPID grant, Holman, Silver, and co-investigators Dana Rose Garfin and Rebecca R. Thompson conducted a national survey of more than 6,500 U.S. residents in March and April 2020, as illness and deaths were rising around the country. Using the NORC AmeriSpeak panel, the study was the first of its kind to examine early predictors of rising mental health problems across the nation. The design let researchers evaluate the effects of the pandemic as it was unfolding in real time.

"Over the course of the study, the size of the pandemic shifted dramatically," Holman said. Accordingly, people surveyed later in the study period reported the highest rate of acute stress and depressive symptoms.

The UCI team's findings offer insights into priorities for building community resilience in the face of the COVID-19 pandemic:

  • Those with pre-existing mental and physical conditions are more likely to show both acute stress and depressive symptoms.
  • Secondary stressors—job and wage loss, a shortage of necessities—are also strong predictors in the development of these symptoms.
  • Extensive exposure to pandemic-related news and conflicting information in the news are among the strongest predictors of pandemic-specific acute stress.

"It's critical that we prioritize providing resources to communities most in need of support right now—the unemployed, poor or chronically ill people, and young people," Holman said. "We also encourage the public to limit exposure to media as an important public health intervention. It can prevent mental and physical health symptoms and promote resilience."

 

Curcumin protects bone properties and microarchitecture in type 2 diabetes with osteoporosis

Zhaoqing Medical College (China) and Inner Mongolia Medical University, September 17, 2020

 

According to news reporting originating in Guangdong, People’s Republic of China, research stated, “Type 2 diabetic osteoporosis (T2DOP) has become a common secondary cause of osteoporosis that accelerates bone loss and leads to bone fractures. The aim of the current study was to investigate the association between the anti-osteoporotic effect of curcumin (Cur) and the transforming growth factor (TGF)beta /Smads signaling pathway.”

The news reporters obtained a quote from the research from the Department of Pharmacy, “Male Sprague-Dawley rats were used in the experiments. The type 2 diabetes mellitus (T2DM) animals were treated with Cur for 8 weeks and blood lipid markers, bone microstructure and bone biomechanics were then evaluated. The mRNA expression levels of TGF beta 1, type I TGF beta receptor (T beta RI), T beta RII and Smad2/3 were determined using reverse transcription-quantitative PCR (RT-qPCR) and immunohistochemistry. The body weight of rats with type 2 diabetes-induced osteoporosis increased (P <0.05), while the lipid (total cholesterol, triglyceride and low-density lipoprotein) and fasting blood glucose levels were decreased by Cur (P <0.05). In addition, Cur significantly improved bone biomechanical properties (maximum load, breaking load, elastic load and the bone rigidity coefficient) and preserved bone microarchitecture (P <0.05). The RT-qPCR and IHC results revealed that Cur increased TGF <beta >1, T beta RI, T beta RII and Smad2/3 expression levels and promoted Smad2/3 phosphorylation in bones.”

According to the news reporters, the research concluded: “The present results also indicated that Cur regulated lipid and glucose levels, improved bone biomechanical properties and preserved bone microarchitecture, and that these effects may be mediated via TGF beta /Smad2/3 pathway activation.”

 

 

20 Minutes in Nature a Day Is Your Ticket to Feeling Better

University of Michigan, September 19, 2020

 

Nature soothes our stressed-out souls. We instinctively know nature is the best prescription, but research is revealing how little time we need to set aside to reap the benefits.

In one study, published in the journal Frontiers in Psychology, researchers tried to identify the most effective "dose" of nature within the context of normal daily life. As more doctors prescribe nature experiences for stress relief and other health benefits — sometimes referred to as a "nature pill" — the study's authors hoped to clarify the details of these treatments. More biophilia is generally better for us, but since not everyone can spend all day in deep wilderness, the study looked for a sweet spot.

"We know that spending time in nature reduces stress, but until now it was unclear how much is enough, how often to do it, or even what kind of nature experience will benefit us," says lead author MaryCarol Hunter, an associate professor at the University of Michigan's School for Environment and Sustainability, in a statement. "Our study shows that for the greatest payoff, in terms of efficiently lowering levels of the stress hormone cortisol, you should spend 20 to 30 minutes sitting or walking in a place that provides you with a sense of nature."

A nature pill can be a low-cost, low-risk way to curb the negative health effects of urbanization and indoor lifestyles. To find the most efficient dosage, Hunter and her co-authors asked 36 city dwellers to have nature experiences of at least 10 minutes three times per week over eight weeks. (A nature experience was defined as "anywhere outside that, in the opinion of the participant, made them feel like they've interacted with nature," Hunter explains.) Every two weeks, the researchers collected saliva samples to measure levels of the stress hormone cortisol, both before and after the participants took their nature pill.

The data showed that just a 20-minute nature experience was enough to significantly reduce cortisol levels. The effect was most efficient between 20 to 30 minutes, after which benefits continued to accrue but at a slower rate. Researchers in the United Kingdom who analyzed the routines of roughly 20,000 people came up with a similar prescription: 2 hours a week totalspent in a park or woodland setting will improve your health.

Nature Time Doesn't Have to Mean Exercise, Either 

Those results dovetail with the findings of other studies, one of which found that spending 20 minutes in an urban park can make you happier, regardless of whether you use that time to exercise. That study was published in the International Journal of Environmental Health Research,

"Overall, we found park visitors reported an improvement in emotional well-being after the park visit," lead author and University of Alabama at Birmingham professor Hon K. Yuen said in a statement. "However, we did not find levels of physical activity are related to improved emotional well-being. Instead, we found time spent in the park is related to improved emotional well-being."

For this study, 94 adults visited three urban parks in Mountain Brook, Alabama, completing a questionnaire about their subjective well-being before and after their visit. An accelerometer tracked their physical activity. A visit lasting between 20 and 25 minutes demonstrated the best results, with a roughly 64 percent increase in the participants' self-reported well-being, even if they didn't move a great deal in the park. That last point is particularly positive since it means almost anyone can benefit from visiting a nearby park, regardless of age or physical ability.

The study's co-author and another UAB professor, Gavin Jenkins, acknowledges the study pool was small, but its findings illustrate the importance of urban parks.

"There is increasing pressure on green space within urban settings," Jenkins said in the statement. "Planners and developers look to replace green space with residential and commercial property. The challenge facing cities is that there is increasing evidence about the value of city parks but we continue to see the demise of these spaces."

In another review published in Frontiers in Psychology, researchers at Cornell University examined the results of 14 studies that focused on the impact of nature on college students. They found that you might not even need the full 20 minutes to reap the benefits of some outdoor time. The studies showed that as little as 10–20 minutes of sitting or walking in nature can help college students feel happier and less stressed.

“It doesn’t take much time for the positive benefits to kick in,” said lead author Gen Meredith, associate director of the Master of Public Health Program and lecturer at the College of Veterinary Medicine, in a statement. “We firmly believe that every student, no matter what subject or how high their workload, has that much discretionary time each day, or at least a few times per week.”

 

 

Astaxanthin Supplementation Reduces Depression and Fatigue in Healthy Subjects

BGG North America and BGG, Beijing, August 26 2020

Objective: Natural Astaxanthin from Haematococcus pluvialis microalgae (NAX) has been researched in hundreds of clinical trials, pre-clinical animal studies and in-vitro surveys for various bioactive properties that indicate potential preventive and therapeutic health benefits. Among the most widely-researched properties of astaxanthin in the literature are broad-spectrum anti-inflammato- ry activity and powerful antioxidant capacity. In addition, both human and animal research have revealed a wide range of potential benefits for neurological and eye health, cardiovascular function, exercise endurance, enhancement of the immune response and skin health. This study’s goal was to explore the effects of a daily dose of 12 mg per day of NAX on psychological mood state in healthy subjects.

Abstract

Methods: This study employed placebo control and parallel design under double blind conditions. A total of 28 healthy subjects, half male and half female, with a median age of 42, supplemented with 12 mg per day of NAX or placebo. Before Day 0 and again at the end of the 8-week supplementation period, subjects completed a validated Profile of Mood States (POMS) survey to assess global mood state (GM) and related subscales: Vigor (V), Tension (T), Depression (D), Anger (A), Fatigue (F) and Confusion (C).

Results: Significant improvements were found in the NAX treatment group for positive mood state parameters: GM (+11%, p < 0.05) and V (+5%, NS); and negative mood state parameters: D (-57%, p < 0.05), F (-36%, p < 0.05), T (-20%, NS), A (-12%, NS), and C (-28%, NS).

Conclusions: While previous studies have shown NAX supplementation to improve parameters associated with brain health (neuro- inflammation and cognition), these data are the first to suggest that natural astaxanthin supplementation reduces negative mood state parameters (depression and fatigue) and improves global mood state and thus supports mental wellness.

 
 

 

Excessive exercise may tire your mind and body, reveals study

Pitie Salpetgriere University (France), September 18, 2020

 

Too much exercise can make your brain tired too, suggests a study published in the journal Current Biology.

French researchers found a form of mental fatigue among athletes subjected to a heavy training load. The athletes acted impulsively, having sought immediate rewards instead of bigger ones that take longer to achieve.

This form of mental fatigue affected a region of the brain that was previously linked to decreased cognitive control, said the researchers.

“The lateral prefrontal region that was affected by sport-training overload was exactly the same that had been shown vulnerable to excessive cognitive work in our previous studies,” said co-author Mathias Pessiglione of Pitie-Salpetriere University Hospital in Paris.

These findings demonstrate that mental and physical activity both require cognitive control, a finding that can benefit not only athletes but also policymakers, economic leaders, students and dieters.

Poorer decision-making due to fatigue

The researchers came up with the study after observing athletes training under the National Institute of Sport, Expertise and Performance in France, a public organization that runs elite sports programs in preparation for the Olympics.

According to the researchers, some athletes experienced an “overtraining syndrome,” in which performance levels drop as a trainee experiences an overwhelming sense of fatigue. The team wanted to know whether the syndrome was caused by the same kind of cognitive fatigue that was linked to excessive intellectual work.

For the study, they enlisted 37 competitive male endurance athletes with a mean age of 35 years. They were assigned either to continue normal training or undergo increased training intensity that went up by 40 percent per session over a three-week period. The team administered physical and behavioral tests and elicited the participants’ subjective experience of fatigue through questionnaires every two days.

Results showed that the athletes subjected to increased training intensity reported feeling more fatigued compared to the control group. They also acted more impulsively in standard tests used to evaluate economic decision-making by favoring immediate over delayed rewards. The researchers examined their brain activity as they made those choices and found diminished activity in the lateral prefrontal cortex.

“Our findings draw attention to the fact that neural states matter: you don’t make the same decisions when your brain is in a fatigue state,” said Pessiglione.

The study’s findings apply to a broad range of disciplines that include sports medicine, economics, politics, education and nutrition. According to the authors, it may be important to monitor fatigue levels in order to prevent bad decisions from being made. In turn, this can help people choose the right foods, improve study habits and manage finances better, among other applications.

Link between fatigue and poor cognitive health

Other studies also found that fatigue may have adverse effects on cognitive health.

One study examined the link between exercise and poor mental health. Participants were asked to self-report the number of days in the previous month when they felt mentally unwell. They were also asked how often they worked out during that period of time.

The researchers found that exercising for 45 minutes a day for three to five times a week offered the best mental health benefit. However, those who exercised for more than three hours a day displayed poorer mental health than even those who did not work out at all.

The researchers commented that people who exercise too much may be working themselves out to the point of exhaustion.

Meanwhile, another study looked at burnout and its effect on cognitive function. Researchers enlisted individuals who were clinically diagnosed with burnout and healthy individuals. All participants went through tests that measured their ability to regulate negative emotions.

The team found that burnout patients had a more difficult time modulating strong negative emotional responses compared to the healthy control group. (Related: Experts determine burnout and depression are closely linked.)

The findings of these studies serve as an important reminder that any physical and mental work should be done in moderation. Exhaustion has serious effects on brain health.

 

 

Headstand (Sirshasana) Does Not Increase the Blood Flow to the Brain

Saint-Petersburg State University (Russia) and Ohio State University, September 15, 2020

Abstract

Objectives: Most yoga practitioners believe that headstand (Sirshasana) results in increased cerebral perfusion. This, however, is not consistent with autoregulation of the cerebral blood flow. The intent of this study was to demonstrate the effect of Sirshasana on the blood flow to the brain through ultrasound examination of the internal carotid artery (ICA).

Design, location, and subjects: The ICA blood flow was measured with pulsed Doppler in 20 men and women aged 10 to 59 years (median 43) while performing the headstand (Sirshasana). Seventeen subjects were studied in 2018 in Spain at the altitude of 2,000 m, whereas the other three females were studied at sea level.

Results: Although the diameter of the artery under examination during the headstand remained almost unchanged, the decrease in peak flow velocities in systole and diastole caused a significant decrease in arterial blood flow to the brain, followed by return to baseline values immediately after the antiorthostatic postural effect, likely due to the expected consequences of the cerebral blood flow autoregulation of the cerebral blood supply as well as the intracranial pressure.

Conclusions: Contrary to popular belief, Sirshasana does not increase blood flow to the brain through the ICA, but results in predictable reduction in cerebral blood delivery in compliance with known mechanisms of autoregulation of cerebral blood flow. Moreover, increased ICA blood flow while performing the headstand is likely to be a contraindication to this exercise.

The Gary Null Show - 09.18.20

The Gary Null Show - 09.18.20

September 18, 2020

Could breadfruit be the next superfood? researchers say yes

Breadfruit is sustainable, environmentally friendly and a high-production crop

University of British Columbia, September 17, 2020

 

A fruit used for centuries in countries around the world is getting the nutritional thumbs-up from a team of British Columbia researchers. 

Breadfruit, which grows in abundance in tropical and South Pacific countries, has long been a staple in the diet of many people. The fruit can be eaten when ripe, or it can be dried and ground up into a flour and repurposed into many types of meals, explains UBC Okanagan researcher Susan Murch.

"Breadfruit is a traditional staple crop from the Pacific islands with the potential to improve worldwide food security and mitigate diabetes," says Murch, a chemistry professor in the newly-created Irving K. Barber Faculty of Science. "While people have survived on it for thousands of years there was a lack of basic scientific knowledge of the health impacts of a breadfruit-based diet in both humans and animals." 

Breadfruit can be harvested, dried and ground into a gluten-free flour. For the project, researchers had four breadfruits from the same tree in Hawaii, shipped to the Murch Lab at UBC Okanagan. Doctoral student Ying Liu led the study examining the digestion and health impact of a breadfruit-based diet. 

"Detailed and systematic studies of the health impacts of a breadfruit diet had not previously been conducted and we wanted to contribute to the development of breadfruit as a sustainable, environmentally-friendly and high-production crop," Liu says.

The few studies done on the product have been to examine the glycemic index of breadfruit--with a low glycemic index it is comparable to many common staples such as wheat, cassava, yam and potatoes. 

"The objective of our current study was to determine whether a diet containing breadfruit flour poses any serious health concerns," explains Liu, who conducted her research with colleagues from British Columbia Institute of Technology's Natural Health and Food Products Research Group and the Breadfruit Institute of the National Tropical Botanic Garden in Hawaii.

The researchers designed a series of studies--using flour ground from dehydrated breadfruits--that could provide data on the impacts of a breadfruit-based diet fed to mice and also an enzyme digestion model. 

The researchers determined that breadfruit protein was found to be easier to digest than wheat protein in the enzyme digestion model. And mice fed the breadfruit diet had a significantly higher growth rate and body weight than standard diet-fed mice.

Liu also noted mice on the breadfruit diet had a significantly higher daily water consumption compared to mice on the wheat diet. And at the end of the three-week-trial, the body composition was similar between the breadfruit and wheat diet-fed mice.

"As the first complete, fully-designed breadfruit diet study, our data showed that a breadfruit diet does not impose any toxic impact," says Liu. "Fundamental understanding of the health impact of breadfruit digestion and diets is necessary and imperative to the establishment of breadfruit as a staple or as a functional food in the future."

The use of breadfruit is nutritious and sustainable and could make inroads in food sustainability for many populations globally, she adds. For example, the average daily consumption of grain in the United States is 189 grams (6.67 ounces) per day. Liu suggests if a person ate the same amount of cooked breadfruit they can meet up to nearly 57 per cent of their daily fibre requirement, more than 34 per cent of their protein requirement and at the same time consume vitamin C, potassium, iron, calcium and phosphorus.

"Overall, these studies support the use of breadfruit as part of a healthy, nutritionally balanced diet," says Liu. "Flour produced from breadfruit is a gluten-free, low glycemic index, nutrient-dense and complete protein option for modern foods."

 

 

Fructose and glucose in high fructose corn syrup deliver a one-two punch to health

New study links combination of the two sugars in high fructose corn syrup to heart health risks

University of California at Davis, September 17, 2020

 

Consuming high fructose corn syrup appears to be as bad for your health as consuming sugar in the form of fructose alone, according to a new study from researchers at the University of California, Davis. The study reports health risks related to the type of sugar consumed, but also reveals novel risks when sugars are combined, which has important implications for dietary guidelines.

When it comes to health risks, sugar in the form of fructose is clearly the bad guy. This is because a majority of fructose consumed ends up in the liver. When there is too much fructose, the liver produces uric acid and fat in the form of triglycerides, which increase the risk of fatty liver, heart disease and gout. But lead investigator Kimber Stanhope, a researcher with the UC Davis School of Veterinary Medicine, says the new data shows that we shouldn't let glucose off the hook.

"It turns out that the combination of fructose and glucose found in high fructose corn syrup appears to be worse than fructose alone for some heart disease risk factors," said Stanhope. "When we planned this study, we didn't expect to find this."

Research has shown that fructose compared with glucose increases risk factors for heart disease and diabetes. This led to an assumption that the glucose in the high fructose corn syrup is benign. The new study, published in Metabolism Journal, tested this assumption by examining differences in health risk factors based on sugar type. Participants consumed beverages containing fructose, glucose, high fructose corn syrup, or an aspartame control, and researchers analyzed their blood for known risk factors for heart disease and diabetes.

The researchers expected risk factors would be highest for fructose and lowest for glucose, with high fructose corn syrup somewhere in between. This is exactly what they saw for some of the risk factors. However, for others, including the risk factors many scientists believe are the most predictive for heart disease, the increases were highest for high fructose corn syrup due to an interaction of fructose and glucose.

CONSUMER CHOICES AND DIETARY GUIDELINES 

The results of the current study suggest that dietary guidelines and consumer choices should not be based on the assumption that all adverse effects from dietary sugars are due to fructose content.

"Our study shows that nutrition is more than looking at individual food components," said first author Bettina Hieronimus with the Department of Child Nutrition at the Max-Rubner Institut in Karlsruhe, Germany. "To understand the way our food affects our bodies, we need to study diets as a whole."

 

 

We are predisposed to forgive, new research suggests

Yale University and Oxford University, September 17, 2020

     

When assessing the moral character of others, people cling to good impressions but readily adjust their opinions about those who have behaved badly, according to new research.

 

This flexibility in judging transgressors might help explain both how humans forgive -- and why they sometimes stay in bad relationships, said the study's authors.

 

The research -- conducted by psychologists at Yale, University of Oxford, University College London, and the International School for Advanced Studies -- in the journal Nature Human Behaviour.

 

"The brain forms social impressions in a way that can enable forgiveness," said Yale psychologist Molly Crockett, senior author of the paper. "Because people sometimes behave badly by accident, we need to be able to update bad impressions that turn out to be mistaken. Otherwise, we might end relationships prematurely and miss out on the many benefits of social connection."

 

Across a series of experiments, more than 1500 subjects observed the choices of two strangers who faced a moral dilemma: whether to inflict painful electric shocks on another person in exchange for money. While the "good" stranger mostly refused to shock another person for money, the "bad" stranger tended to maximize their profits despite the painful consequences. The subjects were asked their impressions of the strangers' moral character and how confident they were about those impressions.

 

Subjects rapidly formed stable, positive impressions of the good stranger and were highly confident of their impressions. However, the subjects were far less confident that the bad stranger was truly bad and could change their minds quickly. For instance, when the bad stranger occasionally made a generous choice, subjects' impressions immediately improved -- until they witnessed the stranger's next transgression."

 

This pattern of impression updating may provide some insight into why people sometimes hold on to bad relationships, Crockett said. "We think our findings reveal a basic predisposition towards giving others, even strangers, the benefit of the doubt. The human mind is built for maintaining social relationships, even when partners sometimes behave badly."

 

The research also may eventually help shed light on psychiatric disorders involving social difficulties, such as Borderline Personality Disorder.

 

"The ability to accurately form impressions of others' character is crucial for the development and maintenance of healthy relationships" said Jenifer Siegel, an Oxford doctoral student and lead author of the paper. "We have developed newtools for measuring impression formation, which could help improve our understanding of relational dysfunction."

 

 

Intermittent Fasting Diet Improves Health Without Altering The Body’s Core Clock

University of Copenhagen, Australian Catholic University and Karolinska Institutet, September 17, 2020

 

When it comes to metabolic health, it’s not just what you eat, it’s when you eat it. Studies have shown that one effective means of losing weight and tackling obesity is to reduce the number of hours in the day that you eat. Time-restricted feeding – otherwise known as intermittent fasting – has also been shown to improve health even before weight loss kicks in.

The biological explanation for the phenomenon remains poorly understood. So scientists from the University of Copenhagen, the Australian Catholic University and Karolinska Institutet investigated the body’s early adaptations to time-restricted feeding. Their study identified a number of key changes in the genetic activity of muscles, as well as the content of muscle fats and proteins, which could explain the positive impact of time-restricted feeding.

Novel insights on short-term time-restricted feeding

The study is the first time scientists have examined the oscillations of metabolites in skeletal muscle and in blood, as well as gene expression in skeletal muscle after time-restricted feeding. By focusing on the short-term and early effects of time-restricted feeding, the goal was to disentangle the signals that govern health from those associated with weight loss.

“We observe that the rhythm of skeletal muscle core clock genes is unchanged by time-restricted feeding, suggesting that any differences are driven more by diet, rather than inherent rhythms,” says Postdoc Leonidas Lundell, from the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) at the University of Copenhagen.

“We also see that the metabolite profile of skeletal muscle switches from being predominantly lipid based, to amino acid based, after time-restricted feeding. This coincides with changes in rhythmicity of amino acid transporters, indicating that part of the amino acid profile could be due to absorption from the blood.”

Research Fellow Evelyn Parr from the Mary MacKillop Institute for Health Research at the Australian Catholic University, adds: “Our research is an important step towards understanding how time-restricted eating can improve metabolic health, while bridging the gap between animal models and human intervention studies. It was important to capture these early metabolic responses before assessing what changes might occur after a longer period following a time-restricted feeding pattern.”

Eating behavior does not impact the body’s core clock

In the study, 11 men with overweight/obesity were assigned one of two eating protocols for a period of five days, either unrestricted feeding, or eight-hours of time restricted feeding. On the fifth day, samples were taken every four hours for a full day. After a 10-day break, they repeated the experiment following the other eating protocol.

After each intervention, the team of scientists studied the gene expression in muscles, as well as the profile of metabolites – molecules that are formed through metabolic processes – in the blood and muscles.

They discovered that time-restricted feeding changed the rhythmic concentration of metabolites in blood and muscle. Time-restricted feeding also influenced the rhythmic expression of genes expressed by muscle, particularly those responsible for helping the transport of amino acids, the building blocks of proteins.

Critically, the study showed that time-restricted feeding did not alter the muscle’s core clock – the cell’s inbuilt metronome that regulates its daily cycle of activity. This suggests that the altered rhythmicity of metabolite and gene expression caused by time-restricted feeding could be responsible for the positive health impact.

“Our findings open new avenues for scientists who are interested in understanding the causal relationship between time-restricted feeding and improved metabolic health. These insights could help develop new therapies to improve the lives of people who live with obesity,” says Professor Juleen Zierath from Karolinska Institutet and CBMR at the University of Copenhagen.

 

 

 

Green soy extract could prevent cognitive dysfunction: Mouse data

University of Shizuoka (Japan), September 16, 2020

 

Intake of green soybean extract could help reverse cognitive dysfunction and its associated accumulation of beta-amyloid proteins in the brain, say researchers.

 

The accumulation of beta-amyloid proteins has long been linked to the development of brain stunting conditions including Alzheimer’s disease and other forms of dementia. 

 

The new findings come from a Japanese trial in mice with cognitive dysfunction.

 

Writing in the Journal of Functional Foods, the team revealed that brain functions were ‘significantly better-preserved’ in aged mice fed green soybean than age-matched control mice with or without yellow soybean feeding.

 

The molecular mechanisms of these beneficial effects on brain function were examined using transcriptome analysis. An increased expression of lipocalin-type prostaglandin Dsynthase (Ptgds) and a significant reduction in the amyloid precursor protein Aplp1 was reported by the team, led by Keiko Unno from the University of Shizuoka in Japan.

 

“As Ptgds binds and transports small lipophilic molecules (…) it has been proposed as the endogenous Aβ chaperone,” noted the team, adding that lower levels of the usually abundant protein “may play an important role in the development of dementia and of Alzheimer's disease (AD).”

“Furthermore, the amount of beta-amyloid 40 and 42 was reduced in the insoluble fraction of cerebral cortex,” the team noted.

 

Unno and colleagues noted that previous research has suggested several beneficial effects of soybean components such as so isoflavones, including previous suggestions of benefits for cognitive function and the prevention of oxidative damage.

 

In the current study, the isoflavones found to be present in soybean extracts were mostly the glycosides genstin and daidzin.

 

“The levels of genistein and daizein, aglycones of genstin and daidzin, respectively, were very low or not detected,” reported the team – adding that the content of oligo sugars, especially sucrose, was significantly higher in green soybean than in yellow. Furthermore, the contents of saponin and carotene in green soybean were found to be slightly higher in the green than in yellow, however the contents of other components were not different between green and yellow soybeans.

 

“Soybean feeding did not change the weight of body, liver or cerebrum,” Unno and colleagues said – adding that the average food consumptions of each group were also not different. 

 

 

 

Coffee associated with improved survival in metastatic colorectal cancer patients

Dana Farber Cancer Institute, September 17, 2020

 

In a large group of patients with metastatic colorectal cancer, consumption of a few cups of coffee a day was associated with longer survival and a lower risk of the cancer worsening, researchers at Dana-Farber Cancer Institute and other organizations report in a new study.

The findings, based on data from a large observational study nested in a clinical trial, are in line with earlier studies showing a connection between regular coffee consumption and improved outcomes in patients with non-metastatic colorectal cancer. The study is being published today by JAMA Oncology.

The investigators found that in 1,171 patients treated for metastatic colorectal cancer, those who reported drinking two to three cups of coffee a day were likely to live longer overall, and had a longer time before their disease worsened, than those who didn't drink coffee. Participants who drank larger amounts of coffee - more than four cups a day - had an even greater benefit in these measures. The benefits held for both caffeinated and decaffeinated coffee.

The findings enabled investigators to establish an association, but not a cause-and-effect relationship, between coffee drinking and reduced risk of cancer progression and death among study participants. As a result, the study doesn't provide sufficient grounds for recommending, at this point, that people with advanced or metastatic colorectal cancer start drinking coffee on a daily basis or increase their consumption of the drink, researchers say.

"It's known that several compounds in coffee have antioxidant, anti-inflammatory, and other properties that may be active against cancer," says Dana-Farber's Chen Yuan, ScD, the co-first author of the study with Christopher Mackintosh, MLA, of the Mayo Clinic School of Medicine. "Epidemiological studies have found that higher coffee intake was associated with improved survival in patients with stage 3 colon cancer, but the relationship between coffee consumption and survival in patients with metastatic forms of the disease hasn't been known."

The new study drew on data from the Alliance/SWOG 80405 study, a phase III clinical trial comparing the addition of the drugs cetuximab and/or bevacizumab to standard chemotherapy in patients with previously untreated, locally advanced or metastatic colorectal cancer. As part of the trial, participants reported their dietary intake, including coffee consumption, on a questionnaire at the time of enrollment. Researchers correlated this data with information on the course of the cancer after treatment.

They found that participants who drank two to three cups of coffee per day had a reduced hazard for death and for cancer progression compared to those who didn't drink coffee. (Hazard is a measure of risk.) Those who consumed more than four cups per day had an even greater benefit.

"Although it is premature to recommend a high intake of coffee as a potential treatment for colorectal cancer, our study suggests that drinking coffee is not harmful and may potentially be beneficial," says Dana-Farber's Kimmie Ng, MD, MPH, senior author of the study.

"This study adds to the large body of literature supporting the importance of diet and other modifiable factors in the treatment of patients with colorectal cancer," Ng adds. "Further research is needed to determine if there is indeed a causal connection between coffee consumption and improved outcomes in patients with colorectal cancer, and precisely which compounds within coffee are responsible for this benefit."

 

 

Research links increased omega-3 intake to improved cardiovascular outcomes

Ochsner Medical Center in New Orleans, Sept. 17, 2020 

 

A new study, the most comprehensive analysis of the role of omega-3 dosage on cardiovascular prevention to date, provides compelling evidence for consuming more EPA and DHA (eicosapentaenoic acid and docosahexaenoic acid, respectively) omega-3 fats. Published in Mayo Clinic Proceedings, the meta-analysis is an in-depth review of 40 clinical trials. According to the research, EPA and DHA omega-3 intake is associated with reduced risk of coronary heart disease (CHD) events, the cause of 7.4 million deaths globally each year, and reduced risk of myocardial infarction (heart attack), including fatal heart attack.  

Specifically, the study found that EPA+DHA supplementation is associated with a statistically significant reduced risk of:

  • myocardial infarction (13%) 
  • fatal myocardial infarction (35%) 
  • CHD events (10%) 
  • CHD mortality (9%)

"The study supports the notion that EPA and DHA intake contributes to cardioprotection, and that whatever you're getting through the diet, you likely need more," said Carl "Chip" Lavie, MD, a cardiologist at Ochsner Health in New Orleans and one of the study authors.

Cardiovascular benefits appear to increase with dosage. The researchers found that adding an extra 1000 mg of EPA and DHA per day decreased the risk of cardiovascular disease and heart attack even more: risk of cardiovascular disease events decreased by 5.8% and risk for heart attack decreased by 9.0%. The study looked at dosages of up to 5500 mg/day.

This research corroborates the results of an earlier meta-analysis from Harvard School of Public Health, published in October 2019, that looked at EPA and DHA dosage using the 13 largest clinical studies. This new paper encompasses more than triple the number of studies, which is the totality of the evidence to date.

"When separate analyses arrive at similar results, that's not only validating; it also underscores the science base needed to inform future intake recommendations," said co-author Aldo Bernasconi, PhD, Vice President of Data Science for the Global Organization for EPA and DHA Omega-3s (GOED), which commissioned this study. "Because this paper included more studies and all dosages, the estimates for a dose-response are more precise and the conclusions stronger."

EPA and DHA omega-3s are long-chain, marine-based fatty acids. Eating fish, particularly fatty fish such as salmon, anchovies and sardines, is the optimal way to get EPA and DHA omega-3s, since fish also provides other beneficial nutrients. However, most people around the world eat much less than the amount of fish recommended, so supplementing with omega-3s helps close the gap. 

"People should consider the benefits of omega-3 supplements, at doses of 1000 to 2000 mg per day – far higher than what is typical, even among people who regularly eat fish," added Dr. Lavie. "Taking omega-3 supplements is a relatively low-cost, high-impact way to improve heart health with few associated risks."

The Gary Null Show -  09.16.20

The Gary Null Show - 09.16.20

September 17, 2020

Turmeric may help ease the pain of a dodgy knee

University of Tasmania, September 11, 2020

An extract of Curcuma longa (CL), commonly known as turmeric, was found to be more effective than placebo for reducing knee pain in patients with knee osteoarthritis. However, CL did not affect structural aspects of knee osteoarthritis, such as swelling or cartilage composition assessed using MRI. Findings from a randomized, double-blind, placebo-controlled trial are published in Annals of Internal Medicine.

Despite its large disease burden, no approved disease-modifying drugs currently are available to treat osteoarthritis. Common treatments, such as acetaminophen and nonsteroidal anti-inflammatory drugs have only mild to moderate effects and are associated with adverse events. As such, an urgent need exists for safer and more effective drugs to treat osteoarthritis.

Researchers from the University of Tasmania, Australia randomly assigned 70 participants with symptomatic knee osteoarthritis and ultrasound evidence of effusion (swelling inside the knee joint) to receive either two capsules per day of CL (n = 36) or matched placebo (n = 34) for 12 weeks to determine the efficacy CL for reducing knee symptoms and joint swelling. Changes in pain and knee effusion-synovitis volume were assessed by standardized questionnaire and MRI, respectively, over 12 weeks. The researchers also looked for changes in cartilage composition, pain medication usage, quality of life, physical performance measures, and adverse events. 

After 12 weeks, they found that patients taking the turmeric supplements reported less pain than those in the placebo group with no adverse events. Besides, participants in the turmeric group consumed fewer pain medications compared to the participants in the placebo group. There was no difference in the structural aspects of knee osteoarthritis between the groups. Due to the modest effect of the turmeric extracts on knee pain, small sample size of the study, short-duration of follow-up and the single research center, the researchers suggest that multicenter trials with larger sample sizes and long duration of follow-up are needed to assess the clinical significance of their findings.

 

Pine bark supplements fight the harmful effects of oxidative stress after exercise: Research

University of Louisiana, September 15, 2020

Researchers from the University of Louisiana at Lafayette said that taking pine bark supplements led to lower levels of malonaldehyde (MDA), a toxic compound that serves as a biomarker for oxidative stress. This effect was seen 48 hours after exercise among individuals who took the supplements for at least two weeks.

The researchers noted that high physical activity often spurs higher levels of oxidative stress. But by taking pine bark supplements, individuals can benefit from an enhanced healing process.

“[Maritime] pine extract as compared to placebo was effective at affording protection from oxidative stress post-exercise,” wrote the researchers.

Pine bark extract protects against oxidative stress

Pine bark extract is an herbal extract that comes from the tree Pinus pinaster, or maritime pine. It grows abundantly in France, where its medicinal uses date back to the 14th century. French sailors used pine bark to combat scurvy, a condition caused by vitamin C deficiency, as they sailed from France to the New World.

Aside from being rich in vitamin C, pine bark extract is also packed with phytochemicals – natural plant compounds that contribute to the color, taste and smell of vegetables. The phytochemicals found in pine bark supplements include procyanidins and flavonoids, both of which lower inflammation and protect from oxidative stress. Previous research also linked pine bark extract to a host of health benefits such as boosting brain function, balancing blood sugar levels and improving blood flow.

In the study, the researchers looked at the effects of pine bark supplements on 20 healthy men. They were randomly assigned to either 200 mg of the extract or a placebo and took these for 14 days prior to the first exercise trial and for 2?days post-exercise. After a seven-day washout period, the men were asked to take the other medication.

Results showed that MDA levels significantly decreased among the pine bark group compared to the placebo group. The placebo group also displayed significant increases in MDA levels before and 48 hours after the exercise.

Given these findings, the researchers recommended further research to evaluate the effects of pine bark extract among individuals who practice intense training. Furthermore, they see great potential in pine bark extract for helping treat metabolic syndrome, a group of diseases that are influenced by oxidative stress.

 

Researchers use soy to improve bone cancer treatment

Washington State University, September 15, 2020

 

Researchers in recent years have demonstrated the health benefits of soy, linking its consumption to reduced risk of cardiovascular disease, obesity, cancer and improved bone health. 

Now, WSU researchers are hoping to use the health benefits of the popular legume to improve post-operative treatment of bone cancer. 

Reporting in the journal, Acta Biomaterialia, graduate student Naboneeta Sarkar and Professor Susmita Bose in WSU's School of Mechanical and Materials Engineering showed that the slow release of soy-based chemical compounds from a 3D-printed bone-like scaffold resulted in a reduction in bone cancer cells while building up healthy cells and reducing harmful inflammation. 

"There is not much research in this area of natural medicinal compounds in biomedical devices," Bose said. "Using these natural medicines, one can make a difference to human health with very minimal or no side effects, although a critical issue remains composition control." 

Although rare, osteosarcoma occurs most often in children and young adults. Despite medical advances, patients with osteosarcoma and metastatic bone cancer experience a high rate of recurrence, and osteosarcoma is second leading cause of cancer death in children. 

Treatment involves surgery to remove the tumor as well as pre- and post-operative chemotherapy. Large areas of bone need to be removed and repaired, and patients often experience a significant amount of inflammation during bone reconstruction, which slows healing. High doses of chemotherapy before and after surgery can also have harmful side effects.

Researchers would like to develop gentler treatment options, especially after surgery when patients are trying to recover from bone damage at the same time that they are taking harsh drugs to suppress tumor growth. Bose's team has been studying bone tissue engineering as an alternative strategy to repair the bone, using materials science principles and advanced manufacturing techniques to develop effective biomedical devices. 

As part of this study, the researchers used 3D printing to make patient-specific, bone-like scaffolds that included three soy compounds and then slowly released the compounds into samples containing bone cancer as well as healthy bone cells. Soybeans contain isoflavones, plant-derived estrogens that have been shown to impede cancer cell growth for many types of cancer without being toxic to normal cells. Isoflavones have also been shown to improve bone health and possibly prevent osteoporosis. 

One of the soybean compounds caused a 90% reduction in bone cancer cell viability in their samples after 11 days. Two other soy compounds, meanwhile, significantly improved the growth of healthy bone cells. Furthermore, using the soy compounds in animal models also reduced inflammation, which could benefit bone health as well as overall recovery. 

"These results advance our understanding in providing therapeutic approaches in using synthetic bone grafts as a drug delivery vehicle," Bose said. 

The researchers are continuing the unique area of research, studying the specific pathways of the genetic expression of natural compounds and the benefits of integrating them in biomedical technology. More detailed long-term studies are needed, using animal research as well as other malignant cells, she said.

 

 

Broccoli extract found to significantly improve autism symptoms; sulforaphane molecule is powerful natural medicine

Mass General Hospital for Children, September 14, 2020

A powerful anti-cancer nutrient found naturally in cruciferous vegetables such as broccoli and cauliflower could help significantly improve health outcomes in autistic men and boys. Research published in the journal The Proceedings of the National Academy of Sciences reveals that sulforaphane, an antioxidant compound, is capable of reversing many of the most common symptoms associated with autism spectrum disorders (ASD).

Although the U.S. Centers for Disease Control and Prevention (CDC) claims that there are no medications currently on the market that can treat or cure ASD, a placebo-controlled, randomized, double-blind pilot study suggests otherwise. Present most richly in broccoli sprouts, sulforaphane has been shown to help drastically improve social interactions and verbal communication in ASD-diagnosed men and boys as well as reduce hyperactivity, irritability and other ASD symptoms.

Conducted on 44 males aged 13 to 27, the study found that after 18 weeks of consuming sulforaphane-rich broccoli sprout extract, more than half of the men saw significant health improvements. Behavioral abnormalities also decreased significantly as a result of the treatment, as did lipid peroxidation and neuroinflammation. These same men also saw improvements in antioxidant capacity, glutathione synthesis, mitrochondrial function and oxidative phosphorylation.

"Sulforaphane, which showed negligible toxicity, was selected because it upregulates genes that protect aerobic cells against oxidative stress, inflammation, and DNA-damage, all of which are prominent and possibly mechanistic characteristics of ASD," the authors wrote.

Sulforaphane in broccoli sprouts regulates cellular health, energy production and detoxification

Depending on their individual weights, the men and boys were assigned to take either 232 mg (for those who weighed 100 pounds or less), 464 mg (101 to 199 pounds), or 696 mg (more than 200 pounds) of sulforaphane-rich broccoli extract daily. Such amounts are difficult to obtain from eating broccoli sprouts whole, but many supplement manufacturers offer capsules containing concentrated extract levels in this range or even higher.

This is good news for parents who are trying to help their autistic children achieve a better quality of life naturally. Sulphorane is an antioxidant nutrient with no negative side effects, meaning it can only help an ASD-afflicted child. Likewise, whole broccoli sprouts are a "superfood," not a drug, so parents do not have to worry that it will harm their children in any way.

As an added benefit, sulforaphane might also help ameliorate a number of other genetic disorders by activating the body's "stress proteome." The stress proteome is responsible for regulating processes such as glutathione synthesis, mitochondrial function (cellular health), and neurological inflammation.

When ASD patients stopped taking sulforaphane, their symptoms returned

In order for sulforaphane to work, however, ASD patients need to continue taking it. At the 22-week reassessment, which took place one month after study participants ceased taking the broccoli sprout extract, most (but not all) of their improvements had waned or disappeared. The researchers involved say this change only reinforces their finding that sulforaphane was directly responsible for the positive improvements observed throughout the study.

"When we broke the code that revealed who was receiving sulforaphane and who got the placebo, the results weren't surprising to us, since the improvements were so noticeable," stated Dr. Andrew Zimmerman, M.D., one of the study's authors and a physician at MassGeneral Hospital for Children (MGHfC).

"The improvements seen on the Social Responsiveness Scale were particularly remarkable, and I've been told this is the first time that any statistically significant improvement on the SRS has been seen for a drug study in autism spectrum disorder," he added, noting that the consensus among the research team was that sulforaphane likely activates the Nrf2 pathway, reducing inflammation in the brain and promoting increased antioxidant protection.

 

 

 

Exercise's Surprising Potential To Treat People With Multiple Chronic Conditions

University of Southern Denmark, September 11, 2020

 

Hundreds of millions of people of all ages worldwide live with two or more chronic conditions – commonly defined as multimorbidity. Those living with it are found to have poorer physical and mental health, higher risk of being admitted to hospital, and higher risk of dying prematurely compared to people with only one chronic condition.

Given that the number of people living with multimorbidity is only expected to rise in the future, finding better treatments is considered the next major health priority. But despite multimorbidity being a leading cause of disability, research on treatments are still in its infancy. Few studies have investigated treatment options – and unfortunately the results of these studies most often offer negligible improvements.

People with multimorbidity want treatments that will improve their physical, mental, emotional, and social health. Our research found that exercise may actually be a surprising treatment for those living with multimorbidity, and offer many of these improvements patients want.

Currently, multimorbidity is managed by treating each chronic conditions separately using available medicines. However, this might not reduce symptoms sufficiently, and can have many adverse health effects. Many people consult several health care providers and also end up taking multiple drugs (often at least one for each condition) which carries a risk of adverse events and can be inconvenient and unsatisfactory for patients.

Exercise as medicine

Research has shown exercise is an effective treatment for 26 chronic conditions, including osteoarthritis, depression and type 2 diabetes. Research also shows exercise could potentially prevent 35 chronic conditions from developing.

Thanks to its overall effects on health (such as lowering blood pressureimproving joint health and cognitive function, exercise therapy can benefit a range of chronic conditions. It also has a lower risk of negative side effects compared to pharmacological treatments. At the same time, exercise requires physical effort, and like pharmacological treatments, the effects will diminish if you stop exercising.

But could exercise therapy benefit people with multiple chronic conditions as well? This is what our recent review aimed to investigate.

We assessed the effect of exercise therapy on the physical and mental health of people with at least two of the following chronic conditions: osteoarthritis of the knee or hip, hypertension, type 2 diabetes, depression, heart failure, ischemic heart disease, and chronic obstructive pulmonary disease. We found 23 studies that looked at adults aged 50 to 80 years old.

The exercise therapy interventions used in the studies were at least partially supervised by a physiotherapist or an exercise physiologist. Most lasted 12 weeks on average and exercise was performed two to three times a week, starting from low intensity and progressing to moderate to high intensity. The exercise therapies included were aquatic exercise, strength training, aerobic training and tai chi.

Our review showed exercise therapy improved quality of life and reduced anxiety and depression symptoms. The benefits were higher in younger patients and patients who had higher depression symptoms before starting exercise therapy. This highlights that people with severe depression – often considered ineligible for exercise due to their depression severity – may benefit highly from exercise therapy.

Patients who participated in exercise therapy were also able to walk longer. Those taking part walked on average 43 metres more than those not taking part in the exercise interventions, over six minutes. This improvement appears to be important for the patient and it reduced their disability.

Exercise therapy also didn’t increase risk of non-serious side effects, such as knee, arm, or back pain, or falls and fatigue. What’s more, it reduced the risk of hospitalisation, pneumonia, and extreme fatigue.

As such, exercise could be a safe and effective therapy instead of increasing drug prescription in people with multiple chronic conditions. The benefits were similar across all the combinations of chronic conditions included in our study. However these findings need to be confirmed in future trials to have a more definitive answer.

Together with patients and healthcare professionals, we are developing and testing an exercise therapy and self-management programme in the MOBILIZE project. This trial will help us understand whether personalised exercise therapy and self-management is effective in managing and treating multimorbidity.

In the meantime, people with multimorbidity can improve mental and physical health by exercising two to three times a week. Aerobic workouts, strength training or a combination of the two can promote similar health benefits, regardless of the conditions a person live with. However, it’s important that the exercise therapy sessions are supervised and that the intensity of the session progresses based on patient capabilities.

 

Plant-based diets found to relieve symptoms of rheumatoid arthritis

George Washington University, September 14, 2020

 

In a major breakthrough, a team of researchers from the George Washington University School of Medicine and Health Sciences and the non-profit health organization Physicians Committee for Responsible Medicine (PCRM) looked at recent studies that assessed the impact of diet on the risk of rheumatoid arthritis.

The group found that certain foods, such as red meat, milk and milk products, could exacerbate the condition. In contrast, diets rich in plant-based foods like fruits, grains and legumes help reduce pain and inflammation in rheumatoid arthritis patients.

In all, these findings suggest that a simple menu change could help patients better manage their disease, said co-author and PCRM clinical research director Hana Kahleova. Sticking to a plant-based diet could also keep the disease in remission for long periods. Their findings appeared online in the journal Frontiers in Nutrition.

Plant-based diets can benefit rheumatoid arthritis patients

Numerous studies indicate that plant-based diets could help decrease the risk of chronic autoimmune conditions like rheumatoid arthritis. In patients, adopting a plant-based diet could help in better management of the disease for the long-term.

There are a number of possible mechanisms behind these beneficial effects. For instance, results of randomized clinical trials (RCT) indicate that a plant-based diet could reduce total cholesterol and induce weight loss better than conventional calorie-restricted diets.

Having high cholesterol and being obese could lead to the onset of rheumatoid arthritis or exacerbate joint pain and inflammation in patients. Therefore, these findings suggest that a plant-based diet decreases the risk and eases the effects of rheumatoid arthritis thanks to its influence on weight and total cholesterol.

Furthermore, several observational studies found strong and consistent evidence that a plant-based diet can reduce inflammation linked to rheumatoid arthritis. In contrast, semi-vegetarian or omnivorous diets that still contained meat and animal products triggered inflammation in patients.

In particular, one RCT found that a gluten-free vegan diet reduced the amount of a pro-inflammatory antibody, called immunoglobulin G (IgG), in rheumatoid arthritis patients. Patients typically have higher than appropriate amounts of IgG in their blood and lymph fluid.

Moreover, another RCT found that a three-month Mediterranean dietary intervention improved rheumatoid arthritis symptoms. A Mediterranean diet is rich in monounsaturated fats that protect against inflammation and oxidative stress. Copious amounts of these fats can be found in plant-based foods like nuts and avocados.

In addition, the researchers found that the state of one’s gut health, which depends on diet and nutrition, could also influence the onset and progression of rheumatoid arthritis. For instance, a permeable intestinal barrier, a marker of poor gut health, allows for bacteria and other microbes to enter the bloodstream.

These harmful agents could then trigger inflammation and joint pain in rheumatoid arthritis patients. Research shows that a plant-based diet modulates the gut microbiome for better gut health. In turn, this leads to less intestinal inflammation, which some studies suggest is connected to joint inflammation.

The researchers attribute these effects to the fibers in many plant-based foods. Fiber feeds the beneficial bacteria in the gut, thus making it less prone to infection and inflammation. Enzymes and amino acids in plant-based foods also increase bacterial diversity in the gut, which rheumatoid arthritis patients often lack.

Taken together, these studies provide empirical evidence that a plant-based diet comprised of fruits, vegetables, grains and legumes could be incredibly beneficial for people with rheumatoid arthritis.

 

 

Researchers Report Recent Findings that Garlic Improves Visual Memory and Attention

University of Dhaka (Bangladesh), September 14, 2020

Researchers from University of Dhaka Report Recent Findings in Complementary and Alternative Medicine that  "Studies have shown that Allium sativum L.  or garlic protects amyloid-beta peptide-induced apoptosis, prevents oxidative insults to neurons and synapses, and thus prevent Alzheimer's disease progression in experimental animals. However, there is no experimental evidence in human regarding its putative role in memory and cognition."

The news correspondents obtained a quote from the research from the University of Dhaka, "We have studied the effect of garlic consumption by healthy human volunteers on visual memory, verbal memory, attention, and executive function in comparison to control subjects taking placebo. The study was conducted over five weeks and twenty volunteers of both genders were recruited and divided randomly into two groups: A Garlic and B (placebo). Both groups participated in the 6 computerized neuropsychological tests of the Cambridge Neuropsychological Test Automated Battery (CANTAB) twice: at the beginning and after five weeks of the study. We found statistically significant difference (p < 0.05) in several parameters of visual memory and attention due to AS ingestion. We also found statistically nonsignificant (p > 0.05) beneficial effects on verbal memory and executive function within a short period of time among the volunteers."

According to the news reporters, the research concluded: "Study for a longer period of time with patients suffering from neuro degenerative diseases might yield more relevant results regarding the potential therapeutic role of garlic."

 

 

 

Why You Should Eat Two Apples a Day

Green Med Info, September 12th 2020 

 

A 2020 study points to apples' ability to mediate significant gut microbial metabolic activity. All it takes: two apples a day. In light of the increasing link between gut microbiota and human wellness, this new association is worth exploring and further vouches for this fruit's superfood and super healer status

The old saying that eating an apple a day will keep the doctor away may have some scientific basis after all, as scientific literature is packed with findings that vouch for this fruit's healthful benefits.

Showing that the saying above goes beyond folk medicine fantasy, a study found that eating one apple a day for four weeks translated to lower blood levels of oxidized low-density lipoprotein//beta2-glycoprotein I complex, which may contribute to atherosclerosis, by 40% among healthy, middle-aged individuals.[i]

Apple consumption has also been the subject of a few studies on reducing cancer risk, including liver cancerbreast cancer and esophageal cancer.[ii] A study published in February 2020 points to apples' ability to mediate significant gut microbial metabolic activity. All it takes: two apples a day.

Study Findings

Apples are a frequently consumed fruit and a reliable source of polyphenols and fiber, an important mediator for their health-protective effects.[iii]

Validated biomarkers of food intake (BFIs) have recently been suggested as a good tool for assessing adherence to dietary guidelines. New biomarkers have[iv] surfaced in recent decades from metabolic profiling studies for different foods, yet the number of comprehensively validated BFIs remains limited.

BFIs offer an accurate measure of intake, independent of the memory and sincerity of the subjects as well as of their knowledge about the consumed foods.[v] They overcome food intake measurement with inherent limitations, such as self-reported dietary intake questionnaires, as they objectively assess food intake without biased self-reported assessment.

The researchers sought to identify biomarkers of long-term apple consumption, exploring how the fruit affects human plasma and urine metabolite profiles. In their randomized, controlled, crossover intervention study, they recruited 40 mildly hypercholesterolemiapatients and had them consume two whole apples or a sugar and energy-matched beverage daily for eight weeks.

At the end of the trial, they found 61 urine and nine plasma metabolites that were statistically significant after the whole apple intake compared to the control beverage. The metabolites included several polyphenols that could serve as BFIs.

Interestingly, the study allowed the group to explore correlations between metabolites significantly modulated by the dietary intervention and fecal microbiota species at genus level -- specifically interactions shared by Granulicatella genus and phenyl-acetic acid metabolites.

"[T]he identification of polyphenol microbial metabolites suggests that apple consumption mediates significant gut microbial metabolic activity which should be further explored," they wrote.[vi]

Gut Health Affects Your Whole Body

The link between the gut microbiota and human wellness is being increasingly recognized, where it is now well-established that healthy gut flora is a key part of your overall health.[vii]

Previous studies corroborate that the richness of the human gut microbiome correlates with metabolic markers. In a study on 123 non-obese and 169 obese Danish individuals, a group of scientists found two distinct groups displaying a difference in the number of gut microbial genes and thus the richness of gut bacteria in the two groups.[viii]

Individuals with a low bacterial richness had more marked overall adiposity and insulin resistance, for instance, compared with high bacterial richness subjects. The obese subjects among the lower bacterial richness group also tended to gain more weight over time.

A series of largely pre-clinical observations showed, too, that changes in brain-gut-microbiome communication may be involved in the pathogenesis and pathophysiology of irritable bowel syndromeobesity and several psychiatric and neurologic disorders.[ix]

Additional Apple Benefits

More benefits of apple intake are coming out of the medical literature, confirming its superfood and super healer status that shouldn't be missed out on.

These benefits include addressing common issues such as aging (reduced rate), allergies, alopecia or hair loss, diarrhea, insulin resistance, radiation-induced illness, and Staphylococcal infection. In the area of cancer treatment, apples have been found to both prevent and suppress mammary cancers in the animal model, while carotenoids extracted from the fruit have been found to inhibit drug-resistant cancer cell line proliferation.[x]

The Gary Null Show - 09.15.20

The Gary Null Show - 09.15.20

September 15, 2020

LIVE Webinar With Dr. Gary Null: Positive Solutions for Today's Problems

 

Healthy diet and exercise during pregnancy could lead to healthier children, study finds

Kings College London, September 13, 2020

 

New research shows improving the lifestyle of women with obesity during pregnancy could mean long-term cardiovascular benefits for their children.

The study, led by King's College London and supported by the British Heart Foundation and Tommy's charity, examined how an antenatal diet and physical activity intervention in pregnant women with obesity could positively influence the health of the women and their children three years after giving birth.

The UPBEAT trial is a randomised controlled trial which aims to improve the diet and physical activity of obese pregnant women across the UK. Women who were given a diet and exercise intervention were compared to women in a control group, who made no changes to their lifestyle during pregnancy.

Follow-up examinations three years after birth showed that the children born to the intervention arm of the trial had a lower resting heart rate of -5 bpm than children treated with standard care. A higher resting heart rate in adults is associated with hypertension and cardiovascular dysfunction.

The study also showed that mothers in the intervention arm maintained a healthier diet three years after birth.

While women reported lower glycaemic load, maternal energy and saturated fatty acids intake, and higher protein intake three years after delivery, there were no differences in self-reported physical activity or in measures of body composition.

Lead author Kathryn Dalrymple from King's College London said: "This research shows that an lifestyle intervention in pregnant women, which focused on improving diet and increasing physical activity, is associated with improved cardiovascular function in the child at three-years of age and a sustained improvement in the mothers diet, three years after the intervention finished. These findings are very exciting as they add to the evidence that pregnancy is a window of opportunity to promote positive health and lifestyle changes which benefit the mother and her child."

Senior author Professor Lucilla Poston, Tommy's Chair for Maternal and Fetal Health, said: "Obesity in pregnancy is a major problem because it can increase the risk of complications in pregnancy as well as affecting the longer-term health of the child. This study strengthens my resolve to highlight just how important it is that we give children a healthy start in life."

Tommy's Research and Policy Director, Lizzie D'Angelo, said: "Pregnancy can be higher risk for women who are obese, but trying to lose lots of weight while pregnant is not advised, so our research focuses on finding new ways to make pregnancy safer for these families. It's very reassuring to see that our researchers have been able to improve mothers' diets and children's heart health in the long term, helping to give these babies the best start in life."

Tracy Parker, Senior Dietitian at the British Heart Foundation, said: "Keeping physically active and maintaining a balanced diet are both important ways of keeping our hearts healthy. This research shows that for pregnant women, the benefits don't end there. A healthy diet before, during and after pregnancy can have positive long-term health benefits for both mother and child."

The team of researchers will follow-up these children again at 8-10 years of age to see if this improvement in cardiovascular function is maintained through childhood.

 

 

Ashwagandha May Calm Generalized Anxiety Disorder 

New findings from a randomized, double-blind, placebo-controlled trial

Mashhad University of Medical Sciences (Iran), September 1, 2020

 

Study Objective:To assess the effect of an extract of Withania somnifera on symptoms of generalized anxiety

Design:  Randomized, double-blind, placebo-controlled trial

Participants

Forty patients who were undergoing treatment with selective serotonin reuptake inhibitors (SSRIs) participated in this trial. They met the criteria for generalized anxiety disorder (GAD) diagnosis as stated in the Diagnostic and Statistical Manual of Mental DisordersFourth Edition, Text Revision (DSM-IV-TR). They were randomly selected for the treatment group (W somnifera root extract, 1 g/day; n=22) or the placebo group (n=18). Patients received either the extract or placebo daily for 6 weeks.

Study Parameters Assessed

To assess the severity of GAD symptoms at baseline as well as at week 2 and week 6 of the trial, researchers used the Hamilton Anxiety Rating Scale (HAM-A). The HAM-A scale contains 14 questions rating the severity of common GAD symptoms, from 0 to 4.

Primary Outcome Measures

HAM-A scores during the course of the trial revealed a significant amelioration of GAD symptoms in the treatment group versus placebo (P<0.05). There was also a significant difference in the reduction of GAD score between the 2nd (P=0.04) and 6th week (P=0.02) in the treatment group. The extract was safe, and researchers observed no adverse effect during the trial.

Key Findings

Withania somnifera (ashwagandha) root extract is statistically efficacious at 1 gram per day after 2 weeks and even more so after 6 weeks of treatment. It has also been found to be safe to use while on SSRIs.

 

 

Pesco-Mediterranean diet, intermittent fasting may lower heart disease risk

Saint Luke's Mid America Heart Institute, September 11, 2020

 

A Pesco-Mediterranean diet rich in plants, nuts, whole grains, extra-virgin olive oil, and fish and/or seafood is ideal for optimizing cardiovascular health, according to a cumulative review published today in the Journal of the American College of Cardiology. Intermittent fasting is recommended as part of this diet.

The traditional Mediterranean diet has been endorsed by national guidelines as well as the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. The Mediterranean diet consists of plant foods (fruits, vegetables, legumes, whole grains, seeds, tree nuts and olives), fish/seafood, olive oil, and moderate amounts of dairy products (yogurt and cheese) and eggs. Multiple studies and randomized clinical trials have indicated that the diet is associated with lower risk for heart disease, diabetes, cognitive decline, depression and some cancers. 

"Although humans are omnivores and can subsist on a myriad of foods, the ideal diet for health remains a dilemma for many people," said James H. O'Keefe, MD, director of preventive cardiology at Saint Luke's Mid America Heart Institute, and lead author of the study. "Plant-rich diets reduce cardiovascular disease risk; however, veganism are difficult to follow and can result in important nutrient deficiencies. On the other hand, many people in modern Western cultures over-consume meat, particularly highly processed meat from animals raised in inhuman conditions. We propose the Pesco-Mediterranean diet as a solution to this 'omnivore's dilemma' about what to eat."

Previous studies have supported including fish as a part of a heart-healthy diet. The 2015-2020 Dietary Guidelines for Americans recommend adults consume fish at least twice a week in place of red meat, poultry or eggs. A pescatarian diet includes fish and/or seafood as the primary source of protein and minimizes the consumption of red meat or poultry. A meta-analysis of five prospective dietary studies found that compared to regular meat-eaters, coronary artery disease mortality was 34% lower in those following a pescatarian diet.

A Pesco-Mediterranean diet also emphasizes using extra-virgin olive oil in place of butter or other fats. Extra-virgin olive oil is a higher-quality, unrefined olive oil, and has been shown in previous studies to have cardiometabolic benefits, such as reducing low density lipoprotein ("bad") cholesterol and increasing high density lipoprotein ("good") cholesterol. The researchers recommend using generous amounts of extra-virgin olive oil (high in polyphenol antioxidants) along with vegetable dishes. To provide an additional source of healthy fats and fibers, the Pesco-Mediterranean diet includes tree nuts. The PREDIMED trial, a randomized clinical trial of primary heart disease prevention, showed a daily serving of mixed nuts resulted in a 28% lower risk of heart disease.

"There is no clear consensus among nutrition experts on the role of dairy products and eggs in heart disease risk, however we allowed for them in the Peso-Mediterranean diet," O'Keefe said. "Low-fat yogurt and cheeses are preferred; butter and hard cheese are discouraged due to a high concentration of saturated fats and salt. Eggs contain beneficial nutrients and can be a healthy substitute for red meat; however, we recommend no more than five yolks be consumed per week."

Intermittent fasting, the practice of limiting daily intake of calories in a specific time window (usually between eight to 12 hours) each day, has been shown to reduce inflammation and improve insulin sensitivity by forcing the body to switch from burning glucose to fatty acids (usually from belly fat) as the primary metabolic fuel. The most common form of intermittent fasting is timed-restricted eating, consisting of limiting to two, rather than three, meals per day and shortening the calorie-consumption window. Evidence regarding time-restricted eating is preliminary and requires more research.

"Our ancient ancestors did not have access to an unlimited supply of food throughout the year. Nor did they routinely eat three large meals, plus snacks, daily. Focusing on fresh whole foods, along with fish, bestows a range of health benefits, particularly when it comes to cardiovascular health. The Pesco-Mediterranean diet with daily time-restricted eating is an ideal cardioprotective diet," O'Keefe said.

 

 

Resveratrol impacts Alzheimer's disease biomarker 

 

Georgetown University Medical Center, September 11, 2020

 

The largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate Alzheimer's disease found that a biomarker that declines when the disease progresses was stabilized in people who took the purified form of resveratrol. 

 

Resveratrol is a naturally occurring compound found in foods such as red grapes, raspberries, dark chocolate and some red wines. 

The results, published in Neurology, "are very interesting," says the study's principal investigator, R. Scott Turner, MD, PhD, director of the Memory Disorders Program at Georgetown University Medical Center. Turner, who treats patients at MedStar Georgetown University Hospital, cautions that the findings cannot be used to recommend resveratrol. "This is a single, small study with findings that call for further research to interpret properly." 

 

The resveratrol clinical trial was a randomized, phase II, placebo-controlled, double blind study in patients with mild to moderate dementia due to Alzheimer's disease. An "investigational new drug" application was required by the U.S. Food and Drug Administration to test the pure synthetic (pharmaceutical-grade) resveratrol in the study. It is not available commercially in this form. 

 

The study enrolled 119 participants. The highest dose of resveratrol tested was one gram by mouth twice daily -- equivalent to the amount found in about 1,000 bottles of red wine. 

 

John Bozza, 80, participated in the study. Five years ago, his wife, Diana, began noticing "something wasn't quite right." He was diagnosed with mild cognitive impairment, but only a year later, his condition progressed to mild Alzheimer's. 

Diana, whose twin sister died from the same disease, says there are multiple reasons she and John decided to participate in the resveratrol study, and they now know he was assigned to take the active drug. 

 

"I definitely want the medical community to find a cure," she says. "And of course I thought there's always a chance that John could have been helped, and who knows, maybe he was." 

 

Patients, like John, who were treated with increasing doses of resveratrol over 12 months showed little or no change in amyloid-beta40 (Abeta40) levels in blood and cerebrospinal fluid. In contrast, those taking a placebo had a decrease in the levels of Abeta40 compared with their levels at the beginning of the study. 

 

"A decrease in Abeta40 is seen as dementia worsens and Alzheimer's disease progresses; still, we can't conclude from this study that the effects of resveratrol treatment are beneficial," Turner explains. "It does appear that resveratrol was able to penetrate the blood brain barrier, which is an important observation. Resveratrol was measured in both blood and cerebrospinal fluid." 

 

The researchers studied resveratrol because it activates proteins called sirtuins, the same proteins activated by caloric restriction. The biggest risk factor for developing Alzheimer's is aging, and studies with animals found that most age-related diseases--including Alzheimer's--can be prevented or delayed by long-term caloric restriction (consuming two-thirds the normal caloric intake). 

 

Turner says the study also found that resveratrol was safe and well tolerated. The most common side effects experienced by participants were gastrointestinal-related, including nausea and diarrhea. Also, patients taking resveratrol experienced weight loss while those on placebo gained weight. 

 

One outcome in particular was confounding, Turner notes. The researchers obtained brain MRI scans on participants before and after the study, and found that resveratrol-treated patients lost more brain volume than the placebo-treated group. 

"We're not sure how to interpret this finding. A similar decrease in brain volume was found with some anti-amyloid immunotherapy trials," Turner adds. A working hypothesis is that the treatments may reduce inflammation (or brain swelling) found with Alzheimer's. 

 

"Given safety and positive trends toward effectiveness in this phase 2 study, a larger phase 3 study is warranted to test whether resveratrol is effective for individuals with Alzheimer's -- or at risk for Alzheimer's," Turner says. 

 

Resveratrol and similar compounds are being tested in many age-related disorders including cancer, diabetes and neurodegenerative disorders. The study Turner led, however, is the largest, longest and highest dose trial of resveratrol in humans to date. 

 

 

 

Vitamin D deficiency associated with greater risk of oral squamous cell carcinoma

King Khalid University (Saudi Arabia),September 14, 2020

 

According to news reporting out Saudi Arabia research stated, “Serum level of vitamin D has been used as a predictor for cancer development. We intend to measure the baseline vitamin D level in patients with oral squamous cell carcinoma (OSCC) and to compare same with non-cancer controls to determine any association.”

The news correspondents obtained a quote from the research from Oral and Maxillofacial Surgery Department: “Patients with OSCC presenting to our clinics were included in this study. Their baseline serum vitamin D levels were measured prior to cancer treatment after obtaining their consents. These patients were then matched with at least 2 cancer-free subjects to serve as controls and whose serum vitamin D levels were also measured. The serum vitamin D levels obtained for the two groups were then categorized into normal (>35 ng/ml), mild deficiency (25-35 ng/ml), moderate deficiency (12.5-25 ng/ml), and severe deficiency (<12.5 ng/ml). The data were analyzed statistically and the two groups compared. A total of 51 patients with OSCC (Male 22 [43%] and female 29 [57%]) and 113 cancer-free controls (Male 36 [31.86%] and female 77 [68.14%]) were included in the study. The commonest site for OSCC was the tongue, accounting for 45% of the cancer cases. Mean age for cancer patients was 59.33 years ±12.54 and 49.24 years ±15.79 for the control. Among the OSCC patients, 74.51% had moderate to severe vitamin D deficiencies, whereas only 20.35% had a moderate deficiency in the control group with no severe deficiency.”

According to the news reporters, the research concluded: “Logistic regression analysis shows a positive association between vitamin D deficiency and OSCC risk especially in levels below 25 ng/ml. This further corroborates the assertion that vitamin D deficiency may be a useful indicator of OSCC. It may, therefore, be necessary to routinely prescribe vitamin D supplements to subjects with moderate to severe deficiencies in order to decrease the chances of OSCC development.”

 

 

Immune system affects mind and body, study indicates

Washington University School of Medicine in St. Louis, September 14, 2020

New research at Washington University School of Medicine in St. Louis helps illuminate a surprising mind-body connection. In mice, the researchers found that immune cells surrounding the brain produce a molecule that is then absorbed by neurons in the brain, where it appears to be necessary for normal behavior.

The findings, published Sept. 14 in Nature Immunology, indicate that elements of the immune system affect both mind and body, and that the immune molecule IL-17 may be a key link between the two.

"The brain and the body are not as separate as people think," said senior author Jonathan Kipnis, Ph.D., the Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology and a professor of neurosurgery, of neurology and of neuroscience. "What we've found here is that an immune molecule—IL-17—is produced by immune cells residing in areas around the brain, and it could affect brain function through interactions with neurons to influence anxiety-like behaviors in mice. We are now looking into whether too much or too little of IL-17 could be linked to anxiety in people."

IL-17 is a cytokine, a signaling molecule that orchestrates the immune response to infection by activating and directing immune cells. IL-17 also has been linked to autism in animal studies and depression in people.

How an immune molecule like IL-17 might influence brain disorders, however, is something of a mystery since there isn't much of an immune system in the brain and the few immune cells that do reside there don't produce IL-17. But Kipnis, along with first author and postdoctoral researcher Kalil Alves de Lima, Ph.D., realized that the tissues that surround the brain are teeming with immune cells, among them, a small population known as gamma delta T cells that produce IL-17. They set out to determine whether gamma-delta T cells near the brain have an impact on behavior. Kipnis and Alves de Lima conducted the research while at the University of Virginia School of Medicine; both are now at Washington University.

Using mice, they discovered that the meninges are rich in gamma-delta T cells and that such cells, under normal conditions, continually produce IL-17, filling the tissues surrounding the brain with IL-17.

To determine whether gamma-delta T cells or IL-17 affect behavior, Alves de Lima put mice through established tests of memory, social behavior, foraging and anxiety. Mice that lacked gamma-delta T cells or IL-17 were indistinguishable from mice with normal immune systems on all measures but anxiety. In the wild, open fields leave mice exposed to predators such as owls and hawks, so they've evolved a fear of open spaces. The researchers conducted two separate tests that involved giving mice the option of entering exposed areas. While the mice with normal amounts of gamma-delta T cells and levels of IL-17 kept themselves mostly to the more protective edges and enclosed areas during the tests, mice without gamma-delta T cells or IL-17 ventured into the open areas, a lapse of vigilance that the researchers interpreted as decreased anxiety.

Moreover, the scientists discovered that neurons in the brain have receptors on their surfaces that respond to IL-17. When the scientists removed those receptors so that the neurons could not detect the presence of IL-17, the mice showed less vigilance. The researchers say the findings suggest that behavioral changes are not a byproduct but an integral part of neuro-immune communication.

Although the researchers did not expose mice to bacteria or viruses to study the effects of infection directly, they injected the animals with lipopolysaccharide, a bacterial product that elicits a strong immune response. Gamma-delta T cells in the tissues around the mice's brains produced more IL-17 in response to the injection. When the animals were treated with antibiotics, however, the amount of IL-17 was reduced, suggesting gamma-delta T cells could sense the presence of normal bacteria such as those that make up the gut microbiome, as well as invading bacterial species, and respond appropriately to regulate behavior.

The researchers speculate that the link between the immune system and the brain could have evolved as part of a multipronged survival strategy. Increased alertness and vigilance could help rodents survive an infection by discouraging behaviors that increase the risk of further infection or predation while in a weakened state, Alves de Lima said.

"The immune system and the brain have most likely co-evolved," Alves de Lima said. "Selecting special molecules to protect us immunologically and behaviorally at the same time is a smart way to protect against infection. This is a good example of how cytokines, which basically evolved to fight against pathogens, also are acting on the brain and modulating behavior."

The researchers now are studying how gamma-delta T cells in the meninges detect bacterial signals from other parts of the body. They also are investigating how IL-17 signaling in neurons translates into behavioral changes.

 

NASA gives thumbs up to use of colloidal silver as antibiotic in space; FDA has no jurisdiction in high orbit

NASA, September 14, 2020

 In the day-to-day happenings of world politics, the United States and Russia are presented on the global stage as arch-enemies. Up in space, however, it's a completely different story. Enter the International Space Station (ISS), which for years has housed astronauts from both countries along with life-support systems unique to each country's needs. The two sides have long remained separate from one another until recently.

For years, the U.S. side of the ISS utilized iodine as its water cleansing agent of choice, while the Russian side took advantage of antibacterial silver for water purification purposes. Both sides coexisted peacefully in their respective methods, with the U.S. picking up whatever extra water the Russian side had leftover. Russia's water purification process has always been much more efficient than that of the U.S.

It seemed that the two opposing nations would never find a common bond in adopting a single, standardized water purification method that served the interests of everyone. However, the National Aeronautics and Space Administration (NASA) recently made the decision to adopt Russia's method of purifying its water after coming to the realization that adding ionized silver to water is easier, more effective, and much more efficient than adding iodine.

"Unlike iodine, silver doesn't have to be filtered out of the water," explains a report by Bloomberg, noting that iodine has to be filtered out of the U.S. water after use. "Epsom salts (magnesium) are added to improve its taste."

"Due to widespread growth in the use of colloidal silver as a biocidal agent, development of a simple and cost efficient method of silver testing is valuable," admits NASA on its website. "On station, silver is used as a biocidal agent based on its antimicrobial properties in the potable water system."

Too much silver may be toxic to humans, so NASA is supporting research into a simple technique that it says will allow ISS crew members to test silver levels in water in less than two minutes.

 

 

 

Red Clover Beats Inflammation and Oxidative Stress

Green Med Info, September 12th 2020

Red clover has been touted as one of the top herbal medicines in the world and now scientists are discovering how red clover actually works in your body

Red clover, a native flowering plant found in Europe and Asia, is the source of many health benefits, including the abilities to beat inflammation and lower oxidative stress.

Infections, allergies, and autoimmune diseases upset the balance of your cells, which leads to inflammation, and major diseases associated with aging, such as heart attacksstrokecancer and Type 2 diabetesNeurodegenerative conditions like Alzheimer's and Parkinson's show increased oxidative stress and inflammation as well.[i] It is not surprising that current interest in red clover and its healing elements is rising.

Three Components of Red Clover

  1. Formononetin

One of the key elements of red clover is formononetin, a dietary isoflavone, which is helpful in controlling diseases that are thought to be caused by inflammation and oxidative stress, such as diabetes, obesity and metabolic syndrome.[ii]

A treatment with formononetin controlled hypoglycemia and significantly reduced insulin resistance and oxidative stress in sciatic nerve tissue in diabetic animal research, making it an effective candidate for treatment of Type 2 diabetic neuropathy.[iii]

In other research, red clover treatment in diabetic rats successfully reduced hyperglycemia, improved insulin sensitivity and contributed to higher longevity (SIRT1 expression in rat pancreatic tissue).[iv]

Red clover sprouts (high in formononetin) reduced metabolic syndrome by decreasing obesity, lowering blood glucose levels and improving the lipid metabolism in obese mice that were given a high-carbohydrate and high-fat diet.[v]

Red clover isoflavones, such as formononetin, decreased total cholesterol by 29% in a meta-analysis covering 12 studies of 910 peri- and postmenopausal women.[vi]

Similarly, in a meta-analysis of 12 randomized control trials of 1,284 peri- and postmenopausal women, those who took red clover isoflavones for four weeks to 18 months improved their lipid profiles (significant decreases in total cholesterol, low-density lipoprotein cholesterol and triglycerides and a significant increase in high-density lipoprotein cholesterol).[vii]

Red clover isoflavone supplementation for 90 days also improved the lipid profile (significant decreases in total and low-density lipoprotein cholesterol) of 88% of the 60 postmenopausal women studied who had an increased body mass index.[viii]

In both human umbilical cord cells and zebrafish cell studies, formononetin also produced proangiogenesis effects (increased blood vessel creation in embryos) through binding cell signaling pathways (estrogen receptor alpha-enhanced ROCK-II).[ix]

In addition, formononetin ameliorated myocardia ischemia/reperfusion injury (loss of oxygen to the heart, which prevents pumping, and when oxygen returns but injures tissues, respectively) in rats (as measured by cardiac dysfunction, infarct size and cardiac markers) and inhibited the inflammatory response by impacting the "reactive oxygen species-thioredoxin interacting protein-nucleotide-binding domain and leucine-rich repeat-containing protein 3" (ROS-TXNIP-NLRP3) pathway.[x]

In a mouse model, formononetin also exhibited significant anticancer effects in multiple myeloma cancers (found in plasma cells) and decreased inflammation (through the ROS-regulated inhibition of the signaling cascade of aberrant cells impairing the immune system, called STAT3 and STAT5).[xi]

In a human study, 20 men treated with 160 milligrams (mg) per day of red clover-derived dietary isoflavones, (genistein, daidzein, formononetin and biochanin A) also showed significantly higher apoptosis (prostate cancer cell death) than in control subjects specifically for low to moderate-grade cancer.[xii]

Research affirms that formononetin isoflavones in red clover have cancer fighting benefits for breast, colorectal, ovarian,[xiii] bladder[xiv] and prostate cancers, decrease tumors and metastasis and interfere with inflammation-causing signals that allow cancer cells to grow and survive chemotherapy.[xv] In addition, formononetin has also shown neuroprotective properties by suppressing inflammation in the brain neurons of rats.[xvi]

Inflammation is involved in a host of diseases from obesity, atherosclerosis, and rheumatoid arthritis to cancer, neurological and cardiac diseases, and isoflavones, such as formononetin, show strong antioxidant, anticancer, antimicrobial and anti-inflammatory properties.[xvii]

  1. Anthocyanins

Anthocyanins are pigment-related compounds found in red clover giving the plant its purplish color. These compounds fight both inflammation and oxidative stress.[xviii]Interest in anthocyanin pigments has intensified recently because of potential health benefits -- as dietary antioxidants to prevent neuronal diseases, cardiovascular illnesses, cancer, diabetes, inflammation and atherosclerosis -- and scientific progress in stabilizing the compounds by encapsulating them.[xix],[xx]

In a recent in vitro study, anti-inflammatory and antioxidant effects of red clover extract and red clover anthocyanins showed prevention of reactive oxygen species (ROS) and suppression of genes such as tumor necrosis factor, interleukin, inducible nitric oxide synthase, monocyte chemoattractant protein and cyclooxygenase.

In addition, the anthocyanins in red clover regulated two signaling pathways in cells, called nuclear factor kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (NRF2), which are important to reduce inflammation and oxidative stress, respectively.[xxi]

You produce less NRF2 (a regulator of oxidants) as you age and that interferes with NRF2's cross-talk with NF-κB, which then increases cytokine production (inflammatory proteins), which slowly tips the balance toward the oxidative side -- a condition known as oxidative stress.[xxii]

For example, it has been found that two cytokines, interleukin-1 and tumor necrosis factor-alpha, are produced in excess in rheumatoid arthritis where they create inflammation and tissue destruction.[xxiii]

It is no wonder that anthocyanins found in red clover are recommended as powerful natural antioxidants that help reduce inflammation, contribute to the health of connective tissue and are effective in defusing dangerous free radicals that can irritate body tissues and cause the inflammation and joint pain prevalent in arthritis.[xxiv],[xxv]

In a study of 88 healthy, overweight and obese children ages 6 to 10, urinary biomarkers of inflammation and oxidative stress were elevated in obese children and signaled endothelial dysfunction.[xxvi] This imbalance between dilation and constriction of the blood vessels determines blood pressure and how well the heart is pumping blood out to the body and can contribute to increased inflammation and various heart diseases.[xxvii]

In a randomized, double blind trial of 150 subjects with hypercholesterolemia, those who consumed a purified anthocyanin mixture (320 mg per day) showed improved lipid profiles and reduced inflammatory responses compared to those who took a placebo twice a day for 24 weeks.[xxviii] Dietary anthocyanin consumption was associated with a 15% reduction of Type 2 diabetes risk in a meta-analysis of 200,894 participants and 12,611 Type 2 diabetes cases.[xxix]

In a meta-analysis of 14 cohort studies of flavonoids, subjects taking anthocyanins showed significantly lower risk for cardiovascular disease as well.[xxx] Intake of foods/extracts rich in anthocyanin improved vascular health, as shown in a meta-analysis of 24 randomized-controlled trials; two measures (vascular reactivity and stiffness) were significantly improved.[xxxi]

  1. Polysaccharides

Polysaccharide compounds in red clover (including glucose, galacturonic acid, arabinose and galactose) can be used as natural hypoglycemic agents and antioxidants. DPPH (2,2-Diphenyl-1-picrylhydrazyl) and ABTS (2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)) are stable free radicals that are used to measure the radical scavenging activity of antioxidants.

Red clover polysaccharides were found to be 87% as effective as acarbose (a current glucosidase inhibition drug used for Type 2 diabetes)[xxxii] and nearly as effective as an antioxidant (92% scavenging rate of DPPH radicals and 99% of ABTS radicals) as ascorbic acid or pure vitamin C.[xxxiii]

In a breakdown study of polysaccharide types in red clover, rhamnogalactouronans exhibited the highest nitric oxide activity as an antioxidant.[xxxiv] Botanical polysaccharides found in plants, such as red clover, enhance macrophage immune responses, leading to immunomodulation, anti-tumor activity, wound healing and other therapeutic effects.[xxxv]

Red Clover Attacks the Root Causes of Diseases

Recent scientific research has uncovered how red clover successfully attacks two important root causes and markers of diseases, namely inflammation and oxidative stress, to help your body gain balance at the molecular cell level. Read more at GreenMedInfo.com about the amazing health benefits of red clover and its three components: formononetinanthocyanin and polysaccharides.

The Gary Null Show - 09.14.20

The Gary Null Show - 09.14.20

September 15, 2020

Probiotic skin therapy improves eczema in children, study suggests

National Institute of Allergy and Infectious Diseases, September 10, 2020

An experimental treatment for eczema that aims to modify the skin microbiome safely reduced disease severity and increased quality of life for children as young as 3 years of age, a National Institutes of Health study has found. These improvements persisted for up to eight months after treatment stopped, researchers report Sept. 9 in Science Translational Medicine.

Atopic dermatitis, commonly called eczema, is a chronic inflammatory skin disease characterized by dry, itchy skin and rashes. The disease is most common in children and is linked to an increased risk of developing asthma, hay fever and food allergy. While available treatments can help manage eczema symptoms, current options can be costly, and many require multiple daily applications.

The experimental therapy contains strains of live Roseomonas mucosa—a bacterium naturally present on the skin—originally isolated from healthy volunteers and grown under carefully controlled laboratory conditions. For four months, clinical trial participants or their caregivers periodically applied this probiotic therapy to areas of skin affected by eczema.

"A child suffering from eczema, which can be itchy, painful and distracting for the child, also is very difficult for the entire family," said Anthony S. Fauci, M.D., director of NIH's National Institute of Allergy and Infectious Diseases (NIAID), which led the study. "These early-stage findings suggest that R. mucosatherapy may help relieve some children of both the burden of eczema symptoms and the need for daily treatment."

Numerous genetic and environmental factors contribute to eczema, and scientists are learning more about the role that the skin's microbiome plays in this condition. In 2016, NIAID researchers reported that R. mucosa strains isolated from healthy human skin improved outcomes in cell culture and mouse models of eczema.

To build on these preclinical findings, NIAID launched a Phase 1/2 clinical trial at the NIH Clinical Center in Bethesda, Maryland, to assess the safety and potential benefit of R. mucosa therapy in people with eczema. Interim results reported in 2018 for 10 adults and five children aged 9 to 14 years indicated that the treatment was safe and associated with reduced eczema severity. Since then, the trial has enrolled an additional 15 children, for a total of 20 children with mild to severe eczema ranging in age from 3 to 16 years.

Twice weekly for three months and every other day for an additional month, children or their caregivers sprayed a solution of sugar water containing live R. mucosa onto areas of skin with eczema. For the first 15 children enrolled in the study, the dose of live R. mucosa was gradually increased each month. The last five children to enroll received the same dose throughout the four-month treatment period. Regardless of dosing strategy, no serious adverse events were attributed to the therapy.

"Most children in the study experienced substantial improvements in their skin and overall wellbeing following R. mucosa therapy. Encouragingly, the therapeutic bacteria stayed on the skin and continued to provide benefit after therapy stopped," said NIAID's Ian Myles, M.D., principal investigator of the trial. "These results support a larger study to further assess the safety and effectiveness of this experimental treatment by comparing it with a placebo."

Seventeen of the 20 children experienced a greater than 50% improvement in eczema severity following treatment. Improvement occurred on all treated skin sites, including the inner elbows, inner knees, hands, trunk and neck. The scientists also observed increases in the skin's barrier function—its ability to seal in moisture and keep out allergens. Additionally, most children needed fewer corticosteroids to manage their eczema, experienced less itching, and reported a better quality of life following the therapy. These benefits persisted after treatment ended, and the therapeutic R. mucosa strains remained on the skin for up to eight months.

The NIAID researchers next set out to better understand how R. mucosa therapy improves eczema symptoms. They found that treated skin had increased microbial diversity and reduced levels of Staphylococcus aureus—a bacterium known to exacerbate eczema.

In addition to imbalances in the microbiome, the skin of people with eczema is deficient in certain lipids, or oils. By conducting experiments in cell and animal models of eczema, the NIAID scientists found that a specific set of lipids produced by R. mucosa strains isolated from healthy skin can induce skin repair processes and promote turnover of skin tissue. Study participants had increased levels of these lipids on their skinafter treatment with R. mucosa.

The researchers emphasize that additional studies are needed to further elucidate the mechanism of R. mucosa therapy and to explore whether genetic or other factors may explain why some participants did not benefit from the experimental treatment.

 

Gestational diabetes may accelerate child's biological age

Long-term health risks include cardiovascular disease, high blood pressure and higher weight, Rutgers study says

Rutgers University, September 10, 2020

 

Children born to mothers who had diabetes during pregnancy may age faster biologically and be at an increased risk for obesity and high blood pressure, according to Rutgers researchers. 

The study, published in the journal Epigenetics, explored how more than 1,000 children born to mothers in China aged on a cellular level. Researchers examined their exposure to gestational diabetes in utero and their DNA methylation, or epigenetic age, which indicates how experiences and exposures reflect true biological age even in early childhood. 

Accelerated aging, which can be determined by evaluating if a person's estimated DNA methylation age is greater than their chronological age, has been shown to be associated with cardiovascular risks and poor health outcomes later in life. 

The researchers measured the epigenetic age of 1,156 children who were ages 3 to 10 in Tianjin, China, to see how it differed from their chronological age. They found that children born to mothers who had diabetes while pregnant had a higher epigenetic age -- or were "older" than their actual age -- and that this epigenetic age is associated with higher weight, body mass index, body fat percentage, upper-arm circumference and blood pressure.

"These findings suggest that gestational diabetes may have long-term effects on epigenetic aging in offspring and lead to poorer cardiometabolic health outcomes," said lead author Stephanie Shiau, an instructor at the Rutgers School of Public Health. 

The findings support the need for further studies using longitudinal samples to evaluate the association between epigenetic age and later onset of adult metabolic diseases. 

In the United States, between 2 percent to 10 percent of pregnancies are affected by the condition annually, according to the National Institutes of Health.

 

 

Ten minutes of massage or rest will help your body fight stress: study

University of Konstanz (Germany) September 13, 2020

Allowing yourself a few minutes of downtime significantly boosts mental and physical relaxation. Research by psychologists at the University of Konstanz observed higher levels of psychological and physiological relaxation in people after only ten minutes of receiving a massage. Even ten minutes of simple rest increased relaxation, albeit to a lesser degree than massage. The findings, reported on 8 September 2020 in the journal Scientific Reports, provide the first indication that short-term treatments can robustly reduce stress on a psychological and physiological level by boosting the body's principal engine for relaxation—the parasympathetic nervous system (PNS).

Stress is known to have negative consequences for health and disease. However, our bodies have an inbuilt regenerative system, the PNS, to ward off stress during times of threat. Launching a relaxation response is thus key to protecting our health and restoring balance in our body. Massage has been used to improve relaxation, yet no systematic approach exists to robustly confirm its effect on the PNS and whether or not this could be used as rehabilitation for patients suffering from stress-related disease.

Boosting the body's engine for relaxation

This study indicates that massage is an easy-to-apply intervention that can boost the body's principal engine for relaxation—the PNS—and also lead to a reduction in perceived mental stress. The discovery that massage is effective on the level of both psychology and physiology via the PNS will pave the way for future studies on understanding the role of relaxation on stress.

"To get a better handle on the negative effects of stress, we need to understand its opposite—relaxation," says Jens Pruessner, head of the Neuropsychology lab and Professor at the Cluster of Excellence "Center for the Advanced Study of Collective Behavior" at the University of Konstanz. "Relaxation therapies show great promise as a holistic way to treat stress, but more systematic scientific appraisal of these methods is needed."

Standardized testing approach

Researchers from the Department of Psychology in Konstanz developed a standardized approach for testing if tactile stimulation could improve mental and physical relaxation. They applied two different ten-minute massages on human subjectsin the laboratory to test: A head-and-neck massage was designed to actively stimulate the PNS by applying moderate pressure on the vagal nerve, which is the largest nerve running to the PNS. Then a neck-and-shoulder massage with soft stroking movements was designed to examine whether just touch can also be relaxing. Finally, a control group of participants sitting quietly at a table was tested for the effect of rest without tactile stimulation. Physiological relaxation was gaged by monitoring the heart rate of participants and measuring heart rate variability (HRV), which indicates how flexibly the PNS can respond to changes in the environment. The higher the HRV, the more relaxed is the body. Psychological relaxation was gaged by asking participants to describe how relaxed or stressed they feel.

Ten minutes of resting or receiving either massage resulted in psychological and physiological reduction in stress. All participants reported that they felt more relaxed, and less stressed, compared with before the treatments. Further, all participants showed significant increases in heart rate variability, which demonstrates that the PNS was activated and the body physiologically relaxed just by resting alone. The physiological effect was more pronounced when participants received a massage. It was, however, not important whether the massage was soft or moderate—tactile contact in general seemed to improve the relaxation of the body.

Small moments with big impact

"We are very encouraged by the findings that short periods of dis-engagement are enough to relax not just the mind but also the body," says Maria Meier, a doctoral student in the lab of Neuropsychology and first author on the study. "You don't need a professional treatment in order to relax. Having somebody gently stroke your shoulders, or even just resting your head on the table for ten minutes, is an effective way to boost your body's physiological engine of relaxation."

By developing a standardized method for robustly testing and validating relaxation therapies, the study allows further experiments to test the effects of additional relaxation interventions that could be used in prevention or rehabilitation programs for people suffering from stress-related diseases such as depression.

"Massage, being such a commonly used relaxation therapy, was our first study," says Meier. "Our next step is to test if other short interventions, like breathing exercises and meditation, show similar psychological and physiological relaxation results."

 

Processed food linked to age-marker in chromosomes

University of Navarra (Spain), September 10, 2020 

 

People who eat a lot of industrially processed junk food are more likely to exhibit a change in their chromosomes linked to aging, according to research presented at an online medical conference.

Three or more servings of so-called “ultra-processed food” per day doubled the odds that strands of DNA and proteins called telomeres, found on the end of chromosomes, would be shorter compared to people who rarely consumed such foods, scientists reported at the European and International Conference on Obesity.

Short telomeres are a marker of biological aging at the cellular level, and the study suggests that diet is a factor in driving the cells to age faster.

While the correlation is strong, however, the causal relationship between eating highly processed foods and diminished telomeres remains speculative, the authors cautioned.

Each human cell has 23 pairs of chromosomes that contain our genetic code.

Telomeres do not carry genetic information, but are vital for preserving the stability and integrity of chromosomes and, by extension, the DNA that all the cells in our body relies on to function.

As we get older, our telomeres shorten naturally because each time a cell divides, part of the telomere is lost.

That reduction in length has long been recognized as a marker of biological age.

Scientists led by professors Maria Bes-Rastrollo and Amelia Marti, both of the University of Navarra in Spain, wanted to explore a suspected connection between the regular consumption of highly processed junk food and shrinking telomeres.

Earlier studies had pointed to a possible link with sugar-sweetened drinks, processed meats and other foods loaded with saturated fats and sugar, but the findings were inconclusive.

Ultra-processed foods are industrially manufactured substances composed of some mix of oils, fats, sugars, starch and proteins that contain little if any whole or natural foods.

They often include artificial flavorings, colorings, emulsifiers, preservatives and other additives that increase shelf-life and profit margins.

These same properties, however, also mean that such foods are nutritionally poor compared to less processed alternatives, the researchers said.

Earlier studies have shown strong correlations between ultra-processed foods and hypertension, obesity, depression, type 2 diabetes and some forms of cancer.

These conditions are often age-related in so far as they are linked to oxidative stress and inflammation known to influence telomere length.

Marti and colleagues looked at health data for nearly 900 people aged 55 or older who provided DNA samples in 2008 and provided detailed data about their eating habits every two years thereafter.

The 645 men and 241 women were equally divided into four groups, depending on their consumption of ultra-processed foods.

Those in the high-intake group were more likely to have a family history of cardiovascular disease, diabetes and abnormal blood fats.

That also consumed less foods associated with the Mediterranean diet — fibre, olive oil, fruits, vegetable and nuts.

Compared to the group who ate the fewest ultra-processed foods, the other three showed an increased likelihood — 29, 40 and 82 percent, respectively — of having shortened telomeres.

The findings were published earlier this year in the peer-reviewed American Journal of Clinical Nutrition.

 

 

Mother's iodine status related to child's IQ

Bothwell OB/GYN Associates, September 9, 2020

For a woman planning to have a baby, there are many health factors to take into consideration. One that may be overlooked is the mother's iodine level.

Iodine is a trace mineral in our bodies that is essential for the production and integration of thyroid hormones that regulate metabolism, development and important body functions. Low levels of iodine result in decreased levels of the thyroid hormone t4 or thyroxine.

According to Dr. Lori Nolla, obstetrician with Bothwell OB/GYN Associates, low levels of this hormone in pregnant women can result in permanent intellectual disability in the baby and is associated with higher newborn and infant death rates.

"Iodine is crucial for the production of thyroid hormones, which play a key role in the brain development of fetuses," Nolla said. "Pregnant women or women planning to be pregnant must have adequate amounts of iodine, particularly in the first trimester, to ensure their baby's central nervous system develops properly."

Nolla said our bodies don't naturally make iodine, so the only way to get this nutrient is through diet.

"Iodine intake in the United States has decreased due to reduced iodine content in dairy products and increased use of noniodized salt in the food industry," she said. "However, women who are pregnant or planning to be can make simple changes to increase their iodine intake including watching what they eat, taking prenatal vitamins and using iodized salt in place of regular salt."

The World Health Organization recommends pregnant women should take 250 micrograms of iodine a day during pregnancy and lactation.

"The months leading up to pregnancy are the most important in terms of optimizing iodine levels, so supplementation should be considered before conception," Nolla said. "When iodine supplements are begun before conception, children show better neurological and developmental outcomes."

For that reason, Nolla recommends women start taking prenatal vitamins three months before attempting to conceive. In addition to iodine levels, iron, selenium and vitamin A levels should also be monitored because deficiencies can worsen the problems of low iodine.

Goiter, or a swelling of the thyroid glands in the neck, is the most obvious symptom of iodine deficiency. However, even if there are no obvious signs of deficiency, iodine levels should be monitored to ensure the health of the mother and child, Nolla said.

"A mother's iodine level has a significant impact on a baby's health," she said. "Women who are pregnant or planning to be should talk to their doctors about checking and monitoring their iodine to ensure a healthy pregnancy and healthy baby."

 

 

Cannabidiol (CBD) found to alleviate seizures in those with neurodevelopmental conditions: Study

University of North Carolina, September 13, 2020

 

Cannabidiol (CBD) is one of the 113 organic compounds in the Cannabis sativa plant, commonly known as hemp. Previous studies on CBD have focused on its medicinal uses for pain relief, epileptic seizures, insomnia and Parkinson’s disease.

But a recent study from the University of North Carolina at Chapel Hill (UNC) found that CBD could also benefit children and adults suffering from Angelman syndrome (AS).

First author Bin Gu and his colleagues tested the effects of CBD on seizures, motor deficits and brain abnormalities in a mouse model of the said neurogenetic disorder.

Their experiments demonstrated that CBD treatment can reduce the severity of seizures in mice with AS. In addition, CBD also caused mild sedation and restored the mice’s normal brain rhythms.

Gu is hopeful that their findings, published in the Journal of Clinical Investigation, could inspire further research into the use of CBD as a treatment for seizures caused by AS and other neurological disorders.

CBD reduces seizures and causes mild sedation

AS is a rare neurogenetic disorder that occurs in one in 15,000 live births, or about 500,000 people around the globe. It tends to cause developmental problems that become noticeable when an infant reaches six to 12 months of age.

AS can also cause other abnormalities, such as seizures, balance disorders and speech problems. Because of the rare nature of AS, there is scant research on possible treatments and therapies.

Benjamin Philpot, the associate director of the UNC Neuroscience Center and the study’s senior author, said that there is an unmet need for better treatments for children suffering from the disorder. In response to this need, he and his colleagues created genetically modified mouse models of AS that they could use to find a possible treatment.

The researchers chose to test CBD because of its anti-epileptic properties. In 2018, the U.S. Food and Drug Administration approved the use of CBD as a treatment for seizures caused by two rare forms of epilepsy. (Related: Treating neurological disorders in children with oriental herbal medicine.)

To assess the effects of CBD on AS symptoms, the researchers injected the genetically-modified mice they created with various doses of CBD an hour prior to behavioral testing. Regardless of dose, CBD did not have a major impact on motor coordination or balance.

However, injection of a standard anti-convulsant dose of CBD caused mild sedation in the mice and reduced the severity of their experimentally triggered seizures. CBD also helped stabilize brain pulses linked to neural deficits and abnormalities.

These results expand the therapeutic spectrum of the anti-epileptic effects of CBD. The researchers also believe that their study could help address the need for better treatments for children with AS.

CBD reduces seizures and autism-like behaviors in a mouse model of another childhood brain disorder

This isn’t the first time that scientists attempted to assess the therapeutic effects of CBD on rare and less-studied neurological disorders.

In 2017, researchers from the University of Washington (UW) used CBD to treat mice with Dravet syndrome (DS), a severe type of epilepsy characterized by prolonged seizures that begin in the first year of life.

But unlike AS patients whose symptoms tend to improve with age, DS patients tend to suffer from worse intellectual impairments, autism-like behaviors and other debilitating neurological problems over time.

DS is also a rare and life-long condition that affects one in 20,000 to 40,000 people worldwide. Its drug-resistant nature has further complicated the development of treatments and therapies for it.

The UW researchers assessed the effects of CBD treatment on a mouse model of DS. Their experiments showed that high doses of CBD could reduce the severity, frequency and duration of DS-induced seizures.

In addition, mice treated with low doses of CBD spent more time interacting with other mice compared with the untreated mice, indicating an improvement of autism-like behaviors. However, this effect was lost at the higher doses needed to reduce seizures.

Nephi Stella, the founder of the UW Center for Cannabis Research and a member of the research team, said that their findings highlight the need for a treatment that could confer both benefits at once.

Nevertheless, the researchers noted that their findings contribute to the emerging data supporting the use of CBD in the treatment of drug-resistant and debilitating neurological conditions.

 

A Novel Approach to Treating COVID-19 Using Nutritional and Oxidative Therapies

David Brownstein, M.D. (journal, Science, Public Health Policy and the Law

 

 

Objective: This report is a case series of consecutive patients diagnosed with COVID-19 treated with a nutritional and oxidative medical approach. We describe the treatment program and report the response of the 107 COVID-19 patients.

 

Study Design: Observational case series consecutive.


Setting: A family practice office in a suburb of Detroit, Michigan.


Patients: All patients seen in the office from February through May 2020 diagnosed with COVID-19 were included in the study. COVID-19 was either diagnosed via PCR or antibody
testing as well as those not tested diagnosed via symptomology.


Interventions: Oral Vitamins A, C, D, and iodine were given to 107 subjects (99%). Intravenous solutions of hydrogen peroxide and Vitamin C were given to 32 (30%) and 37 (35%) subjects. Thirty-seven (35%) of the cohort was treated with intramuscular ozone. A dilute, nebulized hydrogen peroxide/ saline mixture, with Lugol’s iodine, was used by 91 (85%).


Main Outcome Measures: History and physical exam were reviewed for COVID-19 symptoms including cough, fever, shortness of breath, and gastrointestinal complaints. Laboratory reports were examined for SARS-CoV-2 results. Symptomatic improvement after treatment was reported for each patient consisting of first improvement, mostly better, and completely better. 

 

Results: There were a total of 107 patients diagnosed with COVID-19. Thirty-four were tested for SARS-CoV-2(32%) and twenty-seven (25%) tested positive. Three were hospitalized (3%) with two of the three hospitalized before instituting treatment and only one requiring hospitalization after beginning treatment. There were no deaths. The most common symptoms in the cohort were fever (81%), shortness of breath (68%), URI which included cough (69%), and gastrointestinal distress symptoms (27%). For the entire cohort, first improvement was noted in 2.4 days. The cohort reported symptoms mostly better after 4.4 days and completely better 6.9 days after starting the program. For the SARS-CoV-2 test positive patients, fever was present in 25 (93%), shortness of breath in 20 (74%) and upper respiratory symptoms including cough in 21 (78%) while gastrointestinal symptoms were present in 9 (33%). The time to improvement in the SARS-CoV-2 test positive group was slightly longer than the entire cohort.


Conclusion: At present, there is no published cure, treatment, or preventive for COVID-19 except for a recent report on dexamethasone for seriously ill patients. A novel treatment program combining nutritional and oxidative therapies was shown to successfully treat the signs and symptoms of 100% of 107 patients diagnosed with COVID-19.


Each patient was treated with an individualized plan consisting of a combination of oral, IV, IM, and nebulized nutritional and oxidative therapies which resulted in zero deaths and recovery from COVID-19.

 

 

Milk thistle protects against COPD caused by secondhand smoke

Sichuan University, (China), September 11, 2020

 

According to the U.S. Centers for Disease Control and Prevention (CDC), 15.7 million people suffer from chronic obstructive pulmonary disease (COPD) – a serious respiratory condition which can cause scarring of the lungs, narrowing of the airway and extreme difficulty breathing. Taking enough milk thistle – on a regular basis – can help protect you from harm. (But, don’t expect to hear about this from the big pharma-owned media.)

Exposure to tobacco smoke – whether through actively smoking or simply inhaling the smoke from another’s cigarette – is the primary cause of COPD. Although Western medicine currently offers no cure for COPD, recent studies generate a ray of hope. Groundbreaking newresearch suggests that milk thistle extracts may not only prevent COPD but, help to treat it.

WARNING: Carcinogenic secondhand smoke is a major contributor to COPD

“Passive” smoking – the act of inhaling secondhand smoke – exposes the victim’s lungs to a truly noxious cocktail of poisons. In fact, secondhand smoke has been classified as a carcinogen by both the Environmental Protection Agency (EPA) and the National Toxicology Program.

Among the toxins found in secondhand smoke are butane, ammonia, hydrogen cyanide – which is used in chemical warfare – carbon monoxide (think: “car exhaust”) and toluene, found in paint thinners, lacquers and glues. Other constituents include the toxic heavy metals arsenic, lead and cadmium.

Although lung cancer is probably the disease most often associated with secondhand smoke, this lethal form of air pollution is also a primary factor in COPD – which is currently the third leading cause of death in the United States.

Having COPD raises the risk of developing lung cancer and heart disease. To make matters worse, this condition is associated with osteoporosis, anxiety, depression, frailty and malnutrition.

While Western medicine attempts to manage COPD symptoms with oxygen therapy and drugs such as bronchodilators and corticosteroids, these treatments don’t reduce mortality at all – and some feature serious (unwanted) side effects.

In light of these discouraging facts, the promising results of recent milk thistle studies stand out as a particularly welcome development. (to say the least!)

Silymarin, a flavonoid in milk thistle, alleviates inflammatory response

In a study published in the journal Inflammation, researchers exposed mice to the equivalent of 1.5 packs of cigarettes a day for four weeks, creating drastic increases in peribronchial inflammation, thickening of airway walls and airway obstruction.

The team found that pretreating the mice with silymarin – the active component of milk thistle – an hour before exposure dramatically decreased inflammatory changes, and cut production of pro-inflammatory chemicals such as TNF-alpha and interleukin.

Encouragingly, silymarin also helped safeguard levels of superoxide dismutase, an important disease-fighting antioxidant produced in the body.

A year later, the same team of researchers took another, closer look at the workings of milk thistle. And what they found was encouraging.

In a study of human bronchial cells published in Scientific Report, the team explored the molecular and cellular mechanisms of silymarin – and found once again that the flavonoid attenuated cigarette smoke-induced upregulation of pro-inflammatory chemicals.

And, researchers discovered for the first time that silymarin modulated a certain pathway – known as MAPK – that governs inflammation.

The takeaway? The team concluded that silymarin might be “an ideal agent for treating inflammatory pulmonary diseases.”

Primary constituent in silymarin suppresses inflammation and scarring

In a third study, recently published in Food and Chemical Toxicology, researchers treated mice with silibinin (a constituent of silymarin) one hour before exposure to cigarette smoke.

The team found that the silibinin caused the mice to not only experience the sharp reductions in inflammatory changes seen in earlier studies – but discovered that it also suppressed the scarring and fibrosis that are typical of COPD in humans.

This means that silibinin may not only help prevent COPD – but, reverse it!

Intriguingly, the silibinin directly affected the expression of a certain pro-inflammatory protein – transforming growth factor beta-1 – that is activated and spurred on by exposure to smoke, making it appear that this compound is custom-designed to protect against secondhand smoke.

How do I take milk thistle extracts to protect against COPD?

Milk thistle extracts are available in the form of pills, powders, extracts, liposomes and teas. Look for a high-quality preparation that is standardized to contain 70 to 80 percent silymarin.

Naturopathic doctors may recommend milk thistle extracts in dosages ranging from 20 to 300 mg a day. As always, you should consult a trusted healthcare provider before supplementing with milk thistle – especially if you have a serious medical condition.

For maximum benefit, some natural health experts advise taking a silymarin-phosphatidylcholine complex, a formulation which helps beneficial silymarin attach to cell membranes more easily.

Note: Milk thistle is a member of the aster family. Don’t take milk thistle if you are allergic to any of its “cousins,” such as ragweed, chrysanthemum, chamomile, marigolds, yarrow or daisies.

Notwithstanding its unglamorous resume as a common weed that thrives in fields and pastures, the humble milk thistle is actually a potent herbal hero that can help defend against a debilitating and deadly disease. If you have been – or are currently – exposed to firsthand or secondhand cigarette smoke, supplementing with milk thistle to protect against COPD could be a wise move.

 
 
 
 
AIbEiAIAAABECMGluKapjLPytAEiC3ZjYXJkX3Bob3RvKihhNTIxNGZmYzhhZGE0MDc3N2Y1NjZkZWEzOGM1ODdlYjdiMmZhMzA3MAGanPOZ_jaEjC_zLgxcW9COXb5Ijw?sz=40
ReplyReply allForward
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
The Gary Null Show - 09.11.20

The Gary Null Show - 09.11.20

September 11, 2020

The Gary Null Show is here to inform you on the best news in health, healing, the environment.

The Gary Null Show - 09.10.20

The Gary Null Show - 09.10.20

September 11, 2020

The Gary Null Show is here to inform you on the best news in health, healing, the environment.

The Gary Null Show - 09.09.20

The Gary Null Show - 09.09.20

September 9, 2020

The Gary Null Show is here to inform you on the best news in health, healing, the environment.

The Gary Null Show - 09.08.20

The Gary Null Show - 09.08.20

September 8, 2020

The Gary Null Show is here to inform you on the best news in health, healing, the environment. 

Protective effects of polyphenols present in Mediterranean diet against endothelial dysfunction

University of Valencia (Spain), September 2, 2020

 

According to news originating from Valencia, Spain, by NewsRx correspondents, research stated, “Endothelial dysfunction tends to be the initial indicator in proinflammatory state and macro- and microvascular complications, such as atherosclerosis and cardiovascular diseases.”

Our news journalists obtained a quote from the research from University of Valencia: “It has been shown that certain compounds in diet can generate beneficial effects on cardiovascular disease due to its interactions with endothelial cells. Thus, this review is aimed at investigating whether certain polyphenols present in the Mediterranean diet, specifically catechin, quercetin, resveratrol, and urolithin, could exert positive effects on endothelial dysfunction. After analysis of numerous papers, we found that polyphenols aiding endothelial function is beneficial not only for patients with cardiovascular disease, diabetes, or endothelial dysfunction but for all people as it can improve the effects of aging on the endothelia. The additional benefit of these polyphenols on weight loss further improves health and lowers the risk of several diseases, including those caused by endothelial dysfunction.”

According to the news reporters, the research concluded: “However, it is important to note that the dosages in the majorities of the studies mentioned in this review were of supplemental rather than nutritionally relevant quantities, and therefore, the recommended dosages are difficult to determine.”

 

 

How screen time and green time may affect youth psychological outcomes

University of Adelaide (Australia), September 4, 2020

Less screen time and more green time are associated with better psychological outcomes among children and adolescents, according to a study published September 2 in the open-access journal PLOS ONE by Tassia Oswald of the University of Adelaide, and colleagues.

The prevalence of mental illness among children and adolescents is increasing globally. Technological developments in recent decades have increased young people's engagement with screen-based technologies (screen time), and a reduction in young people's contact with nature (green time) has been observed concurrently. This combination of high screen time and low green time may affect mental health and well-being. But research investigating the psychological impacts of screen time or green time typically considers each factor in isolation and fails to delineate the reciprocal effects of high technology use and low contact with nature on mental health and cognitive outcomes. To address this question, Oswald and colleagues analyzed the findings of 186 studies to collate evidence assessing associations between screen time, green time, and psychological outcomes (including mental health, cognitive functioning, and academic achievement) for children and adolescents.

In general, high levels of screen time appeared to be associated with unfavorable psychological outcomes, while green time appeared to be associated with favorable psychological outcomes. Young people from low socioeconomic backgrounds were underrepresented in the literature overall and may be disproportionately affected by high screen time and low green time, making this a priority group for future research. However, additional longitudinal studies and RCTs are needed to determine whether decreasing screen time and increasing green time would improve psychological outcomes. According to the authors, preliminary evidence suggests that green time could potentially buffer the consequences of high screen time, meaning nature may be an under-utilized public health resource to promote youth psychological well-being in a high-tech era. Investment in more rigorous research is needed to explore this.

Oswald adds: "This systematic scoping review highlights that nature may currently be an under-utilised public health resource, which could potentially function as an upstream preventative and psychological well-being promotion intervention for children and adolescents in a high-tech era. However, robust evidence is needed to guide policies and recommendations around appropriate screen time and green time at critical life stages, to ultimately ensure optimal psychological well-being for young people."

 

Ginseng gintonin, aging societies and geriatric brain diseases

Konkuk University (South Korea), September 4, 2020

 

According to news reporting out of Seoul, South Korea, research stated, “A dramatic increase in aging populations and low birth rates rapidly drive aging societies and increase aging-associated neurodegenerative diseases. However, functional food or medicinal formulations to prevent geriatric brain disorders are not readily available. Gintonin is a candidate, since ginseng has long-been consumed as a rejuvenating agent.”

Our news journalists obtained a quote from the research from Konkuk University, “However, the underlying molecular mechanisms and the components of ginseng that are responsible for brain rejuvenation and human longevity are unknown. Accumulating evidence shows that gintonin is a candidate for the anti-aging ingredient of ginseng, especially in brain senescence. Gintonin, a glycolipoprotein complex, contains three lipid-derived G protein-coupled receptor ligands: lysophosphatidic acids (LPAs), lysophosphatidylinositols (LPIs), and linoleic acid (LA). LPA, LPI, and LA act on six LPA receptor subtypes, GPR55, and GPR40, respectively. These G protein-coupled receptors are distributed within the nervous and non-nervous systems of the human body. Gintonin-enriched fraction (GEF) exhibits anti-brain senescence and effects against disorders such as Alzheimer’s disease (AD), Huntington’s disease (HD), and Parkinson’s disease (PD). Oral administration of gintonin in animal models of d-galactose-induced brain aging, AD, HD, and PD restored cognitive and motor functions. The underlying molecular mechanisms of gintonin-mediated anti-brain aging and anti-neurodegenerative diseases include neurogenesis, autophagy stimulation, anti-apoptosis, anti-oxidative stress, and anti-inflammatory activities. This review describes the characteristics of gintonin and GEF, and how gintonin exerts its effects on brain aging and brain associated-neurodegenerative diseases.”

According to the news editors, the research concluded: “Finally, we describe how GEF can be applied to improve the quality of life of senior citizens in aging societies.”

 

How we sleep today may forecast when Alzheimer's disease begins

Don't despair. deep, restorative sleep may defend against this virulent form of dementia

University of California Berkeley, September 6, 2020

 

What would you do if you knew how long you had until Alzheimer's disease set in? Don't despair. New research from the University of California, Berkeley, suggests one defense against this virulent form of dementia -- for which no treatment currently exists -- is deep, restorative sleep, and plenty of it.

UC Berkeley neuroscientists Matthew Walker and Joseph Winer have found a way to estimate, with some degree of accuracy, a time frame for when Alzheimer's is most likely to strike in a person's lifetime.

"We have found that the sleep you're having right now is almost like a crystal ball telling you when and how fast Alzheimer's pathology will develop in your brain," said Walker, a UC Berkeley professor of psychology and neuroscience and senior author of the paper published today, Sept. 3, in the journal Current Biology.

"The silver lining here is that there's something we can do about it," he added. "The brain washes itself during deep sleep, and so there may be the chance to turn back the clock by getting more sleep earlier in life."

Walker and fellow researchers matched the overnight sleep quality of 32 healthy older adults against the buildup in their brains of the toxic plaque known as beta-amyloid, a key player in the onset and progression of Alzheimer's, which destroys memory pathways and other brain functions and afflicts more than 40 million people worldwide.

Their findings show that the study participants who started out experiencing more fragmented sleep and less non-rapid eye movement (non-REM) slow-wave sleep were most likely to show an increase in beta-amyloid over the course of the study.

Although all participants remained healthy throughout the study period, the trajectory of their beta-amyloid growth correlated with baseline sleep quality. The researchers were able to forecast the increase in beta-amyloid plaques, which are thought to mark the beginning of Alzheimer's.

"Rather than waiting for someone to develop dementia many years down the road, we are able to assess how sleep quality predicts changes in beta-amyloid plaques across multiple timepoints. In doing so, we can measure how quickly this toxic protein accumulates in the brain over time, which can indicate the beginning of Alzheimer's disease," said Winer, the study's lead author and a Ph.D. student in Walker's Center for Human Sleep Science at UC Berkeley.

In addition to predicting the time it is likely to take for the onset of Alzheimer's, the results reinforce the link between poor sleep and the disease, which is particularly critical in the face of a tsunami of aging baby boomers on the horizon.

While previous studies have found that sleep cleanses the brain of beta-amyloid deposits, these new findings identify deep non-REM slow-wave sleep as the target of intervention against cognitive decline.

And though genetic testing can predict one's inherent susceptibility to Alzheimer's, and blood tests offer a diagnostic tool, neither offers the potential for a lifestyle therapeutic intervention that sleep does, the researchers point out.

"If deep, restorative sleep can slow down this disease, we should be making it a major priority," Winer said. "And if physicians know about this connection, they can ask their older patients about their sleep quality and suggest sleep as a prevention strategy."

The 32 healthy participants in their 60s, 70s and 80s who are enrolled in the sleep study are part of the Berkeley Aging Cohort Study headed by UC Berkeley public health professor William Jagust, also a co-author on this latest study. The study of healthy aging was launched in 2005 with a grant from the National Institutes of Health.

For the experiment, each participant spent an eight-hour night of sleep in Walker's lab while undergoing polysomnography, a battery of tests that record brain waves, heart rate, blood-oxygen levels and other physiological measures of sleep quality.

Over the course of the multi-year study, the researchers periodically tracked the growth rate of the beta-amyloid protein in the participants' brains using positron emission tomography, or PET scans, and compared the individuals' beta-amyloid levels to their sleep profiles.

Researchers focused on the brain activity present during deep slow-wave sleep. They also assessed the study participants' sleep efficiency, which is defined as actual time spent asleep, as opposed to lying sleepless in bed.

The results supported their hypothesis that sleep quality is a biomarker and predictor of disease down the road.

"We know there's a connection between people's sleep quality and what's going on in the brain, in terms of Alzheimer's disease. But what hasn't been tested before is whether your sleep right now predicts what's going to happen to you years later," Winer said. "And that's the question we had."

And they got their answer: "Measuring sleep effectively helps us travel into the future and estimate where your amyloid buildup will be," Walker said.

As for next steps, Walker and Winer are looking at how they can take the study participants who are at high risk of contracting Alzheimer's and implement methods that might boost the quality of their sleep.

"Our hope is that if we intervene, then in three or four years the buildup is no longer where we thought it would be because we improved their sleep," Winer said.

"Indeed, if we can bend the arrow of Alzheimer's risk downward by improving sleep, it would be a significant and hopeful advance," Walker concluded.

 

Link between positive emotions and health depends on culture

University of Wisconsin, September 8, 2020

Positive emotions are often seen as critical aspects of healthy living, but new researchsuggests that the link between emotion and health outcomes may vary by cultural context. The findings, published in Psychological Science, a journal of the Association for Psychological Science, show that experiencing positive emotions is linked with better cardiovascular health in the US but not in Japan.

"Our key finding is that positive emotions predict blood-lipid profiles differently across cultures," says psychological scientist Jiah Yoo of the University of Wisconsin-Madison. "American adults who experience high levels of positive emotions, such as feeling 'cheerful' and 'extremely happy', are more likely to have healthy blood-lipid profiles, even after accounting for other factors such as age, gender, socioeconomic status, and chronic conditions. However, this was not true for Japanese adults."

"Our findings underscore the importance of cultural context for understanding links between emotion and health, something that has been largely ignored in the literature," Yoo adds. "Although some studies have examined cultural differences in links between positive emotions and healthy functioning, this work is novel in that it includes biological measures of health and large representative samples from both countries."

The fact that positive emotions are conceived of and valued differently across cultures led Yoo and colleagues to wonder whether the health benefits observed in tandem with positive emotions might be specific to Western populations.

"In American cultures, experiencing positive emotions is seen as desirable and is even encouraged via socialization. But in East Asian cultures, people commonly view positive emotions as having dark sides - they are fleeting, may attract unnecessary attention from others, and can be a distraction from focusing on important tasks," says Yoo.

The researchers designed a cross-cultural comparison, examining data from two large representative studies of adults: Midlife in the United States and Midlife in Japan, both funded by the National Institute on Aging. Data included participants' ratings of how frequently they felt 10 different positive emotions in the previous 30 days and measures of blood lipids, which provided objective data on participants' heart health.

"Because of the global prevalence of coronary artery disease, blood lipids are considered important indices of biological health in many Western and East Asian countries," Yoo explains.

As expected, the data indicated that experiencing frequent positive emotions was associated with healthy lipid profiles for American participants. But there was no evidence of such a link for Japanese participants.

The differences may be due, in part, to the relationships between positive emotions and BMI in each culture. Higher positive emotions were linked with lower BMI and, in turn, healthier lipid profiles among American participants, but not among Japanese participants.

"By demonstrating that the cultural variation in the connection between emotional well-being and physical well-being, our research has wide-ranging relevance among those who seek to promote well-being in the communities and the workplace, including clinicians, executives, and policy makers," Yoo concludes.

In future work, the researchers will examine longitudinal data to determine whether the evidence suggests a direct causal link between emotions and health. They also hope to identify emotional profiles that may be more relevant or important to health outcomes in East Asian cultures.

 

Experimental research suggests co-administration of Panax ginseng and Brassica oleracea plants (kale, broccoli, cabbage, etc) may help protect against osteoporosis

Inha University School of Medicine (South Korea), September 4, 2020

 

According to news reporting out of Incheon, South Korea, research stated, “Postmenopausal osteoporosis is a common disorder resulting from increased osteoclastic activity.”

The news reporters obtained a quote from the research from Inha University School of Medicine: “To determine the effect of * * Panax ginseng* * on postmenopausal osteoporosis, ovariectomized (OVX) mice were treated with 500 mg/kg/day * * P. ginseng* * extract (Pg) alone or in combination with hot water extract of * * Brassica oleracea* * (Bo) daily for 10 weeks, and the effect of the treatments on OVX-induced bone loss was examined. Bone weight, bone mineral density (BMD), osteoclast (OC) formation, OC marker expression, and biochemical parameters in blood were determined. OVX significantly increased body weight and decreased bone weight compared with those in the Sham group (* * p* * < 0.01). Pg or Bo alone did not affect OVX-induced bone loss, but a combination of Pg and Bo (Pg:Bo) recovered bone weight. The bones of OVX mice showed lower BMD than that of Sham mice, and the Pg:Bo = 3:1 restored the decreased BMD. Single treatment with Pg or Bo did not alter OC formation; however, the Pg:Bo = 3:1 inhibited OC formation.”

According to the news editors, the research concluded: “In addition, Pg and Bo lowered the OVX-induced elevation in blood glucose level. Thus, we suggest that Pg in combination with proper materials, such as Bo, might be a potential candidate treatment with minimal side effects protect against postmenopausal osteoporosis.”

 

 

 

Rest Days Are Important For Fitness — Here’s Why, According To Science

University Of Aberdeen, September 4, 2020

 

In 2017, world famous distance runner, Ron Hill, ended his record of 52 years and 39 days of consecutive running by taking a day’s rest after feeling unwell during one of his runs.

Hill writes in his autobiography that he ran at least one mile a day, and tasked himself with training 13 times per week. His training was conducted without a coach, and was done on a trial and error basis.

Though successful – he even competed twice in the Olympics – there were occasions that he describes the symptoms of over-training. These included sore and heavy legs, increased susceptibility to colds and infections, and weight loss. Though Hill found a training regimen that helped him prepare for competition, he wondered if some of his substandard performances were a consequence of not taking any rest days.

When starting a new fitness regime, we’re often told it’s important to take “rest days” between workouts. The reason many recommend rest days is to allow the body’s muscles to recover from any damage they’ve sustained during workouts, and to allow them to grow. And numerous scientific studies show that rest days do indeed play an important role in helping us maintain good health and fitness.

We usually define rest as a period of time without any training. For most people, this is usually about 24 hours between workouts. However, recovery is different, and could indicate a time span of several minutes to hours (such as taking a short break during training between rounds). Recovery could also indicate the time required to induce some form of physiological adaptation, such as the observed rapid increase in plasma volume, which could improve aerobic fitness. But how necessary are both rest and recovery as part of a training program?

Take a break

Most studies indicate that rest and recovery between workouts are both necessary for helping the body adapt and recuperate from one’s last workouts. Exercise requires us to use our body’s energy stores (primarily carbohydrates) and fluids (in producing sweat), so rest and recovery give the body time to replenish these energy stores.

Several studies have shown that the body needs at least 24 hours to fully replace our muscle’s store of carbohydrates. Maintaining an adequate store of muscle glycogen (glycogen is the body’s store of carbohydrate), is important for training and maintaining stable blood sugar levels.

However, less time is required to recover our fluids. Numerous studies have found it takes only around one to two hours to replace our fluids lost as sweat during exercise. But our bodies still require several hours of rest following exercise to maintain hydration due to the continued production of urine.

Training may also damage our body’s tissues. Under some circumstances this damage can be beneficial, but is not an essential part of building muscle. But in order for muscle to recover and improve (known as physiological adaptation) they require several weeks of cycles of exercise and recovery.

Research shows our bodies require a longer rest period in order to build muscle tissue (protein synthesis). But given the turnover of protein for muscle, tendon and ligaments is between 0.4-1.2% a day, this shows there’s a constant exchange of protein in our body related to dietary intake, urinary nitrogen excretion and the added effect of exercise.

The hours just after the initial workout may actually be most important for making this happen. Researchers reported that a three-hour feeding pattern of whey protein was more effective at increasing protein synthesis than feeding every 1.5 or six hours over a 12-hour period.

Many other adaptations that occur as a consequence of training (such as increasing the activity of enzymes and glucose transporters, which are key in oxygen consumption and fuel use), require a period in excess of 12 hours before changes are detected. These changes are important, as when we increase our exercise intensity, we need to use glucose instead of fat to fuel our exercise.

Longer-term adaptations, such as increasing the number of blood vessels in our exercised muscles, or increasing the size of the heart, are a much longer process, requiring months of training and rest to observe any measurable change. Both adaptations are key to increasing our aerobic capacity.

The quality of rest has also been a source of much interest, and sleep deprivation has been used as a tool to examine the effects of disturbed rest on exercise performance and physical and psychological function. A wide-ranging review concluded that disturbed sleep may have a detrimental effect on performance, such as a reduced time to exhaustion – but they were clear that sleep deprivation had many negative effects on cognitive function.

Overwhelming evidence also shows rest days are also extremely important for preventing overtraining syndrome. Overtraining syndrome can cause fatigue, sleep loss, weight gain, depression – and may even result in decreased performance and may stall progress.

In general, it seems that one day’s rest per week is sound advice and is supported by the scientific evidence, especially when it comes to repairing tissues, building and adapting skeletal muscle, and restoring fuel reserves. It may also reduce mental stress. Although Hill set world records at distances between 10 and 16 miles, he is an exceptional example – and even admitted that trying to run every single day may have hindered his performance at the two Olympic games. Based on the evidence, taking a rest day seems to be as important for progress and fitness as exercise itself.The Conversation

 

Probiotics may help manage childhood obesity

University of Piemonte Orientale (Italy), September 5, 2020

Probiotics may help children and adolescents with obesity lose weight when taken alongside a calorie-controlled diet, according to a study being presented at e-ECE 2020. The study found that obese children who were put on a calorie-restricted diet and given probiotics Bifidobacterium breve BR03 and Bifidobacterium breve B632, lost more weight and had improved insulin sensitivity compared with children on a diet only. These findings suggest that probiotic supplements and a calorie-controlled diet may help manage obesity in the younger population and reduce future health risks, such as heart disease and diabetes.

Obesity is a global health concern and can lead to a number of life-threatening conditions, such as diabetes and heart disease. Treatment and prevention is a serious public health challenge, especially in children and adolescents. Bifidobacteria are a group of probiotic bacteria that are part of the natural gut microbiome and help with preventing infection from other bacteria, such as E.coli, and digestion of carbohydrates and dietary fibre. During digestion, they release chemicals called short-chain fatty acids, which play an important role in gut health and controlling hunger. Low numbers of Bifodobacteria may impair digestion, affect food intake and energy expenditure, leading to body weight gain and obesity. 

Previous studies suggested that probiotic supplementation with Bifidobacteria could help restore the composition of the gut microbiome, which may aid weight loss and could be a potential approach for obesity management. However, current research uses mixtures of different strains of probiotics and does not examine the effects of administering Bifidobacteria alone.

Dr Flavia Prodam and her team at the University of Piemonte Orientale, aimed to assess the impact of Bifidobacteria probiotic treatment in children and adolescents with obesity on a controlled diet, on weight loss and gut microbiota composition. 100 obese children and adolescents (6-18 years) were put on a calorie-controlled diet and randomly given either probiotics Bifidobacterium breve BR03 and Bifidobacterium breve B632, or a placebo for 8 weeks. Clinical, biochemical and stool sample analyses were carried out to determine the effect of probiotic supplementation on weight gain, gut microbiota and metabolism.

The results suggested that children who had taken probiotics had a reduction in waist circumference, BMI, insulin resistance and E.coli in their gut. These beneficial effects demonstrate the potential of probiotics in helping to treat obesity in children and adolescents, when undergoing dietary restrictions.

"Probiotic supplements are frequently given to people without proper evidence data. These findings start to give evidence of the efficacy and safety of two probiotic strains in treating obesity in a younger population," Dr Prodam comments. 

The study suggests that supplementation with probiotics could modify the gut microbiome environment and beneficially affect metabolism, helping obese children or adolescents who are also undergoing a restricted diet to lose weight. However, larger studies over a longer period of time are needed to investigate this.

Dr Prodam explains, "The next step for our research is to identify patients that could benefit from this probiotic treatment, with a view to creating a more personalised weight-loss strategy. We also want to decipher more clearly the role of diet and probiotics on microbiome composition. This could help us to understand how the microbiota is different in young people with obesity."

The Gary Null Show - 09.07.20

The Gary Null Show - 09.07.20

September 7, 2020

Curcumin suppresses aldosterone-induced CRP generation in 

Hebei University of Chinese Medicine (China), September 2, 2020

 

According to news reporting from Shijiazhuang, People’s Republic of China, research stated, “Aldosterone regulates the initiation and development of atherosclerosis which is identified as a chronic inflammatory disease by promoting the generation of C-reactive protein in vascular smooth muscle cells.”

Our news correspondents obtained a quote from the research from Hebei University of Chinese Medicine: “Curcumin is the most active ingredient of turmeric with anti-inflammation and antioxidation effects. Here, the effect of curcumin on aldosterone-induced C-reactive protein generation in vascular smooth muscle and the molecular mechanisms involved were explored. Primary rat vascular smooth muscle cells and hyperaldosteronism model rats were used in this study. The amount of C-reactive protein, reactive oxygen species, and the signaling pathway-related molecules generated were estimated. We found that curcumin inhibited aldosterone-induced C-reactive protein generation in vascular smooth muscle cells by interfering with the reactive oxygen species-ERK1/2 signal pathway.”

According to the news reporters, the research concluded: “The results provide new evidence for the potential anti-inflammatory and cardiovascular protective effects of curcumin.”

 

 

Meta-analysis finds DHA and EPA have similar anti-inflammatory effects

Laval University (Quebec), August 26, 2020

 

According to news originating from Quebec City, Canada, research stated, “Recent data from randomized clinical trials (RCTs) suggest that DHA may have stronger anti-inflammatory effects than EPA. This body of evidence has not yet been quantitatively reviewed.”

Our news journalists obtained a quote from the research from Laval University, “The aim of this study was to compare the effect of DHA and EPA on several markers of systemic inflammation by pairwise and network meta-analyses of RCTs. MEDLINE, EMBASE, and The Cochrane Library were searched through to September 2019. We included RCTs of 7 d on adults regardless of health status that directly compared the effects of DHA with EPA and RCTs of indirect comparisons, in which the effects of DHA or EPA were compared individually to a control fatty acid. Differences in circulating concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a) and adiponectin were the primary outcome measures. Data were pooled by pairwise and network meta-analysis and expressed as mean differences (MDs) with 95% CIs. Heterogeneity was assessed (Cochran Q statistic) and quantified (I2 statistic) in the pairwise meta-analysis. Inconsistency and transitivity were evaluated in the network meta-analysis. The certainty of evidence was assessed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. Eligibility criteria were met by 5 RCTs (N=411) for the pairwise meta-analysis and 20 RCTs (N=1231) for the network meta-analysis. In the pairwise meta-analysis, DHA and EPA had similar effects on plasma CRP [MDDHA versus EPA=0.14 mg/L (95% CI: -0.57, 0.85); I2=61%], IL-6 [MDDHA versus EPA=0.10 pg/mL (-0.15, 0.34); I2=40%], and TNF-a [MDDHA versus EPA=-0.10 pg/mL (-0.37, 0.18); I2=40%]. In the network meta-analysis, the effects of DHA and EPA on plasma CRP [MDDHA versus EPA=-0.33 mg/L (-0.75, 0.10)], IL-6 [MDDHA versus EPA=0.09 pg/mL (-0.12, 0.30)], and TNF-a [MDDHA versus EPA=-0.02 pg/mL (-0.25, 0.20)] were also similar. DHA and EPA had similar effects on plasma adiponectin in the network meta-analysis.”

According to the news editors, the research concluded: “Results from pairwise and network meta-analyses suggest that supplementation with either DHA or EPA does not differentially modify systemic markers of subclinical inflammation.”

 

 

 

Common cold combats influenza

Yale University, September 4, 2020

 

As the flu season approaches, a strained public health system may have a surprising ally—the common cold virus.

Rhinovirus, the most frequent cause of common colds, can prevent the flu virus from infecting airways by jumpstarting the body's antiviral defenses, Yale researchers report Sept. 4 in the journal The Lancet Microbe.

The findings help answer a mystery surrounding the 2009 H1N1 swine flu pandemic: An expected surge in swine flu cases never materialized in Europe during the fall, a period when the common cold becomes widespread.

A Yale team led by Dr. Ellen Foxman studied three years of clinical data from more than 13,000 patients seen at Yale New Haven Hospital with symptoms of respiratory infection. The researchers found that even during months when both viruses were active, if the common cold virus was present, the flu virus was not.

"When we looked at the data, it became clear that very few people had both viruses at the same time," said Foxman, assistant professor of laboratory medicine and immunobiology and senior author of the study.

Foxman stressed that scientists do not know whether the annual seasonal spread of the common cold virus will have a similar impact on infection rates of those exposed to the coronavirus that causes COVID-19.

"It is impossible to predict how two viruses will interact without doing the research," she said.

To test how the rhinovirus and the influenza virus interact, Foxman's lab created human airway tissue from stem cells that give rise to epithelial cells, which line the airways of the lung and are a chief target of respiratory viruses. They found that after the tissue had been exposed to rhinovirus, the influenza virus was unable to infect the tissue.

"The antiviral defenses were already turned on before the flu virus arrived," she said.

The presence of rhinovirus triggered production of the antiviral agent interferon, which is part of the early immune system response to invasion of pathogens, Foxman said.

"The effect lasted for at least five days," she said.

Foxman said her lab has begun to study whether introduction of the cold virus before infection by the COVID-19 virus offers a similar type of protection.

 

 

Highly fluorinated chemicals can increase risk for diabetes and coeliac disease in children

Orebro University (Sweden),  September 4, 2020

 

Tuulia Hyötyläinen and Matej Orešič, both researchers in biomedicine, have published two studies on the connection between highly fluorinated chemicals—per- and polyfluoroalkyl substances (PFASs) – and two diseases in children: type 1 diabetes and coeliac disease (US spelling celiac, or gluten intolerance). Both are autoimmune diseases, which arise from an abnormal immune response to the body's healthy cells or tissues.

The studies are based on a combination of comprehensive metabolomics (analysis of small molecules, i.e. metabolites, in a body), analysis of PFAS, and the system's biology approach to integrate complex data acquired in the study. The data comes from a group of expectant mothers and children.

Type 1 diabetes is one of the most common chronic diseases among children and younger people in the Nordic countries. Over the past decades, the number of cases has markedly increased. However, the incidence curve has flattened in recent years.

Some children are genetically predisposed for type 1 diabetes, but only a fraction of them, around one-tenth, develop the disease. It is clear that some environmental trigger is needed to initiate the progression to this autoimmune disease. For example, viral infections and diet are suspected to have an influence.

Tuulia Hyötyläinen and Matej Orešič show in this study, published in Environment International, how PFAS impacts lipid metabolism and risk of type 1 diabetes in new-born children. The study includes expectant mothers exposed to these harmful substances at various levels, which are then transferred from the expectant mother to the fetus.

Within the same study, these findings were further confirmed in another prospective clinical study involving children at-risk for type1 diabetes, as well as in two studies in mice (experimental models of type 1 diabetes).

"We show that children exposed to the high levels of PFAS during the prenatal stage have a certain lipid profile. We have previously identified this profile to be associated with an increased risk for type 1 diabetes and the development of the disease in children," explains Matej Orešič.

In another study published in Environment Research, Tuulia Hyötyläinen and Matej Orešič show a connection between PFAS and coeliac disease.

"These results show that high exposure to PFAS in the womb and in first years of life can accelerate the development of coeliac disease in children," says Tuulia Hyötyläinen.

PFAS consists of some 5,000 man-made chemical substances in extensive use in society. They are used in a wide range of products, such as coatings in clothing, furniture, adhesives and food packaging as well as in fire-fighting foam.

"Exposure to harmful chemicals in early life, including prenatally, may offer an explanation for the changing incidence of these autoimmune diseases in developed countries and can be connected to other health risks," says Matej Orešič.

The increase of type 1 diabetes has flattened in many industrial countries, especially in the Nordic countries. A possible explanation is the stricter PFAS regulation.

 

T cells need methionine 

University of Michigan School of Medicine, September 2 2020. 

 

Research reported on September 2, 2020 in Nature revealed a mechanism used by cancer cells to evade the immune system.

“Abnormal epigenetic patterns correlate with effector T cell malfunction in tumors, but the cause of this link is unknown,” Yingjie Bian of the University of Michigan School of Medicine and colleagues wrote. “Here we show that tumor cells disrupt methionine metabolism in CD8+ T cells, thereby lowering intracellular levels of methionine and the methyl donor S-adenosylmethionine (SAM) and resulting in loss of dimethylation.”

Dr Bian and colleagues sought to determine why immune cells known as T cells stop combatting tumors and other related questions. They found that low methionine levels were associated with T cell impairment. 

Other research has investigated the effects of starving tumor cells of methionine. However, this also starves T cells of the amino acid, thereby diminishing their function. "You have competition between tumor cells and T cells for methionine,” explained senior author Weiping Zou, MD, PhD, who is a Professor of Surgery, Pathology, Immunology and Biology at the University of Michigan in Ann Arbor. “The T cells also need it. If you starve the tumor cells of methionine, the T cells don't get it either. You want to selectively delete the methionine for the tumor cells and not for the T cells."

Supplementing with methionine restored T cell immunity in tumor-bearing mice and colon cancer patients. "There are still a lot of mechanistic details we have not worked out, particularly the detailed metabolic pathways of methionine metabolism,” Dr Zou remarked. “We also need to understand how metabolism pathways may be different from tumor cells and T cells. We hope to find a target that is relatively specific to tumor cells so that we do not harm the T cells but impact the tumor."

 
 
 

Green tea could hold the key to reducing antibiotic resistance

University of Surrey (UK), September23, 2020
 

Scientists at the University of Surrey have discovered that a natural antioxidant commonly found in green tea can help eliminate antibiotic resistant bacteria.

The study, published in the Journal of Medical Microbiology, found that epigallocatechin (EGCG) can restore the activity of aztreonam, an antibiotic commonly used to treat infections caused by the bacterial pathogen Pseudomonas aeruginosa.

P. aeruginosa is associated with serious respiratory tract and bloodstream infections and in recent years has become resistant to many major classes of antibiotics. Currently a combination of antibiotics is used to fight P. aeruginosa.

However, these infections are becoming increasingly difficult to treat, as resistance to last line antibiotics is being observed.

To assess the synergy of EGCG and aztreonam, researchers conducted in vitro tests to analyse how they interacted with the P. aeruginosa, individually and in combination. The Surrey team found that the combination of aztreonam and EGCG was significantly more effective at reducing P. aeruginosa numbers than either agent alone.

This synergistic activity was also confirmed in vivo using Galleria mellonella (Greater Wax Moth larvae), with survival rates being significantly higher in those treated with the combination than those treated with EGCG or aztreonam alone. Furthermore, minimal to no toxicity was observed in human skin cells and in Galleria mellonella larvae.

Researchers believe that in P. aeruginosa, EGCG may facilitate increased uptake of aztreonam by increasing permeability in the bacteria. Another potential mechanism is EGCG's interference with a biochemical pathway linked to antibiotic susceptibility.

Lead author Dr Jonathan Betts, Senior Research Fellow in the School of Veterinary Medicine at the University of Surrey, said:

"Antimicrobial resistance (AMR) is a serious threat to global public health. Without effective antibiotics, the success of medical treatments will be compromised. We urgently need to develop novel antibiotics in the fight against AMR. Natural products such as EGCG, used in combination with currently licenced antibiotics, may be a way of improving their effectiveness and clinically useful lifespan."

Professor Roberto La Ragione, Head of the Department of Pathology and Infectious Diseases in the School of Veterinary Medicine at the University of Surrey, said:

"The World Health Organisation has listed antibiotic resistant Pseudomonas aeruginosa as a critical threat to human health. We have shown that we can successfully eliminate such threats with the use of natural products, in combination with antibiotics already in use. Further development of these alternatives to antibiotics may allow them to be used in clinical settings in the future."

 

 

Research discovers links among poor sleep, high blood pressure, gut microbiome

University of Illinois, September 3, 2020

 

In the first study of its kind, University of Illinois Chicago researchers have found associations among disrupted sleep, elevated blood pressure and changes in the gut microbiome. 

The research aimed to determine whether a 28-day period of disrupted sleep changed the microbiota in rats. The gut microbiota refers to the collection of microorganisms living in the intestines. The researchers also sought to identify biological features associated with undesirable arterial blood pressure changes. 

The results were published in Physiological Genomics

Using rats, the researcher disrupted their sleep periods. Rats are nocturnal, so the experiments were designed to interfere with their daytime sleep periods. 

Telemetry transmitters measured the rats' brain activity, blood pressure and heart rate. Fecal matter also was analyzed to examine changes in the microbial content. 

The research idea was generated by several of the paper's authors who are or have been health care providers with night-shift schedules. 

"When rats had an abnormal sleep schedule, an increase in blood pressure developed -- the blood pressure remained elevated even when they could return to normal sleep. This suggests that dysfunctional sleep impairs the body for a sustained period," Maki said. 

Undesirable changes also were found in the gut microbiome -- the genetic material of all bacteria living in the colon. 

Contrary to her initial hypothesis, Maki found that the gut microbiome changes did not happen immediately, but instead took a week to show unfavorable responses such as an imbalance among different types of bacteria including an increase in microbes associated with inflammation. 

"When the sleep disruption stopped, everything did not come back to normal immediately," Maki said. "This research shows a very complex system with the presence of multiple pathological factors." 

This was initial research, and studies will continue to examine pathways involving the gut microbiome and metabolites produced by gut bacteria. The researchers will see exactly how sleep characteristics are changed and how long blood pressure and gut microbiome alterations persist. Researchers will then determine how this information translates to humans. 

"We hope to find an intervention that can help people who are at risk for cardiovascular disease because of their work and sleep schedules. People will always have responsibilities that interrupt their sleep. We want to be able to reduce their risk by targeting the microbiome with new therapies or dietary changes," Fink said.

The Gary Null Show - Our 5G Dystopian Future

The Gary Null Show - Our 5G Dystopian Future

September 4, 2020

Our 5G Dystopian Future

Richard Gale and Gary Null PhD

September 4, 2020

 

 

During the past two years, a large number of scientists, medical doctors and consumer activists have presented evidence, including testimony before Congress and state and city councils, that highlight the thousands of peer-reviewed studies showing the dangers of electromagnetic frequency (EMF) radiation on human health and the environment. This is not only true for the new 5G technologies being rolled out by the Trump administration and earlier by Obama, but also for earlier generations of the technology.  From brain cancers, to adversely affecting our immune systems, fertility, and neurological disorders, there is no safe use for any of these EMF devices nor Wifi.  The science behind 5G and its 4G predecessor is overwhelmingly negative. Nevertheless the media and its advertisers are 100 percent behind 5G and portray it as a wonderful technological advance that will improve our lives by enabling us to electronically connect with everything.  The New York Times is in a partnership with Verizon to be one of 5G’s leading sounding boards.  We are told we will be able to download videos, movies and internet content in a fraction of the time compared to 4G’s capabilities. Yet why would $6 trillion be spent to simply increase the speed of our computers and mobile phones?  Surely something else is afoot. 

Anyone who challenges 5G’s benefit-risk ratio is labeled irresponsible, ignorant and a conspiracy theorist.  Disparaging remarks against 5G are immediately cancelled on Google, Youtube and Facebook.  Due to the Clinton administration’s original telecommunications act, our local towns and communities are unable to prevent its installation despite the medical and scientific warnings. Amazon’s Jeff Bezos, Bill Gates and Elon Musk have been given the green light to place tens of thousands of satellites into orbit – exponentially more than, all previous launches since Explorer 1 in 1958. 

On Saturday August 29th, Robert Kennedy Jr stood before approximately 38,000 people in Berlin’s main square and briefly spoke about the dangers of 5G and the real agenda behind its rollout as the world remains in panic over Covid-19.  The crisis before us is clear. Governments are taking advantage of this pandemic, which Kennedy called “a pandemic crisis of convenience” to impose authoritarian control over their populations. This is certainly ALEC’s agenda and it found the perfect village idiot in Trump to do its bidding.  The 5g rollout, Kennedy said, has one purpose. It is for “surveillance 5G data harvesting” of all our personal information and the movements in our lives in order to inaugurate authoritarian regimes. The orchestrators of the destruction of our democratic institutions are the psychopathic billionaire elites such as Gates, Zuckerberg, Bezos and Musk. 

The upcoming presidential election offers us no choice. Both Trump and Biden are fully onboard the 5G train. The only fundamental difference is that Biden claims to favor net neutrality; however, how this can be accomplished under a 5G surveillance regime is anyone’s guess.  More likely it is more Democrat promises lacking critical thought and spineless to boot. 

For many it remains a mystery where Trump receives his guidance.  Is it simply the clanging of noises in his head, imaginary friends, or from individuals and groups who actually know something about what they are speaking and have a private and self-serving agenda contrary the public’s interest?  For the external guidance he receives about 5G, the source is clear.

Our current Regulation Demolition Chief in the White House has been perfectly in sync with the Koch Brothers-funded American Legislative Exchange Council’s (ALEC) playbook to overturn state and city regulations that may hinder the rapid deployment of 5G throughout the nation. 

ALEC’s corporate membership includes the commercial interests of major telecommunication associations such as CTIA (The Wireless Association), Charter Communications, the National Cable and Telecommunications Association (NCTA), and the Satellite Broadcasting and Communications Association. CTIA and NCTA are two of the largest associations promoting the Internet of Things that are publicly lobbying for ALEC’s telecommunication "model legislation." The largest behemoths for the 5G antennae and installation rollout -- AT&T, Cellpoint, Sprint, T-Mobile and Verizon – all hold membership in these associations. Back in early 2016, ALEC was already drafting legislation to “streamline” 5G’s necessary infrastructure to avoid violating city zoning laws.

No other administration since ALEC’s founding has been so packed with its representatives. Our early investigation, “Like it or Not, ALEC is Determined You Will Have 5G,” noted that the Trump administration is and has been stacked with ALEC operatives since day one.  Mike Pence, Nikki Haley, Rick Perry, Betsy DeVos, agriculture secretary Sonny Purdue, Ben Carson, Kellyanne Conway, Labor Secretary Alex Acosta and the head of Health and Human Services Alex Azar are all ALEC alumni or insiders.  This is an ALEC White House.  For example, ALEC's 45th year celebration was held at Trump's International Hotel in DC, a mile from the White House. ALEC's CEO Lisa Nelson expressed her elation that the administration "does have the potential to be an ALEC administration. It is full of the people and ideas we've advanced since 1973. Now is our time. And ALEC is ready."

During a White House Infrastructure and Technology briefing in April 2019, alongside his ALEC insider, FCC chairman Ajit Pai, Trump stated,

“Secure 5G networks will absolutely be a vital link to America’s prosperity and national security in the 21st century.
5G will be as much as 100 times faster than the current 4G cellular networks.  It will transform the way our citizens work, learn, communicate, and travel… Basically, it covers almost everything, when you get right down to it.  Pretty amazing.”

He touted the traditional ALEC agenda to assure 5G rollout, without proper health and environmental risk reviews, will be highly profitable for private industry by removing public oversight

 

“To accelerate and incentivize these investments, my administration is focused on freeing up as much wireless spectrum as needed — we’re going to free it up so they’ll be able to get out there and get it done — and removing regulatory barriers to the build out of networks…By next year, the United States is on pace to have more 5G spectrum than any other country in the world.”

The ALEC-controlled FCC has already “adopted new rules that will reduce federal regulatory impediments to deploying infrastructure needed for 5G and help to expand the reach of 5G for faster, more reliable wireless service.”  More egregious is that Trump is committed to preventng any nationalization of the 5G network and to keep it in the control of private industry. 

Ajit Pai is a former Verizon attorney and a long time ALEC associate. Back in 2013, Pai spokebefore ALEC's Communications and Technology Task Force to commend state efforts to roll back regulations in order to permit the Internet Protocol (IP) Transition -- Washington's term for the 5G technological revolution -- to unfold freely without obstacles from state and city governments. A wolf in sheep's wool, Pai is a committed free market globalist who favors solutions coming from market competition in the absence of government regulations and polices to protect the public. Therefore it came as no surprise that Pai appointed ALEC's director of the Telecommunication's Task Force, Jonathan Hausenschild, to the FCC's new Broadband Development Advisory Council in 2019. Reporting for TechDirt, Karl Bode notedthat ALEC has already helped "the broadband industry pass blatantly protectionist bills in more than 21 states that hamstrung or simply banned towns or cities from building their own networks, even in areas when private industry refuses to."

In the shadow of the pandemic panic, and a severe economic depression that is turning the public’s attention elsewhere, 5G’s installation pace is accelerating.  According to Android Central, AT&T, Verizon, T-Mobile and Sprint have already deployed 5G in hundreds of cities and counties across the nation. In addition there are efforts to transition to a digital currency that will hand over greater control over every person’s finances.  These efforts, aided by the advent of 5G are giving the government further control to monitor and punish behavior. Its long-term goal, Kennedy observed, is to indoctrinate the public into obedience. We are essentially surrendering our human rights for the sake of faster electronic devices. The payoff will be the demolition of democracy as we know it. 

As the average person views 5G has a marvelous enhancement to their lives, and the younger generation embrace it without any discernable forethought, we are about to enter an authoritative and dystopian era.  Echoes of Aldous Huxley’s soma and Orwell’s ministry of truth are already here.  And our mainstream media seems perfectly fine with that. 

The Gary Null Show - The Flu Shot Will Protect Us From Covid?  But Where is the Science? - 09.03.20

The Gary Null Show - The Flu Shot Will Protect Us From Covid? But Where is the Science? - 09.03.20

September 3, 2020

The Flu Shot Will Protect Us From Covid?  But Where is the Science?

 

Richard Gale and Gary Null

Progressive Radio Network, September 3, 2020

 

In the midst of the Covid-19 pandemic, states are making efforts through their legislatures to mandate the influenza vaccine for everyone. Several days ago, Massachusetts became the first state to mandate the shot for students, and other states such as New Jersey, New York and Vermont are in session to consider following suit.

Although there is absolutely no confirmatory evidence to even suggest that the flu vaccine can prevent or protect someone from Covid-19, health officials nevertheless are eager to push forward with this ridiculous strategy. Where is the actual science that is sufficiently rigorous to reach a consensual conclusion for this belief?  It doesn’t exist.  We might be reminded of historian Daniel Boorstin’s insightful realization in his book The Discoverers: “The greatest enemy of knowledge is not ignorance, it is the illusion of knowledge.”  This is the dilemma of delusional thinking that pervades the biological, medical and cognitive sciences rather than the hard sciences of physics, chemistry and mathematics. Whenever we are faced with proclamations from the medical establishment, and especially Bill Gates and the World Health Organization, when they advertise propaganda about safety and efficacy of many vaccines on the market, we must learn to take a step back and question their certainty.

Rather than charging forward with bogus assumptions, it would seem wiser to consider several studies that indicate that rather than protecting us from potential Covid-19 infection, the flu vaccine actually increases our susceptibility to other infectious respiratory illnesses, including coronavirus strains.

Sometimes our world has an unusual way of providing warnings that we have an opportunity to either heed or disregard to our benefit or detriment. The great physicist and Nobel laureate Niels Bohr called this synchronicity. On December 31, 2019 in order to usher in the New Year, China reported the first case of an "unusual pneumonia" in its port city of Wuhan. A week later on January 7th, the pathogen was identified as a novel strain of coronavirus.  That same month, the prestigious journal Vaccinepublished a study conducted by the Armed Forces Health Surveillance Branch at Wright Patterson Air Force Base. Researchers investigated viral interference due to receiving the flu shot; in other words, does the flu vaccine make a recipient more susceptible to other non-influenza respiratory viral infections? The study's conclusions state "Vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus." However this is not the first time that viral interference from the flu vaccine has been associated with an increase in non-influenza respiratory infections.

To date there is only one gold standard clinical trial with the flu vaccine that compares vaccinated vs. unvaccinated, and it is not good news for considering any possible legitimacy for even recommending a flu shot during this pandemic. This University of Hong Kong double-blind placebo controlled study followed the health conditions of vaccinated and unvaccinated children between the ages of 6-15 years for 272 days. The trial concluded the flu vaccine holds no health benefits. In fact, those vaccinated with the flu virus were observed to have a 550% higher risk of contracting non-flu virus respiratory infections. It was the dramatic number of incidences of non-influenza infections found in the flu-vaccinated group (105 cass, which included rhinovirus, coxsackie, echovirus AND coronavirus, as opposed to those who received a placebo. In other words, the results suggest that receiving the flu shot may increase one's risk of contracting another infectious virus such as Covid-19.

For some odd and strange reason, underlying the efforts to mandate the flu vaccine for all students is a false belief that Covid-19 poses a far greater lethal threat than influenza.  So where is the proof?  It doesn’t exist. In fact, childhood mortality from seasonal flu infections significantly outnumbers child and teen deaths from Covid-19, and the latter’s infection rate has lasted months longer than even a severe flu season.

As of the CDC’s latest Covid-19 statistics published on August 27, there have been 101 reported deaths among children and teens.  Oddly, back in March, Business Insider was reporting that the CDC was confirming 136 pediatric deaths which clearly contradicts the CDC’s own current statistics on its website. This is another indication of systemic incompetence and confusion that has gone viral throughout the federal agency.

So far in the year of corona the CDC has reported 174 childhood flu deaths. For the past 15 years, childhood flu deaths were higher in 9 of those years than Covid-19. During the 2018-2019 season, which was regarded as especially virulent, there were 179 deaths and 110 the year before. The H1N1 swine flu panic in 2009-2010 was the worse in several decades with 282 deaths. Yet there was no lockdown, school closures, or mandatory masks and social distancing in response to the swine flu. Consequently where is the sound scientific evidence to warrant the draconian measures being taken to presumably protect students from cross-infections?  It doesn’t exist. We have looked for firm and convincing medical evidence to even suggest that flu vaccines are a viable means to ward off Covid-19, and we can’t find it.

Earlier we reported how the CDC has re-categorizing influenza and pneumonia cases as Covid-19. In the same vein, how many deaths assigned to corornavirus may actually be caused by a flu strain? German public health expert Dr. Wolfgang Wodarg notes that it is "the well known fact that in every 'flu wave' 7-15% of acute respiratory illnesses (ARI) are coming along with coronaviruses." We still do not know COVID-19's pathogenetic role and impact compared to the common seasonal flu.

Instead of blindly mandating flu vaccination, our legislators and media need to be performing their due diligence to validate the CDC’s and Bill Gates’ rhetoric and spin about flu vaccines as a prophylactic to curb the spread of Covid-19. But even more important, they need to look at the volumes of studies indicating the flu vaccine’s lack of inefficacy to protect us from influenza and the vaccine’s terrible safety record and adverse effects.

Sitting on millions of flu shots to be administered and handicapped with a past history of flu vaccines' feeble viral protection, and more Americans realizing the vaccine is either a sham or something not to be bothered with, the CDC and FDA are desperately pulling all of their stops to motivate people and their families to rush to their local WalMart, Costco or pharmacy to get inoculated.

At their best, flu vaccines remain around 50-60% effective according to official health statements. However, the World Health Organization’s predictions for 2014-2015 flu strains were a bust. The match was such a failure that the CDC was forced to warn the American public that the vaccine was only 23% effective.  The 2017-2018 seasonal vaccine was another bomb. Although the CDC claimed the vaccine was 40 percent effective, an independent study at Rice University in Houston determined only a 19 percent efficacy, and they estimated a 20 percent efficacy for the prior season. Given the frequent ineffectiveness of seasonal flu vaccines, especially for the 65 years-plus age group, predictive methodologies to determine which flu strains emerge during any given influenza season have more in common with medieval divination than sound science.

Another less discussed finding about dismal flu vaccine efficacy was determined at Kaiser Permanente Northern California last year. Reviewing 45,000 medical records of patients tested positive for influenza, researchers charted a trend that indicates that the "risk of contracting the flu climbs about 16 percent for every 28 days after vaccination. Therefore, if the particular season's vaccine is a dud to begin with, immune protection could potentially wane within a month in some patients.

In a study by Dr. Danuta Skowronski in Canada, individuals with a history of receiving consecutive seasonal flu shots over several years had an increased risk of becoming infected with H1N1 swine flu.  Skowronski commented on his findings that “policy makers have not yet had a chance to fully digest them [the study’s conclusions] or understand the implications.”  He continued, “Who knows, frankly? The wise man knows he knows nothing when it comes to influenza, so you always have to be cautious in speculating.”

According to Dr. Tom Jefferson formerly at the Cochrane Collaboration, it makes little sense to keep vaccinating against seasonal influenza based on the evidence. Jefferson has also endorsed more cost-effective and scientifically-proven means of minimizing the transmission of flu, including regular hand washing and wearing masks. There is also substantial peer-reviewed literature supporting the supplementation of Vitamin D.

Dr. Sherri Tenpenny reviewed the Cochrane Database reviews on the flu vaccine’s efficacy. In a review of 51 studies involving over 294,000 children, there was “no evidence that injecting children 6-24 months of age with a flu shot was any more effective than a placebo. In children over 2 years of age, flu vaccine effectiveness was 33 percent of the time preventing flu. In children with asthma, inactivated flu vaccine did not prevent influenza related hospitalizations in children. The database shows that children who received the flu vaccine were at a higher risk of hospitalization than children who did not receive the vaccine.[1]

In a separate study involving 400 children with asthma receiving a flu vaccine and 400 who were not immunized, there was no difference in the number of clinic and emergency room visits and hospitalizations between the two groups.[2]

During every annual quarter, the CDC’s Advisory Commission on Childhood Vaccines meets, and the Department of Justice releases its report on settlements made for vaccine injuries and deaths. In recent years, the flu vaccine has topped the charts. It bears noting that the CDC itself admits that only 10% of vaccine adverse effects go reported. However, independent analysis from Harvard University indicates it may be as small as 1-2% at best.

For almost a decade, the CDC has known influenza vaccines are ineffective and life-threatening for the elderly but continues to market them without hesitation. The good news is that Americans are rapidly losing confidence in the CDC. The panic being orchestrated by the CDC’s inept response to Covid-19 should convince everyone that the agency is no longer serving public interests.

Imagine the tens of thousands of children and families who would have been saved from life-long neurological damage and immeasurable suffering if the CDC was not indebted to protecting the toxic products of the pharmaceutical industry and was serving the health and well-being of American children? And we can begin to further dismantle this citadel of despotic medical fascism by simply refusing the flu vaccine and protecting ourselves by adopting a healthier lifestyle during the flu season.

 

NOTES

 

[1] 105th International Conference of the American Thoracic Sociey, May 15-20, 2009 (quoted in , Sherri.  “The Truth about Flu Shots”.  Idaho Observer, June 1, 2009)

 

The Gary Null Show - 09.02.20
The Gary Null Show - Wikipedia: Dumb and Dumber About Fluoridation - 09.01.20

The Gary Null Show - Wikipedia: Dumb and Dumber About Fluoridation - 09.01.20

September 1, 2020

Wikipedia: Dumb and Dumber About Fluoridation

 

Richard Gale & Gary Null PhD

Progressive Radio Network, September 1, 2020

In the satirical black comedy film Dr. Strangelove there is the iconic scene when the rogue general Jack D Ripper, played by Sterling Hayden, tells Peter Sellers character, “Ever hear of the fluoridation of water? Do you realize that fluoridation is the most monstrously conceived and dangerous Communist plot we ever had to face?”

From that day until now, the entire pharmaceutical industry, public health officials and the mainstream media have assumed that fluoride is absolutely safe, and anyone who dares to criticize water fluoridation and its dental use is a loon or conspiracy theorist who threatens national health.   Yet, as with so many medical and health challenges we face, the dominant consensus is wrong. The large body of evidence to support anti-fluoridation advocacy is substantial and continues to grow. In fact, throughout the US and other nations, concerned citizens, consumer activists and whistleblowers are putting pressure on state and local governments and public utilities to cease and desist in spiking our drinking water with fluoride.

Recently, the pushback against decades of lies, misinformation and media propaganda to seduce into accepting corporate and government sponsored junk research supporting fluoridation is reaching a tipping point towards public safety.  Earlier this year, an alliance of public health organizations and watch groups filed suit against the Environmental Protection Agency in a federal court trial to bring an end to fluoridation once and for all. In a more recent ruling the judge has permitted the suit, represented by two distinguished attorneys – Robert F Kennedy Jr and Michel Connett -- to continue given “the merits in light of the substantial scientific evidence proffered at trial.”  And earlier this past August, researchers at Mount Sinai School of Medicine announced their findings that low-level chronic exposure to fluoride in drinking water induces adverse changes in kidney and liver function in young people. The evidence against fluoride continues to pile up.

The CDC’s and EPA’s farce has earned a powerful voice. Wikipedia is a staunch defender of water fluoridation and promoter of this toxic propaganda. Parroting the statements of arch-Skeptic Stephen Barrett, Wikipedia’s editors sacrifice reams of scientific data to push the scientifically-debunked theories of those who would put this proven neurotoxin into every reservoir and public water utility thereby exposing generation after generation to a drug whose harms are well established yet still vehemently suppressed.

Wikipedia’s quick summary description of sodium fluoride merely states that it is “used to prevent cavities” and that it is the 215th most prescribed medication in the US. This benevolent description is posted without any context and stated as a matter-of-fact commandment that orally-consumed fluoride has no proven effect on dental health aside from causing dental fluorosis, an unsightly mottling of the teeth. Studies that suggest this can be a sign of fluoride-induced brain damage are ignored. Also missing are the scientific warnings about fluoride’s detrimental effects on nearly every system of the human body, which have been repeatedly studied and confirmed.

Under the heading “Dental Caries,” Wikipedia repeats the faulty wisdom about how fluoride is supposed to work to enhance the formation of fluorapatite, a component of tooth enamel. It does not mention that studies have shown that this fluorapatite layer is just six nanometers thick, less than 1/10000th the width of a strand of hair and therefore unlikely to have much of an impact strengthening or re-mineralizing teeth.

To its credit, Wikipedia does admit – without explaining the implications – that sodium fluoride is rarely used in the US for fluoridating water. Instead, hexafluorosilicic acid and sodium hexafluorosilicate, toxic byproducts of phosphate fertilizer and aluminum manufacturing, are used. Wikipedia does not discuss the industrial origins of these compounds (called silicofluorides or SiFs) nor their toxicity – both are deemed industrial pollutants if released into the air via factory smokestacks or into the environment via drainpipes. Yet when deliberately added to drinking water they are classified as benevolent. Nor does Wikipedia mention that these fluoride compounds have never been approved or even tested by the FDA for safety. Nor are we informed that studies have shown that SiFs can double or even triple the rate of lead uptake into children’s bloodstreams by only citing a single study to discredit this “hypothesis.”

Adding SiFs to drinking water lowers its pH, rendering it more corrosive and thus more likely to leach lead and other contaminants as it flows through pipes. But even when a neutralizing agent is added, SiFs’ “unique affinity for lead” leach even tiny amounts of the metal from any lead-containing pipe or fixture through which treated water flows. Used in combination with chlorine and chloramine, common disinfectants added to drinking water, the rate of lead uptake from SiF-treated water is off the charts. SiFs and lead have a synergistic effect, meaning consuming both is significantly more damaging to brain tissue than consuming either alone, wreaking particular havoc in the hippocampus, the area responsible for learning and memory, and causing a marked decline in IQ.

Even Wikipedia can’t deny that lead exposure causes brain damage, although its entry for lead poisoning fails to mention the correlation between lead exposure in children and criminal behavior, lumping it under the vague rubric of “behavioral problems” instead. So how is it that Wikipedia gives SiFs a certificate of safety? Nowhere in the article on hexafluorosilicic acid are the safety risks even mentioned, aside from a single sentence about the dangers of inhaling its vapors. In fact, the article has more to say about hexafluorosilicic acid's effects on “glass and stoneware” than on the human body!

Wikipedia briefly notes the negative effects of fluoride overexposure, though it is careful not to suggest that such overexposure can occur merely by drinking tap water. It references “the higher doses used to treat osteoporosis” after acknowledging earlier in the article that fluoride is utterly ineffective at treating osteoporosis, mentioning “pain in the legs” and “incomplete stress fractures when the doses are too high” (no comment on why a substance that causes stress fractures would be used to treat a bone-weakening disease like osteoporosis), as well as stomach irritation.

According to Wikipedia, the only “clear adverse effect” of water fluoridation is dental fluorosis! Hundreds of scientific studies would beg to differ. In 2018 alone over a dozen studies pointing to this toxic substance’s detrimental effects have been published, only to be ignored by the mainstream media and barred from addition to Wikipedia. A Mexican study published in Toxicology and Applied Pharmacology concluded “Fluoride could be considered an environmental kidney toxicant” after studying populations exposed to both fluoride and arsenic in drinking water. At least Wikipedia admits arsenic is poisonous! But it is ironic that arsenic was found to have a less nephrotoxic effect than fluoride. A Kenyan study published in the American Journal of Medicine and Medical Sciences reported that auditory working memory significantly declined as fluoride concentration in drinking water increased, confirming the results of an earlier systematic review showing lower IQ in children in high-fluoride areas. These effects were observed at concentrations as low as 0.5 mg/L – the low end of the scale recommended by the World Health Organization, which recommends fluoridation at concentrations as high as 1.5 mg/L. Another Mexican study found prenatal fluoride exposure positively correlated to ADHD symptoms in children as much as 12 years later, “consistent with the growing body of evidence suggesting neurotoxicity of early-life exposure to fluoride.” A pair of Polish studies published in the International Journal of Molecular Sciences and the International Journal of Environmental Research and Public Health observed strong evidence for fluoride's role in triggering and progressing Alzheimer’s disease and other dementias, given the substance’s role in oxidative stress and inflammation.

Fluoride’s toxicity extends from the skeletal system, through the endocrine system, reproductive system, and neurological system, but none of these myriad effects are discussed in Wikipedia. Decades of solid scientific research are memory-holed with the blanket statement that there is “no clear evidence”. Wikipedia even claims there have been only three reported cases of fluoride toxicity associated with toothpaste ingestion, when in fact there are over 23,000 reports of toothpaste-related fluoride poisoning annually. This represents hundreds of emergency rooms visits for fluoride poisoning at substantial and unnecessary medical cost.

There’s a sound reason why so few of these kinds of studies are conducted in the heavily-fluoridated US and find their way into Wikipedia.  One study published in Medical Hypotheses touched on this discrepancy, finding organizational bias “can and does compromise the integrity of fluoride research.” The only logical explanation for how so many studies have found evidence of neurotoxicity and toxicity in other tissues – even sky-high rates of dental fluorosis, despite the prevailing wisdom that fluoridation is that it is “good for teeth.” Nevertheless this practice persists and the American Dental Association fully endorses this charade. The Orthomolecular Medicine News Service reported that the CDC’s public relations make the dubious claim that for every dollar invested in fluoridation, $38 are saved in dental costs. In fact, the actual analysis indicates that the best case scenario is a $3 savings, which is rapidly “eliminated by the estimated cost of treating dental fluorosis.”

Ever since Harvard University researcher Philippe Grandjean first added fluoride to a list of developmental neurotoxicants considered especially harmful to the developing brain in a 2014 paper published in The Lancet, our health officials have suffered from institutionalized cognitive dissonance by categorically denying fluoride-induced illness. As more papers identifying the adverse risks of environmental toxins, including fluoride, are added to the list of chemicals most damaging to human development, Dr. Grandjean and his colleagues have called for the formation of an international clearinghouse to coordinate research into the neurotoxicants and their role in the rising global prevalence of neurodevelopmental disabilities. Sadly, such an urgent endeavor would likely be completely ignored by the US's federal health and environmental authorities.

In the meantime, Wikipedia is firmly lodged in this carry-over of scientific-naivety that was the public rage in the 1950s, when fluoride was the magic ingredient for whiter teeth, DDT would keep the bugs away, and humanity would be saved by our friend the atomic bomb.

Podbean App

Play this podcast on Podbean App